
<html lang="en"     class="pb-page"  data-request-id="e37a1df0-af61-4b2e-a47a-7acadcaaf665"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01300;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2018.61.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity" /></meta><meta name="dc.Creator" content="Baoli  Li" /></meta><meta name="dc.Creator" content="Shuaishuai  Ni" /></meta><meta name="dc.Creator" content="Fei  Mao" /></meta><meta name="dc.Creator" content="Feifei  Chen" /></meta><meta name="dc.Creator" content="Yifu  Liu" /></meta><meta name="dc.Creator" content="Hanwen  Wei" /></meta><meta name="dc.Creator" content="Wenhua  Chen" /></meta><meta name="dc.Creator" content="Jin  Zhu" /></meta><meta name="dc.Creator" content="Lefu  Lan" /></meta><meta name="dc.Creator" content="Jian  Li" /></meta><meta name="dc.Description" content="CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections. More than 100 new compounds were synthesized, which target the overwhelming t..." /></meta><meta name="Description" content="CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections. More than 100 new compounds were synthesized, which target the overwhelming t..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 28, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01300" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01300" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01300" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01300" /></link>
        
    
    

<title>Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01300" /></meta><meta property="og:title" content="Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0027.jpeg" /></meta><meta property="og:description" content="CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections. More than 100 new compounds were synthesized, which target the overwhelming the defects of the CrtN inhibitor 1. Analogues 23a and 23b demonstrated a significant activity against pigmented S. aureus Newman and 13 MRSA strains (IC50 = 0.02–10.5 nM), along with lower hERG inhibition (IC50 &gt; 30 μM, ∼10-fold decrease in comparison with 1). Furthermore, 23a and 23b were confirmed to reduce the staphylococcal load in the kidney and heart in a mouse model with normal treatment deeper than pretreatment ones, comparable even with vancomycin and linezolid. Remarkably, 23a could strongly block the pigment biosynthesis of these nine multidrug-resistant MRSA strains, including excellent activity against LRSA strains and VISA strains in vivo, and all of which demonstrated that 23a has a huge potential against intractable MRSA, VISA, and LRSA issues as a therapeutic drug." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01300"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01300">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01300&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01300&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01300&amp;href=/doi/10.1021/acs.jmedchem.7b01300" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 224-250</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01279" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01323" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Baoli++Li">Baoli Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shuaishuai++Ni">Shuaishuai Ni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fei++Mao">Fei Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feifei++Chen">Feifei Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7251-1956" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yifu++Liu">Yifu Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hanwen++Wei">Hanwen Wei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wenhua++Chen">Wenhua Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Zhu">Jin Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3934-0312" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lefu++Lan">Lefu Lan</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-5551-5496" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Li">Jian Li</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c8a4a4a9a688bba1a5a5e6a9abe6aba6"><span class="__cf_email__" data-cfemail="412d2d202f0132282c2c6f20226f222f">[email protected]</span></a>. Phone: +86-21-50803109.</div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e2888b838c8e8ba28781979196cc878697cc818c"><span class="__cf_email__" data-cfemail="a0cac9c1ceccc9e0c5c3d5d3d48ec5c4d58ec3ce">[email protected]</span></a>. Phone: +86-21-64252584. Fax: +86-21-64252584.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01300&amp;href=/doi/10.1021%2Facs.jmedchem.7b01300" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 224–250</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 15, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 August 2017</li><li><span class="item_label"><b>Published</b> online</span>28 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 January 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01300" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01300</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D224%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBaoli%2BLi%252C%2BShuaishuai%2BNi%252C%2BFei%2BMao%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D1%26contentID%3Dacs.jmedchem.7b01300%26title%3DNovel%2BTerminal%2BBipheny-Based%2BDiapophytoene%2BDesaturases%2B%2528CrtN%2529%2BInhibitors%2Bas%2BAnti-MRSA%252FVISR%252FLRSA%2BAgents%2Bwith%2BReduced%2BhERG%2BActivity%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D250%26publicationDate%3DJanuary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01300"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1771</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01300" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Baoli&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Shuaishuai&quot;,&quot;last_name&quot;:&quot;Ni&quot;},{&quot;first_name&quot;:&quot;Fei&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Feifei&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Yifu&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Hanwen&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Wenhua&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Lefu&quot;,&quot;last_name&quot;:&quot;Lan&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Li&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;28&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;224-250&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01300&quot;},&quot;abstract&quot;:&quot;CrtN has been identified as an attractive and druggable target for treating pigmented Staphylococcus aureus infections. More than 100 new compounds were synthesized, which target the overwhelming the defects of the CrtN inhibitor 1. Analogues 23a and 23b demonstrated a significant activity against pigmented S. aureus Newman and 13 MRSA strains (IC50 = 0.02–10.5 nM), along with lower hERG inhibition (IC50 &gt; 30 μM, ∼10-fold decrease in comparison with 1). Furthermore, 23a and 23b were confirmed to reduce the staphylococcal load in the kidney and heart in a mouse model with normal treatment deeper than pretreatment ones, comparable even with vancomycin and linezolid. Remarkably, 23a could strongly block the pigment biosynthesis of these nine multidrug-resistant MRSA strains, including excellent activity against LRSA strains and VISA strains in vivo, and all of which demonstrated that 23a has a huge potential against intractable MRSA, VISA, and LRSA issues as a therapeutic drug.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01300&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01300" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01300&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01300" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01300&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01300" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01300&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01300&amp;href=/doi/10.1021/acs.jmedchem.7b01300" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01300" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01300" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01300%26sid%3Dliteratum%253Aachs%26pmid%3D29243920%26genre%3Darticle%26aulast%3DLi%26date%3D2018%26atitle%3DNovel%2BTerminal%2BBipheny-Based%2BDiapophytoene%2BDesaturases%2B%2528CrtN%2529%2BInhibitors%2Bas%2BAnti-MRSA%252FVISR%252FLRSA%2BAgents%2Bwith%2BReduced%2BhERG%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D1%26spage%3D224%26epage%3D250%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291685" title="Dyes and pigments">Dyes and pigments</a>,</li><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291214" title="Bacteria">Bacteria</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/jmcmar.2018.61.issue-1/20180111/jmcmar.2018.61.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">CrtN has been identified as an attractive and druggable target for treating pigmented <i>Staphylococcus aureus</i> infections. More than 100 new compounds were synthesized, which target the overwhelming the defects of the CrtN inhibitor <b>1</b>. Analogues <b>23a</b> and <b>23b</b> demonstrated a significant activity against pigmented <i>S. aureus</i> Newman and 13 MRSA strains (IC<sub>50</sub> = 0.02–10.5 nM), along with lower hERG inhibition (IC<sub>50</sub> > 30 μM, ∼10-fold decrease in comparison with <b>1</b>). Furthermore, <b>23a</b> and <b>23b</b> were confirmed to reduce the staphylococcal load in the kidney and heart in a mouse model with normal treatment deeper than pretreatment ones, comparable even with vancomycin and linezolid. Remarkably, <b>23a</b> could strongly block the pigment biosynthesis of these nine multidrug-resistant MRSA strains, including excellent activity against LRSA strains and VISA strains in vivo, and all of which demonstrated that <b>23a</b> has a huge potential against intractable MRSA, VISA, and LRSA issues as a therapeutic drug.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><i>Staphylococcus aureus</i> (<i>S. aureus</i>), a major human pathogen, causes serious skin and soft tissues infections,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> respiratory disease. and more serious illnesses like pneumonia, endocarditis, and sepsis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Infections caused by <i>S. aureus</i> has gained growing concern worldwide due to its capability for the rapid development of drug resistance induced by antibiotic misuse.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Resistance to antibiotics represents one of the most pressing challenges to the infectious disease community.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a> Increasing rates of infectious diseases caused by different methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) strains have resulted in a high infiltration of hospital and community settings.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11">(7-11)</a> Antibiotics that are approved for treatment of MRSA infections includevancomycin (VAN, glycopeptide antibiotic), linezolid (LZD, oxazolidinone antibiotic), daptomycin (lipopeptide antibiotic), dalbavancin (lipoglycopeptide antibiotic), oritavancin (glycopeptide antibiotic), ceftaroline (β-lactam antibiotic), and tedizolid (anoxazolidinone antibiotic). The appearance of VAN-intermediate resistance MRSA (VISA/MRSA)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and LZD-resistant MRSA (LRSA/MRSA) has especially left patients vulnerable. Recently, a report from the U.S. Centers for Disease Control and Prevention (CDC) stated that more than 2 million people have suffered from MRSA infections, and 23 000 people have died directly due to these infections.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> A great importance has been attached by governments and organizations worldwide, including the ND4BB project initiated by the European Union<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and National Efforts by the United States.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> On 27 February 2017, the World Health Organization (WHO) released its first list of the world’s deadliest superbugs, a catalog of 12 families of bacteria. The treatment of MRSA (VISA or LRSA) is urgent at high priority tiers.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21">(16-21)</a></div><div class="NLM_p">Antivirulence strategies aiming at “disarming” the pathogen rather than inhibiting growth with weak selective pressure for the development of antibiotic resistance are now gaining interest.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Staphyloxanthin (STX) is an important virulence factor for pigmented <i>S. aureus.</i> Nonpigmented <i>S. aureus</i> is susceptible to be killed by reactive oxygen species. Hence, blocking STX biosynthesis is an underlying magnetically therapeutic target against all pigmented MRSA.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> STX biosynthesis begins with the condensation of farnesyl diphosphate followed by a series of catalytic reactions of important enzymes (CrtM, CrtN, etc.). In 2008, Eric Oldfield and co-workers reported a CrtM inhibitor (BPH-652), which was introduced in our previous work,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and based on this work, several types of CrtM inhibitors have been identified by the same group; BPH-652 was selected for these experiments because it had a good IC<sub>50</sub> in pigment inhibition (110 nM).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The same group continued to develop a series of CrtM inhibitors (published in 2009), and the most active compounds are halogen-substituted phosphonosulfonates, with <i>K</i>i values as low as 5 nM against the enzyme and IC<sub>50</sub> values for STX inhibition in <i>S. aureus</i> as low as 11 nM.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Furthermore, in 2012, Fuyang Lin and co-workers reported X-ray crystallographic structures of three inhibitors bound to CrtM, and their results provided structural clues for the mechanism and inhibition of the head-to-head prenyl transferases.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">In our previous work, we demonstrated that the enzyme CrtN is an attractive and druggable target for fighting pigmented <i>S. aureus</i> infections<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and that a potent CrtN inhibitor <b>1</b> (<b>5m</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), which could inhibit the STX biosynthesis of <i>S. aureus</i> Newman and three MRSA strains, sensitizes four strains to immune clearance and effectively attenuates the virulence of three strains in vivo. However, prophylactic administration (24 h before infection) with high-dosage treatment (200 mg/kg) of <b>1</b>, along with the high hERG inhibition (IC<sub>50</sub> = 3.71 μM), was impractical for clinical applications.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0024.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical modification strategies and purpose for lead compound <b>1</b> and pigment inhibition activities of analogues <b>2a</b>–<b>j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In this study, we synthesized a series of CrtN inhibitors with new scaffolds, which not only demonstrated an excellent activity against MRSA in in vitro and in vivo at a lower dosage but also overcame the disadvantages of hERG inhibition. Linezolid and vancomycin, the last-resort antimicrobial agents, were introduced as positive control drugs into a murine model of <i>S. aureus</i> abscess formation to evaluate the effectiveness of our new analogues.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Design and Chemistry</h3><div class="NLM_p">In previous work, the varied scaffold and series of different substituents about benzofuran-derived CrtN inhibitors were not enough to investigate the relationship of structure and activity comprehensively. In this study, to further improve the affinity of the lead compound <b>1</b> and obtain novel structural scaffolds, chemical modifications were performed in four cycles. First, in region A (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), we first explored different heteroaromatic rings and the related positions of substitutions (in region A) to generate novel scaffold compounds <b>2a</b>–<b>j</b>. In general, we observed that pigment inhibition varied greatly by the scaffold hopping, and compound <b>2b</b> revealed the strongest efficiency among these derivatives, which was enough for a further modification study. Additionally, considering the structural diversity, compound <b>2j</b>, the second-best scaffold, was also identified as the lead compound. Then, we replaced the <i>N</i>-methyl group of either <b>2b</b> or <b>2j</b> in region B (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) with various steric alkyl groups (including hydrogen atom), and 6 analogues (<b>3a</b>–<b>f</b>) were designed (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Subsequently, we incorporated different substituted phenyls, furanyl, naphthalenyls, and (cyclo)alkyls at the section C of either <b>2b</b> or <b>2j</b>, and 74 analogues (<b>4a</b>–<b>40a</b> and <b>4b</b>–<b>40b</b>) were further designed (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In addition, 10 analogues (<b>41a</b>–<b>45a</b> and <b>41b</b>–<b>45b</b>, <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) were prepared to evaluate whether the various linkers (allyl in region D) affected the pigment inhibitory activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Chemical Structures of Derivatives <b>3a</b>–<b>f</b> and Their Pigment Inhibitory Activities against <i>S. aureus</i> Newman</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0016.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0017.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The values given are the IC<sub>50</sub> values for pigment inhibition in <i>S. aureus</i> Newman. The values are reported as the average ± SD.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and Pigment Inhibition Activities of the Analogues of Compounds <b>4a</b>–<b>40a</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0018.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0019.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">The values given are the IC<sub>50</sub> values for pigment inhibition in <i>S. aureus</i> Newman. The values are reported as the average ± SD.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structures and Pigment Inhibition Activities of the Analogues of Compounds <b>4b</b>–<b>40b</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0020.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0021.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">The values given are the IC<sub>50</sub> values for pigment inhibition in <i>S. aureus</i> Newman. The values are reported as the average ± SD.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structures and Pigment Inhibition Activities of the Analogues of Compounds <b>41a</b>–<b>45a</b> and <b>41b</b>–<b>45b</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0022.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0023.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">The values given are the IC<sub>50</sub> values for pigment inhibition in <i>S. aureus</i> Newman. The values are reported as the average ± SD.</p></div></div><div></div></div><div class="NLM_p">The synthesis routes of derivatives <b>2a</b>–<b>d</b> and <b>5a</b>–<b>40a</b> were outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Intermediate <b>47</b> could be synthesized from the commercial indole derivative <b>46b</b> via reductive amination and was further coupled with <i>trans</i>-4-fluorocinnamaldehyde by the reductive amination to afford the target analogue <b>3a</b>. Replacing the methyl with an ethyl group or isopropyl group afforded target analogues <b>3b</b> and <b>3c</b>. In parallel, <b>46a</b> and <b>46b</b> were suffered with methylamine under the reaction of reductive amination to yield intermediates <b>48a</b>–<b>b</b>. Various substituted acraldehydes were reduced by sodium borohydride and accompanied by the bromination reaction for obtaining the intermediates <b>49a</b>–<b>z</b> and <b>50a</b>–<b>k</b>. Finally, the nucleophilic reactions of compounds <b>51a</b>–<b>z</b> and <b>52a</b>–<b>k</b> with <b>48a</b> and <b>48b</b> yielded target analogues <b>2a</b>–<b>d</b> and <b>5a</b>–<b>40a</b>. Meanwhile, derivatives <b>2e</b>–<b>j</b>, <b>3d</b>–<b>f</b>, and <b>5b</b>–<b>40b</b> were prepared as described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, and synthesis of these derivatives corresponded closely to <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Derivatives <b>2a</b>–<b>d</b> and <b>5a</b>–<b>40a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ammonia in THF, DCM, NaBH(OAc)<sub>3</sub>, rt, 2 h, 30%; (b) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 43–85%, (2) bubbled into hydrogen chloride gas; (c) iodoethane or 2-iodopropane, NaH, DMF 0 °C to rt, overnight, under N<sub>2</sub>, 50%; (d) methylamine, MeOH, NaBH<sub>4</sub>, rt, 0 °C, 10 min, 55%; (e) NaBH<sub>4</sub>, methanol, 0 °C, 30 min; (f) phosphorus tribromide, diethyl ether, 0 °C to rt, overnight, under N<sub>2</sub>, 57–84% (2 steps); (g) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 43–85%, (2) bubbled into hydrogen chloride gas.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Derivatives <b>2e</b>–<b>j</b>, <b>3d</b>–<b>f</b>, and <b>5b</b>–<b>40b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ammonia in THF, DCM, NaBH(OAc)<sub>3</sub>, rt, 2 h, 30%; (b) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 43–85%, (2) bubbled into hydrogen chloride gas; (c) iodoethane or 2-iodopropane, NaH, DMF 0 °C to rt, overnight, under N<sub>2</sub>, 50%; (d) methylamine, MeOH, NaBH<sub>4</sub>, rt, 0 °C, 10 min, 55%; (e) NaBH<sub>4</sub>, methanol, 0 °C, 30 min; (f) phosphorus tribromide, diethyl ether, 0 °C to rt, overnight, under N<sub>2</sub>, 57–84% (2 steps); (g) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 43–85%, (2) bubbled into hydrogen chloride gas.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> outlines the synthesis strategy for the synthesis of derivatives <b>41a</b> and <b>41b</b>. The coupling of commercially obtained 4-iodo-1,1′-biphenyl and <i>tert</i>-butyldimethyl(prop-2-yn-1-yloxy)silane gave <b>56</b>, which was reduced by TBAF to give <b>57</b>, and was further brominated by PBr<sub>3</sub> to give intermediate <b>58</b>. The coupling of intermediate <b>58</b> with either <b>48b</b> or <b>55f</b> yielded analogues <b>41a</b> and <b>41b</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0011.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Derivatives <b>41a</b> and <b>41b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, TEA, 90 °C; (b) TBAF/THF; (c) PBr<sub>3</sub>, Et<sub>2</sub>O; (d) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 41–45%, (2) bubbled into hydrogen chloride gas.</p></p></figure><div class="NLM_p">Derivatives <b>42a</b> and <b>42b</b> were prepared as described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. <b>49t</b> was reduced by sodium borohydride, followed by bromination to give intermediate <b>60</b>. The nucleophilic substitution of intermediate <b>60</b> with <b>48b</b> or <b>55f</b> yielded analogues <b>42a</b> and <b>42b</b></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0012.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of Derivatives <b>42a</b> and <b>42b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, MeOH; (b) PBr<sub>3</sub>, CCl<sub>4</sub>, reflux, 4 h; (c) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 25–35%, (2) bubbled into hydrogen chloride gas.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a> outlines the synthesis strategy for the synthesis of derivatives <b>43a</b> and <b>43b</b>. By the Wittig–Horner olefination, <b>61</b> was yielded from [1,1′-biphenyl]-4-carbaldehyde, and then through reduction and bromination, intermediate <b>63</b> was generated. The nucleophilic substitution of intermediate <b>63</b> with <b>48b</b> or <b>55f</b> yielded analogues <b>43a</b> and <b>43b</b>.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0013.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Derivatives <b>43a</b> and <b>43b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl 2-(triphenyl-l5-phosphanylidene)propanoate, toluene, 100 °C; (b) DIABL-H, DCM, 0 °C; (c) PBr<sub>3</sub>, Et<sub>2</sub>O; (d) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 41–55%, (2) bubbled into hydrogen chloride gas.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a> outlines the synthesis strategy used for the synthesis of derivatives <b>44a</b> and <b>44b</b>. Through Wittig–Horner olefination, intermediate <b>64</b> was yielded from [1,1′-biphenyl]-4-carbaldehyde, and then through reduction and bromination, intermediate <b>66</b> was generated. The nucleophilic substitution of intermediate <b>66</b> with <b>48b</b> or <b>55f</b> yielded analogues <b>44a</b> and <b>44b</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0014.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Syntheses of Derivatives <b>44a</b> and <b>44b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a)(1) (2-carboxyethyl)triphenylphosphonium, NaH in THF/DMSO, (2) EtOH/H<sub>2</sub>SO<sub>4</sub>; (b) DIABL-H, DCM, 0 °C; (c) CBr<sub>4</sub>, PPh<sub>3</sub>, DCM; (d) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, (2) bubbled into hydrogen chloride gas.</p></p></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>, by the Wittig–Horner olefination, intermediate <b>67</b> was yielded from (<i>E</i>)-3-([1,1′-biphenyl]-4-yl)acrylaldehyde, followed by reduction of the ethyl ester and bromination reaction to generate <b>69</b>. The nucleophilic substitution of compound <b>69</b> with <b>48b</b> or <b>55f</b> yielded analogues <b>45a</b> and <b>45b</b>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Syntheses of Derivatives <b>45a</b> and <b>45b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl 2-(triphenyl-l5-phosphanylidene)acetate, toluene, 100 °C; (b) DIABL-H, DCM, 0 °C; (c) PBr<sub>3</sub>, Et<sub>2</sub>O; (d) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 28–37%, (2) bubbled into hydrogen chloride gas.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84812" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84812" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In total, 100 novel derivatives (<b>2a</b>–<b>j</b>, <b>3a</b>–<b>f</b>, <b>4a</b>–<b>45a</b>, and <b>4b</b>–<b>45b</b>) were designed and synthesized. Their chemical structures are shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. The details of the synthesis procedures and structural characterization are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf" class="ext-link">Supporting Information</a>. All derivatives were confirmed to have ≥95% purity and were identified with non-PAINS on the web at <a href="http://fafdrugs3.mti.univparis-diderot.fr/" class="extLink">http://fafdrugs3.mti.univparis-diderot.fr/</a> recommended by editors from the ACS (American Chemical Society).</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vitro Pigment Inhibitory Activities against <i>S. aureus</i> Newman</h3><div class="NLM_p">These synthesized compounds were evaluated for pigment inhibitory activities against <i>S. aureus</i> Newman, and the results are shown in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. We replaced the <i>N</i>-methyl group with various steric alkyl groups (including hydrogen), and 6 analogues (<b>3a</b>–<b>f</b>) were designed (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). As shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, in the respect of the substituents with various alkyl groups at <i>N</i> atom (including hydrogen atom, <b>2b</b>, <b>2j</b>, <b>3a</b>–<b>f</b>), compounds with a <i>N</i>-methyl group exhibited the best pigment inhibitory activity (<b>2b</b> vs <b>3a</b>–<b>c</b>; <b>2j</b> vs <b>3d</b>–<b>f</b>), indicating that the <i>N</i>-methyl group is the optimal substituent for pigment inhibition.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, substitution of phenyl with various types of groups (R<sup>3</sup>) could significantly affect pigment inhibitory activity. Generally, (cyclo)alkyl, heteroaromatic, or 1-naphthyl groups were detrimental to pigment inhibitory activity (<b>4a</b>–<b>9a</b> vs <b>2b</b>, <b>4b</b>–<b>9b</b> vs <b>2j</b>), while the introduction of the 2-naphthyl group was favorable (<b>10a</b> vs <b>2b</b>), but was inferior to analogue <b>2j</b>. Our previous studies found that the electron-withdrawing groups and electron-donating groups at the phenyl ring may have minor effects on activity.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> To investigate the effect of substituted groups, more electron-withdrawing (fluoro, chloro, bromo, trifluoromethyl, difluoromethyl, nitro, phenyl, formate, and cyan) and electron-donating groups (methyl, methoxyl, ethoxyl, and <i>t</i>-butyl) were introduced at the phenyl ring. The results in <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> demonstrated that there was no relationship between activity and electronic effect. However, the substituted positions at the phenyl ring significantly affected the activity, and substitution at the para position of the phenyl ring showed the best activity (<b>12a</b> vs <b>24a</b> vs <b>30a</b>, <b>12b</b> vs <b>24b</b> vs <b>30b</b>). Moreover, the substitution at the para position with chloro, bromo, methyl, nitro, difluoromethyl, formate, and phenyl (<b>12a</b>, <b>14a</b>, <b>15a</b>, <b>18a</b>, <b>19a</b>, <b>22a</b>, <b>23a</b>, and <b>23b</b>) resulted in significant improvements in activity. Especially, analogues <b>23a</b> (IC<sub>50</sub> = 2.0 ± 0.1 nM) and <b>23b</b> (IC<sub>50</sub> = 3.3 ± 0.4 nM) displayed a better potency than other derivatives. Notably, the R<sup>3</sup> group of both <b>23a</b> and <b>23b</b> was 4-phenylphenyl (biphenyl).</div><div class="NLM_p last">As shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>, compounds <b>41a</b>–<b>45a</b> and <b>41b</b>–<b>45b</b> were assessed to determine whether the allyl linker had influence on the pigment inhibition potency. The results indicated that the change of the allyl linker moiety was detrimental to improve pigment inhibitory activity. When the allyl linker was replaced by propargyl (<b>41b</b>, IC<sub>50</sub> = 101.8 ± 5.2 nM) or vinyl (<b>45b</b>, IC<sub>50</sub> = 19.4 ± 0.2 nM), the pigment inhibitory activity decreased. Additionally, other linkers listed in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> were detrimental to the pigment inhibitory activity.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Structure–Activity Relationship</h3><div class="NLM_p last">Based on the structural features and pigment inhibitory activities data, the SARs are summarized in detail. (1) <i>N</i>-Substituent variation exerts a great influence on pigment inhibitory activity (<b>2b</b> vs <b>3a</b>–<b>c</b>, <b>2j</b> vs <b>3d</b>–<b>f)</b>, and the <i>N</i>-methyl is optimal. (2) The impact of the electronic characteristics of substituent in the phenyl ring on the potency is weak, while the impact of the substituted position is critical. The substituent group on the para position can enhance the potency significantly (<b>12a</b> vs <b>24a</b> vs <b>30a</b>, <b>12b</b> vs <b>24b</b> vs <b>30b</b>). (3) Replacement the phenyl ring with furanyl, thiophene, or (cyclo)alkyl is not tolerable to the potency (<b>2b</b> vs <b>7a</b>/<b>8a</b>, <b>2j</b> vs <b>7b</b>/<b>8b</b>). (4) The unsubstituted allyl linker is critical for high potency, and the other linkers are on the contrary (<b>2b</b> vs <b>41a</b>–<b>45a</b>, <b>2j</b> vs <b>41</b>–<b>45b</b>).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Cytotoxicity of Human Embryonic Kidney Cell (HEK-293) and Human Hepatocellular Carcinoma Cell (HepG2)</h3><div class="NLM_p">Based on the in vitro pigment inhibitory activities, four compounds (<b>12a</b>, <b>14a</b>, <b>23a</b>, and <b>23b</b>), whose IC<sub>50</sub> values of pigment inhibitory activity of which are lower than 5 nM, were selected for a cytotoxicity evaluation in HEK-293 and HepG2. As shown in <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>, in comparison with amphotericin B, all compounds displayed far less cytotoxicity; especially, <b>23a</b> (CC<sub>50</sub> = 48.1 μM by HEK-293, and CC<sub>50</sub> = 105.8 μM by HepG2, respectively) was superior to amphotericin B (CC<sub>50</sub> = 4.2 μM by HEK-293, and CC<sub>50</sub> = 3.1 μM by HepG2, respectively).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Cytotoxicity of <b>12a</b>, <b>14a</b>, <b>23a</b>, and <b>23b</b> on Human Embryonic Kidney Cell (HEK-293) and Human Hepatocellular Carcinoma Cell (HepG2)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="," /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=",">HEK-293 CC<sub>50</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">HepG2 IC<sub>50</sub><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">amphotericin B</td><td class="colsep0 rowsep0" align="char" char=",">4.2</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=",">42.1</td><td class="colsep0 rowsep0" align="char" char=".">60.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="char" char=",">41.9</td><td class="colsep0 rowsep0" align="char" char=".">33.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=",">48.1</td><td class="colsep0 rowsep0" align="char" char=".">105.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="char" char=",">26.5</td><td class="colsep0 rowsep0" align="char" char=".">21.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">The values given are the IC<sub>50</sub> values for cytotoxicity of HEK-293.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">The values given are the IC<sub>50</sub> values for cytotoxicity of HepG2.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vitro Pigment Inhibitory Activities against Four MRSA strains</h3><div class="NLM_p">Four MRSA strains (Table S4, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf" class="ext-link">Supporting Information</a>), USA400 MW2 and USA300 LAC,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> two clones liable for the epidemic of community-acquired MRSA (CA-MRSA) infectious diseases in the United States; Mu50, a hospital-acquired MRSA (HA-MRSA) strain with VAN-intermediate resistance MRSA (MRSA/VISA); and NRS271, a linezolid resistance MRSA (MRSA/LRSA),<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> were used to investigate the pigment inhibition activity of <b>23a</b> and <b>23b</b>. The results are shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>. We were delighted to find that the color of all strains (USA400 MW2, USA300 LAC, Mu50, and NRS271) faded by the incubation with our compounds <b>23a</b> and <b>23b</b>, and the IC<sub>50</sub> value against MRSA were comparable with that against <i>S. aureus</i> Newman. Moreover, according to the results of the bacterial growth assay (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), different from conditional antibiotics, <b>23a</b> and <b>23b</b> did not affect the growth of <i>S. aureus</i> strains and MRSAs, even given a high concentration (0.2 mM).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effects of <b>23a</b> and <b>23b</b> on Pigment Production of <i>S. aureus</i> USA400 MW2, USA300 LAC, Mu50, and NRS271</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">USA400 MW2 IC<sub>50</sub><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="±">USA300 LAC IC<sub>50</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="±">Mu50 IC<sub>50</sub><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="±">NRS271 IC<sub>50</sub><a class="ref internalNav" href="#t6fn4" aria-label="d">d</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">3.4 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">5.5 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">6.7 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char="±">7.9 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">5.6 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="char" char="±">8.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">4.0 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.04</td><td class="colsep0 rowsep0" align="char" char="±">10.1 ± 0.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">The values given are the IC<sub>50</sub> values against USA400 MW2. The values are reported as the average ± SD</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">The values given are the IC<sub>50</sub> values against USA300 LAC. The values are reported as the average ± SD.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">The values given are the IC<sub>50</sub> values against Mu50. The values are reported as the average ± SD.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">The values given are the IC<sub>50</sub> values against NRS271. The values are reported as the average ± SD.</p></div></div></div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0025.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of <b>23a</b> and <b>23b</b> on the bacterial growth of <i>S. aureus</i> Newman (A and E), USA400 MW2 (B and F), USA300 LAC (C and G), and Mu50 (D and H). Data are presented as means ± SEM, <i>n</i> = 2 independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> In Vitro Water Solubility, hERG Inhibition, and CrtN Enzymatic Inhibitory Activities</h3><div class="NLM_p">Compounds with a high affinity for the hERG ion channel could induce QT interval prolongation, which is frequently related to potentially lethal arrhythmias (Table S2, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf" class="ext-link">Supporting Information</a>)<i>.</i> As shown in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>, we tested the hERG inhibition activity of <b>23a</b> and <b>23b</b>, and we surprisingly found that their IC<sub>50</sub> values exceeded 30 μM, which achieved our top priority to decrease the heart cardiotoxicity and gave us much confidence for the further development. We next evaluated their capacities of inhibiting the enzymatic activity of CrtN in vitro. Using our previous protocol,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> both compounds were found to significantly inhibit enzymatic activity of CrtN at nanomolar concentrations (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>), However, although <b>23a</b> and <b>23b</b> represented excellent pigment inhibitory activity, cytotoxicity, and hERG inhibition, the water solubility of <b>23a</b> and <b>23b</b> decreased more than <b>1</b> (from 10.0 mg/mL to about 0.2 mg/mL), due to the lipophilic biphenyl.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Results of Water Solubility, hERG, and CrtN Inhibition Activities (IC<sub>50</sub>) of <b>1</b>, <b>23a</b>, and <b>23b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">water solubility<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> (mg/mL)</th><th class="colsep0 rowsep0" align="center">hERG inhibition activities IC<sub>50</sub><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">CrtN IC<sub>50</sub><a class="ref internalNav" href="#t7fn3" aria-label="c">c</a> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">34.8</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">0.2 ± 0.01</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">The values given are the values of water solubility.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">The values given are the IC<sub>50</sub> values of hERG inhibition activity.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">The values given are the IC<sub>50</sub> values against CrtN. The values are reported as the average ± SD.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Vitro Metabolic Stability of <b>23a</b> and <b>23b</b> in the Human Liver Microsome Assay</h3><div class="NLM_p">The human liver microsome assay was utilized to preliminarily evaluate the effect of the stability of compounds in liver in vitro. As shown in <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>, we took midazolam as the control compound for its fast clearance rate in a human liver microsome, and <b>23a</b> and <b>23b</b> showed significant stability (<i>t</i><sub>1/2</sub> = 50.7 min of <b>23a</b> and <i>t</i><sub>1/2</sub> = 93.7 min of <b>23b</b>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Human Microsome Stability of <b>23a</b> and <b>23b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>k</i></th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int,in vitro</sub> (mL/min/mg)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int,in vivo</sub> (mL/min/mg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">midazolam</td><td class="colsep0 rowsep0" align="char" char=".">0.165</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">381.0</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">1.23</td><td class="colsep0 rowsep0" align="char" char=".">31.6</td><td class="colsep0 rowsep0" align="char" char=".">50.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">17.0</td><td class="colsep0 rowsep0" align="char" char=".">93.7</td></tr></tbody></table></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> In Vitro Antifungal Activities of <b>23a</b> and <b>23b</b></h3><div class="NLM_p">Because leading compound <b>1</b> originated from the antifungal agent naftifine,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> we would like to investigate whether our compound reserved the capacity of an antifungal. As shown in <a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>, three fungus strains and three first-line drugs were chosen to proceed with the in vitro assay. Compared with the three positive control groups, <b>23a</b> and <b>23b</b> exhibited weak activities against all three dermatophytes, which verified our compounds losing theirs antifungal activities.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Antifungal Activities of <b>1</b>, <b>23a</b>, and <b>23b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="4" align="center">antifungal activities, MIC<sub>80</sub> (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>Trichophyton rubrum</i></th><th class="colsep0 rowsep0" align="center"><i>Microsporum gypseum</i></th><th class="colsep0 rowsep0" align="center"><i>Tinea barbae</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ketoconazole</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.0625</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">voriconazole</td><td class="colsep0 rowsep0" align="left">0.031 25</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.031 25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fluconazole</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">>64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">>64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td></tr></tbody></table></div></div><div id="sec2_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Effects of <b>23a</b> and <b>23b</b> on Sensitizing <i>S. aureus</i> to Immune Clearance</h4><div class="NLM_p">Since pigment could serve as a protective antioxidant to confer the resistance to immune clearance, we speculated that nonpigment <i>S. aureus</i> could be vulnerable to be killed by the block of STX with the treatment of our CrtN inhibition. Herein, two assays were introduced to investigate the effect of <b>23a</b> and <b>23b</b> on sensitizing <i>S. aureus</i> to immune clearance in vitro, including the hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) killing assay and human whole blood killing assay. To verify this argument experimentally, we first compared the susceptibility of mock-treatment with <b>23a</b>-treated (1 μM) <i>S. aureus</i> to H<sub>2</sub>O<sub>2</sub> killing. As shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, nonpigmented <i>S. aureus</i> cells were more vulnerable to be killed by 1.5% H<sub>2</sub>O<sub>2</sub> compared to the untreated <i>S. aureus</i> (mock) (survival, 3.0% vs 33.3%). In parallel, the survival of the known antioxidant nacetylcysteine (NAC)-treated <i>S. aureus</i> cells were far worse than the mock treatment as expected (51.3% vs 33.3%). Similarly, the survival percentage of the three MRSA strains greatly decreased (2.3% vs 28.7% in USA400 MW2; 2.3% vs 29.0% in USA300 LAC; 2.7% vs 24.3% in Mu50); correspondingly, the survival rates of the three NAC-treated MRSA strains worsened (54.3% vs 28.7% in USA400 MW2, 52.0% vs 29.0% in USA300 LAC, 53.0% vs 24.3% in Mu50). All results proved that the addition of H<sub>2</sub>O<sub>2</sub> (with strong oxidation) exerted an impact on the MRSA strain survival, and the pigment definitely acted as the protective antioxidant. Subsequently, the other experiment was to compare the effect of analogue-treated <i>S. aureus</i> with those of nontreated ones by human whole blood killing. The fresh human whole blood was added to <b>23a</b>-treated (1 μM) and untreated <i>S. aureus</i>, and the bacterial survival was measured. As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, untreated <i>S. aureus</i> survived significantly better than the <b>23a</b>-treated <i>S. aureus</i> (survival, 13.3% vs 1.3% in Newman, 20.0% vs 1.0% in USA400 MW2, 12.3% vs 0.7% in USA300 LAC, 9.6% vs 0.4% in Mu50). We then repeated the same experiment for <b>23b</b>, and the analysis was identical to that of <b>23a</b>. All collected results suggested that <b>23a</b> and <b>23b</b> could render <i>S. aureus</i> more susceptible to immune clearance.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0026.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of <b>23a</b> and <b>23b</b> on susceptibility to hydrogen peroxide killing. <i>S. aureus</i> Newman (A), USA400 MW2 (B), USA300 LAC (C), and Mu50 (D); *** <i>p</i> < 0.001 via two-tailed <i>t</i> test (<i>n</i> = three biological replicates, each with two technical replicates).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0001.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of <b>23a</b> and <b>23b</b> on susceptibility to human whole blood killing. <i>S. aureus</i> Newman (A), USA400 MW2 (B), USA300 LAC (C), and Mu50 (D); *** <i>p</i> < 0.001 via two-tailed <i>t</i> test (<i>n</i> = three biological replicates, each with two technical replicates).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> In Vivo Effects of <b>23a</b> and <b>23b</b> on Attenuating the Virulence of <i>S. aureus</i> Newman and Two MRSA Strains</h3><div class="NLM_p">Since <b>23a</b> and <b>23b</b> had promising activities in vitro, we next investigated the in vivo efficacy in a systematic infection model. We subjected <i>S. aureus</i> Newman to a murine model of abscess formation via retro-orbital injection and measured the bacterial survival in the host organs. It was worth stressing that we first conducted the normal treatment procedure (giving the compounds 6 h after infection). As shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B, the mice were injected with 2.3 × 10<sup>7</sup> colony-forming units (CFU) of <i>S. aureus</i> Newman bacteria via retro-orbital injection. We provided the compounds with four different drug regiments, i.e., both 0.4 mg b.i.d. (giving the compounds twice a day)/4.5 d (180 mg/kg in total), and 0.1 mg b.i.d./4.5 d (45 mg/kg) in the pretreatment case (pretreatment with drugs or compounds 24 h in advance of the infection), along with both 0.4 mg b.i.d./3.5 d (140 mg/kg) and 0.1 mg b.i.d./3.5 d (35 mg/kg) in the normal treatment case (administered 6 h after the infection of strains), while LZD and VAN were set up as two positive control groups at the dosage of 0.4 mg b.i.d./4.5 d (180 mg/kg) with pretreatment. The mice were sacrificed after 4.5 d, and we measured bacterial survival in the kidneys and hearts. First, we analyzed <b>23a</b> and <b>23b</b> in terms of attenuating the virulence of Newman (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B). Compared to the untreated group, the staphylococcal loads of all <b>23a</b>-treated groups were significantly lower in kidneys and hearts (<i>p</i> < 0.01), while <b>23b</b>-treated groups were not as obvious. Surprisingly, both <b>23a</b> treatment and <b>23b</b> treatment with a low dosage in the normal treatment group reduced the bacterial load more than in the other three groups. For further investigation, we performed the same experiment on infection with Mu50 (VISA/MRSA) and NRS271 (LRSA/MRSA). The analysis of the data in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C–F revealed that the compound-treatment groups had significantly decreased Mu50 and NRS271 staphylococcal loads in the kidneys and hearts, all of which corresponded to a greater than 95.0% decrease in surviving bacteria (significance <i>P</i> < 0.001), while all low-dosage compound-treatment groups were better than the high-dosage ones. Encouragingly, all low-dosage groups were not inferior to the positive-controlled ones; especially, <b>23a</b> treatment with a low dosage (0.1 mg b.i.d./3.5 d) in the normal treatment case displayed the best activity again among the groups.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0002.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of analogues <b>23a</b> and <b>23b</b> on <i>S. aureus</i> bacteria (A and B), Mu50 (C and D), and NRS271 (E and F) survival in the hearts and livers of mice (<i>n</i> = 10 for each group) challenged with 2.3 × 10<sup>7</sup> CFU Newman bacteria, 1.1 × 10<sup>9</sup> CFU Mu50 bacteria, and 2.3 × 10<sup>8</sup> CFU NRS271 bacteria. P = pretreatment, drugs or compounds were intraperitoneally administered 24 h before infection compared with the normal treatment. (Drugs or compounds were intraperitoneally administered 6 h after infection.) The statistical significance was determined by a Mann–Whitney test (two-tailed): ** <i>p</i> < 0.01, *** <i>p</i> < 0.001. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Along with the encouraging outcome in vivo described above, we concluded that <b>23a</b> treatment with a low dosage in the normal treatment group was the group with the greatest potential. To confirm the most appropriate treatment dosage, we lowered the dosage to 0.05 mg b.i.d./3.5 d (17.5 mg/kg in total) and 0.01 mg b.i.d./3.5 d (3.5 mg/kg). As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A,B, <b>23a</b> (17.5 mg/kg) significantly decreased the Mu50 staphylococcal loads in kidneys by 1.09 log<sub>10</sub> CFU (more than 91.8% decrease) and in hearts by 2.70 log<sub>10</sub> CFU (more than 99.8% decrease). However, it was not comparable to the 0.1 mg b.i.d./3.5 d (35 mg/kg) group. Generally, we confirmed <b>23a</b> treatment with 0.1 mg b.i.d./3.5 d (35 mg/kg) dosage in normal treatment still as the best treatment. To further evaluate the efficacy of <b>23a</b> at affecting the outcome of <i>S. aureus</i> sepsis, we challenged animals with 2 × 10<sup>8</sup> CFU Newman bacteria. The untreated mice nearly died out (90% animal) within 4 days, with <b>23a</b> resulting in 80% animal survival. By the eighth day, more than 70% of the <b>23a</b>-treated mice were alive, demonstrating a slight advantage over the <b>1</b>-treated group (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>). This investigation clearly proved that the in vivo <b>23a</b> treatment weakened the virulence of <i>S. aureus</i> Newman.</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0003.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of <b>23a</b> and <b>23b</b> on Mu50 survival in the kidneys (A) and hearts (B) of mice challenged with 1.3 × 10<sup>9</sup> CFU Mu50 bacteria. P = pretreatment, drugs or compounds were intraperitoneally administered 24 h before infection compared with the normal treatment. (Drugs or compounds were intraperitoneally administered 6 h after infection.) Statistical significance was determined by a Mann–Whitney test (two-tailed): * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001, n.s. indicates no significant difference. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0004.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>1</b> and <b>23a</b> on <i>S. aureus</i> survival in protecting mice (<i>n</i> = 15) from lethal <i>S. aureus</i> infection challenged with 2 × 10<sup>8</sup> CFU Newman bacteria.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> In Vitro Pigment Inhibitory Activities against an Additional Nine MRSA Strains</h3><div class="NLM_p">In addition to the four <i>S. aureus</i> strains above, nine additional multidrug-resistant MRSA strains, NRS70, NRS100, NRS108, LRSA56, LRSA202,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> LRSA205, HS663,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> NF65Y, and XN108<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (Table S4, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf" class="ext-link">Supporting Information</a>), were selected to further explore the effect of the lead compound <b>23a</b> against multiple resistant bacteria. First, the pigment inhibition of <b>23a</b> was conducted, and the results were shown in <a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>, indicating that <b>23a</b> could strongly block the pigment biosynthesis of these nine MRSA strains (IC<sub>50</sub> = 0.02–10.5 nM), which showed the adaptability of our compound against MRSAs in vitro.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Effects of <b>23a</b> on Pigment Production of NRS271, NRS70, NRS100, NRS108, LRSA56, LRSA202, LRSA205, HS663, NF65Y, and XN108</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="4" align="center">pigment production, IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">MRSA strains (country)</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">MRSA strains (country)</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NRS70 (JPN)</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.01</td><td class="colsep0 rowsep0" align="left">LRSA205 (CHN)</td><td class="colsep0 rowsep0" align="char" char="±">10.5 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NRS100 (USA)</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">HS663 (CHN)</td><td class="colsep0 rowsep0" align="char" char="±">0.02 ± 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NRS108 (FRA)</td><td class="colsep0 rowsep0" align="char" char="±">5.6 ± 0.02</td><td class="colsep0 rowsep0" align="left">NF65Y (CHN)</td><td class="colsep0 rowsep0" align="char" char="±">1.0 ± 0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LRSA56 (CHN)</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">XN108 (CHN)</td><td class="colsep0 rowsep0" align="char" char="±">0.2 ± 0.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LRSA202 (CHN)</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td></tr></tbody></table></div></div><div id="sec2_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> In Vivo Effects of <b>23a</b> on Attenuating the Virulence of <i>S. aureus</i> LRSA102, LRSA56, NF65Y, and XN108</h4><div class="NLM_p">On the basis of the in vitro pigment inhibitory activities (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>) and MIC values of the nine MRSA strains (Table S4, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf" class="ext-link">Supporting Information</a>), we chose four representative MRSA strains, LRSA56 (LRSA), LRSA202 (LRSA), NF65Y (VISA), and XN108 (VISA) to further investigate the in vivo effects of <b>23a</b> in vivo (0.1 mg b.i.d./3.5 d, in normal treatment, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>).</div><figure id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0005.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of <b>23a</b> on LRSA45 (5.0 × 10<sup>7</sup> CFU), LRSA202 (7.0 × 10<sup>7</sup> CFU), NF65Y (3.5 × 10<sup>8</sup> CFU), and XN108 (2.1 × 10<sup>8</sup> CFU) survival in the kidneys (A) and hearts (B) of mice. P = pretreatment, drugs or compounds were intraperitoneally administered 24 h before infection compared with the normal treatment. (Drugs or compounds were intraperitoneally administered 6 h after infection.) Statistical significance was determined by a Mann–Whitney test (two-tailed): * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001, n.s. indicates no significant difference. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A, the mice were injected with 5.0 × 10<sup>7</sup> CFU of <i>S. aureus</i> LRSA56 bacteria via retro-orbital injection. Compared with the untreated group, <b>23a</b> treatment decreased the LRSA56 loads in kidneys by 0.77 log<sub>10</sub> CFU (more than 83.0% decrease) and in hearts by 0.73 log<sub>10</sub> CFU (more than 81.4% decrease). Compared with the LZD-treated group, <b>23a</b> treatment decreased the LRSA56 loads in kidneys by 0.34 log<sub>10</sub> CFU (more than 54.3% decrease) and in hearts by 0.55 log<sub>10</sub> CFU (more than 71.8% decrease); however, it showed no significant difference compared to the VAN-treatment group. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B, the analysis was just like <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A, and <b>23a</b> could be comparable to LZD, but worse than VAN.</div><div class="NLM_p last">As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C,D, for VISA-resistance bacteria NF65Y and XN108, all of the <b>23a</b>-treatment groups had significantly reduced <i>S. aureus</i> loads (<i>p</i> < 0.001) and was comparable to the positive control groups, even though LAZ and VAN were given at higher doses. Especially, in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C, <b>23a</b>-treatment group showed extraordinary activity, exceeding VAN with significance <i>p</i> < 0.01. Consequently, we were quite confident that <b>23a</b> was the best candidate for further development.</div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> In Vivo Effects of <b>23a</b> on Attenuating the Virulence of <i>S. aureus</i> Newman, Mu50, and NRS271 with Oral Administration</h3><div class="NLM_p">Because all of the in vivo investigations above were through intraperitoneal injection, oral administration was utilized for more investigations about curative effects of <b>23a</b> (0.4 mg b.i.d./3.5 d, 0.2 mg b.i.d./3.5 d, and 0.1 mg b.i.d./3.5 d, in normal treatment, <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). We kept VAN and LZD as positive control groups (0.4 mg b.i.d./4.5 d, in pretreatment).</div><figure id="fig9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0006.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of <b>23a</b> on Newman (3.1 × 10<sup>7</sup> CFU), Mu50 (4.6 × 10<sup>9</sup> CFU), and NRS271 (3.5 × 10<sup>8</sup> CFU) survival in the kidneys (A, C, and E) and hearts (B, D, and F) of mice. P = pretreatment, drugs or compounds were intraperitoneally administered 24 h before infection compared with the normal treatment. (Drugs or compounds were intraperitoneally administered 6 h after infection.) Statistical significance was determined by a Mann–Whitney test (two-tailed): * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001, n.s. indicates no significant difference. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A,B, the mice were injected with 3.1× 10<sup>7</sup> CFU of <i>S. aureus</i> Newman bacteria via retro-orbital injection. In the kidneys, compared with the untreated group, <b>23a</b> treatment decreased the Newman loads by 1.00 log<sub>10</sub> CFU (90.0% decrease), but there was no significant difference in hearts. Compared with the VAN-treated group, <b>23a</b> treatment decreased the Newman loads in hearts by 0.38 log<sub>10</sub> CFU (more than 55.3% decrease with significance <i>p</i> < 0.1.). However, all <b>23a</b>-treatment groups were not better than positive control groups. As for <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>C–F, the analysis was just like that of <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A; the best dosage of the three <b>23a</b>-treatment groups was still 0.2 mg b.i.d./ 3.5 d and was not better than VAN- and LZD-treatment groups. Consequently, the most appropriate dose of <b>23a</b> was 0.2 mg b.i.d./ 3.5 d with oral administration, which was not comparable to intraperitoneal injection.</div><div id="sec2_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> In Vitro Effects of <b>23a</b> on CYP Enzymatic Inhibitory Activity</h4><div class="NLM_p">The study on CYP drug metabolizing enzymatic inhibitory activity could be used to predict the side effect of compounds in liver in vitro. The data in <a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a> showed the CYP enzymatic inhibition of <b>23a</b>, and the results indicated that <b>23a</b> exhibited no significant inhibition of CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4M, and CYP3A4T (IC<sub>50</sub> > 3 μM), which preliminarily proved that our compound had no side effect in the liver.</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Effects of <b>23a</b> on Inhibition of CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4M, and CYP3A4T</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">CYP</th><th class="colsep0 rowsep0" align="center">selective inhibitors</th><th class="colsep0 rowsep0" align="center" char=".">inhibition activity IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">inhibition activity IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A2</td><td class="colsep0 rowsep0" align="left">α-naphthoflavon</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2B6</td><td class="colsep0 rowsep0" align="left">ticlopidine</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C8</td><td class="colsep0 rowsep0" align="left">montelukast</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C9</td><td class="colsep0 rowsep0" align="left">sulfaphenazole</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C19</td><td class="colsep0 rowsep0" align="left">omeprazole</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2D6</td><td class="colsep0 rowsep0" align="left">quinidine</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4M</td><td class="colsep0 rowsep0" align="left">ketoconazole</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4T</td><td class="colsep0 rowsep0" align="left">ketoconazole</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char=".">10.0</td></tr></tbody></table></div></div></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> In Vivo Rat and Mice Pharmacokinetics (PK) Profile of <b>23a</b></h3><div class="NLM_p">Because of its potency and attractive adaptability, compound <b>23a</b> was further evaluated by both rat (<a class="ref internalNav" href="#tbl12" aria-label="Table 12">Table 12</a>) and mice (<a class="ref internalNav" href="#tbl13" aria-label="Table 13">Table 13</a>) PK models. Initially, <b>23a</b> was characterized by a low clearance (1750 mL/h/kg in rat and 1840 mL/h/kg in mice) and a terminal half-life after iv administration (2.46 h in rat and 2.05 h in mice), while the peak serum concentrations were observed at 2 h by po administration. As shown in <a class="ref internalNav" href="#tbl12" aria-label="Tables 12">Tables 12</a> and <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a>, the terminal half-life after po administration was 1.29 h in rat and 3.35 h in mice. The oral bioavailability showed obvious differences between species of <b>23a</b>, which was 16.3% in rat and 83.3% in mice, which was high enough for a candidate drug. Furthermore, we supplemented the PK study of the intraperitoneal (ip) injection in rat as shown in <a class="ref internalNav" href="#tbl12" aria-label="Table 12">Table 12</a>. Surprisingly, all of the PK parameters were significantly higher than the two other methods of administrations, especially the terminal half-life that reached 7.61 h, which made us confident that ip was the most appropriate method of administration for <b>23a</b>.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Pharmacokinetic Parameters for <b>23a</b> after Single Dosing in Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose of <b>23a</b> (mg/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0–24h)</sub> (h×ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0–∞)</sub> (h×ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center">CL (mL/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5 (iv)</td><td class="colsep0 rowsep0" align="char" char=".">2805.48</td><td class="colsep0 rowsep0" align="char" char=".">2862.41</td><td class="colsep0 rowsep0" align="char" char=".">4608.78</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="left">1750.00</td><td class="colsep0 rowsep0" align="char" char=".">2.46</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10 (po)</td><td class="colsep0 rowsep0" align="char" char=".">898.70</td><td class="colsep0 rowsep0" align="char" char=".">930.33</td><td class="colsep0 rowsep0" align="char" char=".">212.56</td><td class="colsep0 rowsep0" align="char" char=".">2.00</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">1.29</td><td class="colsep0 rowsep0" align="left">16.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10 (ip)</td><td class="colsep0 rowsep0" align="char" char=".">974 951.40</td><td class="colsep0 rowsep0" align="char" char=".">1 086 152.29</td><td class="colsep0 rowsep0" align="char" char=".">130 484.03</td><td class="colsep0 rowsep0" align="char" char=".">3.00</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">7.61</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. Pharmacokinetic Parameters for <b>23a</b> after Single Dosing in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose of <b>23a</b> mg/kg</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0–24h)</sub> (h×ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0–∞)</sub> (h×ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2 (iv)</td><td class="colsep0 rowsep0" align="char" char=".">1067.27</td><td class="colsep0 rowsep0" align="char" char=".">1086.95</td><td class="colsep0 rowsep0" align="char" char=".">2230.35</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">1840.00</td><td class="colsep0 rowsep0" align="char" char=".">2.05</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10 (po)</td><td class="colsep0 rowsep0" align="char" char=".">4528.41</td><td class="colsep0 rowsep0" align="char" char=".">4556.40</td><td class="colsep0 rowsep0" align="char" char=".">801.19</td><td class="colsep0 rowsep0" align="char" char=".">2.00</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3.35</td><td class="colsep0 rowsep0" align="char" char=".">83.84</td></tr></tbody></table></div></div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Pharmacological Safety</h3><div class="NLM_p last">The favorable PK profile of <b>23a</b> along with its highly desirable inhibitory potency against CrtN warranted its use in in vitro safety studies. The maximum tolerated dose of <b>23a</b> was determined for acute toxicity in rats. A total of 30 rats were randomly divided into three groups and given single oral doses of 60 mg/kg, 250 mg/kg, or 1000 mg/kg of <b>23a</b> on the first day. The animals treated with <b>23a</b> did not exhibit any poisoning symptoms or mortality immediately or during the post-treatment period of 2 weeks. In addition, no abnormal behaviors or significant changes in the water/food consumption and body weight were observed during the period of the experiments. Therefore, <b>23a</b> was well-tolerated up to a dose of 1000 mg/kg with no acute toxicity.</div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Resistance Development Study of <b>23a</b></h3><div class="NLM_p">As the drug resistance development was the central issue to design and evaluate new antibiotics, we wondered whether these CrtN inhibitors could avoid the development of drug resistance under sequential H<sub>2</sub>O<sub>2</sub> selection pressure. Erythromycin, a macrolides antibiotics, was included as a positive control to compare with these CrtN inhibitors for their drug resistance development. In the initial susceptibility testing, we determined that the MIC values of erythromycin and H<sub>2</sub>O<sub>2</sub> were 0.125 μg/mL and 0.15% (v/v), respectively. Subsequent passaging for erythromycin was started with MIC/2 (0.0625 μg/mL). And for H<sub>2</sub>O<sub>2</sub> with CrtN inhibitors, we chose a concentration of 0.15% (v/v) H<sub>2</sub>O<sub>2</sub>, which imposed a selected pressure for bacterial growth and lead to a lagged time for bacteria to reach the exponential phase and IC<sub>90</sub> concentrations of <b>23a</b> and <b>23b</b> for pigment production to initiate passaging. As it was shown in <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>, the MIC value of erythromycin against the <i>S.aureus</i> Newman strain started to increase once beginning passaging, and the value had increased by a factor of over 16 after 12 passages. By contrast, the IC<sub>50</sub> value of the CrtN inhibitors for pigment production of 12th passage of <i>S. aureus</i> Newman (under IC<sub>90</sub> concentrations of <b>23a</b> or <b>23b</b>) was basically unchanged (1.8 nM vs 2.0 nM for <b>23a</b>, 2.6 nM vs 3.3 nM for <b>23b</b>, <a class="ref internalNav" href="#tbl14" aria-label="Table 14">Table 14</a>). Meanwhile, if CrtN was mutated under the sequential H<sub>2</sub>O<sub>2</sub> and CrtN inhibitors selection pressure, a colored single colony would appear on the TSA plate containing these drugs. As shown in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>, when ∼1000 CFUs of the 12th passage bacteria were spread onto a TSA plate containing IC<sub>90</sub> concentrations of <b>23a</b> or <b>23b</b>, all of the colonies still remained nonpigmented. In contrast, pigmented bacteria were observed from a TSA plate without CrtN inhibitors. In total, 100 TSA plates containing IC<sub>90</sub> concentrations of <b>23a</b> or <b>23b</b> were included to determine the frequency of mutations. The frequency of mutations at IC<sub>90</sub> concentrations of CrtN inhibitors for pigment production was less than ∼1 × 10<sup>–5</sup> for both <b>23a</b> and <b>23b</b> after 12 sequential passaging.</div><figure id="fig10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0007.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Development of bacterial resistance in Newman toward erythromycin and H<sub>2</sub>O<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0008.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Images of the treated and nontreated (control) TSA plates of 12 passages Newman (1000 CFU), which were under the sequential H<sub>2</sub>O<sub>2</sub> and CrtN inhibitors selection pressure. The concentrations of <b>23a</b> and <b>23b</b> were 7.5 nM/mL and 10.0 nM/mL (IC<sub>90</sub> of pigment inhibition).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. Effects of <b>23a</b> and <b>23b</b> on Pigment Production of the Original and 12 Passages of <i>S. aureus</i> Newman under IC<sub>90</sub> Concentrations of <b>23a</b> or <b>23b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">pigment production, IC<sub>50</sub> (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">original <i>S. aureus</i> Newman, IC<sub>50</sub><a class="ref internalNav" href="#t14fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center" char="±">12 passages of <i>S. aureus</i> Newman, IC<sub>50</sub><a class="ref internalNav" href="#t14fn2" aria-label="b">b</a> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="char" char="±">2.0 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="char" char="±">3.3 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t14fn1"><div class="footnote" id="t14fn1"><sup>a</sup><p class="last">The values given are the IC<sub>50</sub> against original <i>S. aureus</i> Newman. The values are reported as the average ± SD.</p></div><div class="footnote" id="t14fn2"><sup>b</sup><p class="last">The values given are the IC<sub>50</sub> against 12 passages of <i>S. aureus</i> Newman. The values are reported as the average ± S.D.</p></div></div></div><div class="NLM_p">Finally, the MIC values of <b>23a</b> for the three other pathogens were investigated, including <i>Enterococcus faecium</i>, <i>S. aureus</i> Newman, and <i>Pseudomonas aeruginosa</i>, which all belong to the “ESKAPE” family. As shown in <a class="ref internalNav" href="#tbl15" aria-label="Table 15">Table 15</a>, the three values of MIC of <b>23a</b> were all above 500 μg/mL, which proved the our inhibitor does not affect the growth of these pathogens.</div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. MIC Values of <b>23a</b> for <i>Enterococcus faecium</i>, <i>S. aureus</i> Newman, and <i>Pseudomonas aeruginosa</i></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="4" align="center">MIC(μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>Enterococcus faecium</i></th><th class="colsep0 rowsep0" align="center"><i>S. aureus</i> Newman</th><th class="colsep0 rowsep0" align="center"><i>Pseudomonas aeruginosa</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="left">>500 μg/mL</td><td class="colsep0 rowsep0" align="left">>500 μg/mL</td><td class="colsep0 rowsep0" align="left">>500 μg/mL</td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65613" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65613" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, based on the results of scaffold hopping, 3-substituted benzofuran and 7-substituted indole were key skeletons. Subsequently, with the variation of the <i>N</i>-substituents, allyl linkers, and phenyl moiety, 100 new analogues were synthesized. To investigate the pigment inhibition of <i>S. aureus</i> Newman, the unambiguous SARs were obtained. The most valid four pigment inhibitors <b>12a</b>, <b>14a</b>, <b>23a</b>, and <b>23b</b> (pigment inhibition IC<sub>50</sub> < 5 nM) were chosen among the analogues to test their cytotoxicity for HEK-293 and HepG2 cells; in order to keep the diversity of main structure, we maintained <b>23a</b> and <b>23b</b> for further study. <b>23a</b> and <b>23b</b> had the capacity to block the pigment biosynthesis of USA400 MW2, USA300 LAC, Mu50, and NRS271 at a comparable level to the Newman strain. Notably, the hERG inhibition activity of <b>23a</b> (IC<sub>50</sub> = 34.8 μM) and <b>23b</b> (IC<sub>50</sub> > 40 μM) were largely improved compared to <b>1</b> (IC<sub>50</sub> = 3.71 μM), ∼ 10-fold decrease. We found that <b>23a</b> and <b>23b</b> had a submicromolar activity in the CrtN enzymatic inhibition assay without any bactericidal impact on <i>S. aureus</i> bacteria (up to 200 μM) and proper human microsome stability (50.7 min of <b>23a</b> and 93.7 min of <b>23b</b> for half-life time). Furthermore, <b>23a</b> and <b>23b</b> abandoned the antifungal activities (MIC > 8 μg/mL). According to the concept of antivirulence, sensitized <b>23a</b> and <b>23b</b> (1 μM) <i>S. aureus</i> strains were killed by H<sub>2</sub>O<sub>2</sub> and human whole blood. In the in vivo assay, <b>23a</b> and <b>23b</b> were proven efficacious in the <i>S. aureus</i> Newman and multidrug resistant MRSA (Mu50 and NRS271) model, and <b>23a</b> treatment with 0.1 mg b.i.d./3.5 d (35 mg/kg in total) in the normal treatment group was preferred. Next, all compound-treatment groups significantly decreased Mu50 (VISA/MRSA) loads in the hearts and kidneys, which were compared with the efficacy of the positive groups, VAN and LZD. Regarding NRS271 (LRSA/MRSA), <b>23a</b> and <b>23b</b> strongly decreased the NRS271 loads in the kidneys and hearts (>99% decrease), which were also comparable with the positive control groups. Considering <b>23a</b> had a slight advantage over <b>23b</b>, we preferred <b>23a</b> as the candidate drug and then proved it to be efficacious in the <i>S. aureus</i> Newman sepsis model, with more than 70% survival after 8 d. Considering no better inhibitory activity under the lower dosage, the 0.1 mg b.i.d./3.5 d (35 mg/kg) case was guaranteed to be the most appropriate dosage. The pigment inhibitory activity of <b>23a</b> against another nine MRSA strains was at the same level as the Newman strain, which demonstrated that <b>23a</b> had a broad spectrum bactericidal effect. Then two LRSA strains (LRSA56 and LRSA202) and two VISA strains (NF65Y and XN108) among the nine strains were tested in vivo, and <b>23a</b> showed extraordinary activity again, comparable to LZD and VAN. Moreover, <b>23a</b> showed no inhibitory activity on the CYP enzymatic inhibitory assay and is characterized by an acceptable half-life, high volume of distribution, and low clearance. <b>23a</b> was a potential antibiotic and had 16.3% oral bioavailability in rat and 83.8% oral bioavailability in mice. When we tried ip as the method of administration in rat, <b>23a</b> showed extreme stability (7.61 h for half-life time). Lastly, we verified that <b>23a</b> was not easy to induce the resistance development and used <b>23b</b> as contrast. We developed 12 passages of <i>S. aureus</i> Newman under the pressure of <b>23a</b>, <b>23b</b>, and H<sub>2</sub>O<sub>2</sub> and made sure that the frequency of mutations at IC<sub>90</sub> concentrations of CrtN inhibitors for pigment production was < ∼1 × 10<sup>–5</sup>. In total, <b>23a</b> has the potential to be developed as a therapeutic drug, especially against intractable MRSA (VISA and LRSA) issues, by blocking virulence, and this class of antibiotics holds great promise in the treatment of infections by difficult human pathogens.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> General Chemistry</h3><div class="NLM_p last">Reagents and solvents were obtained from commercial suppliers at high quality and were used without further purification. TLC was performed on a HSGF 254 (150–200 μm thickness; Yantai Huiyou Co., China) unit. UV light and I<sub>2</sub> were used to monitor synthetic progress. Column chromatography was performed on silica gel (200–300 mesh), eluting with ethyl acetate and petroleum ether. NMR spectra data were obtained on a Bruker AMX-400 NMR unit using TMS as an internal standard. Chemical shifts were provided in parts per million. <sup>1</sup>H NMR data were reported from the aspect of multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and br = broad), coupling constant (Hz), and integrated value. Low- and high-resolution mass spectral (MS) data were acquired with electron spray ionization (ESI) produced by Finnigan MAT-95 and LCQ-DECA spectrometers. The purity of each compound (>95%) was determined by HPLC on an Agilent 1100 unit with a quaternary pump and diode-array detector (DAD). The melting points of each compound were determined on an SGW X-4 melting point apparatus.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Preparation of Salts</h3><div class="NLM_p last">Using <b>4a</b> as an example, a solution of oily derivative <b>4a</b> (100 mg) in ethyl ether (10 mL) was stirred at room temperature and bubbled with hydrogen chloride gas for 1 min. After stirring for 15 min, the solvent was removed by rotary evaporation and the residue was suspended in ethyl acetate/petroleum ether (1:100, v/v, 10 mL) for an additional hour of agitation. The precipitate was filtrated and washed with ethyl acetate to obtain the final compound in the form of hydrochloride. All other final derivatives underwent through this process to yield an amorphous, solid form or oil. Spectroscopic data reported below are in their hydrochloride form.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>E</i>)-<i>N</i>-(Benzofuran-2-ylmethyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2a</b>)</h3><div class="NLM_p last">A solution of intermediate <b>48a</b> (X = O, 163.0 mg, 1 mmol), <b>51a</b> (290.0 mg, 1.1 mmol), and K<sub>2</sub>CO<sub>3</sub> (280.0 mg, 2 mmol) in DMF (10 mL) was stirred at room temperature overnight. The mixture was poured into water and extracted with EtOAc. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and condensed. The residue was then purified via flash chromatography on silica gel, eluting with EtOAc/petroleum ether (1/5, v/v) to give the free base of <b>2a</b> as a white solid. Yield: 44%. <b>2a</b> was prepared by the general procedure given above as a white solid, mp 161–162 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72–7.63 (m, 5H), 7.60–7.54 (m, 1H), 7.45–7.36 (m, 1H), 7.35–7.27 (m, 1H), 7.20 (s, 1H), 7.02 (d, <i>J</i> = 15.8 Hz, 1H), 6.56–6.46 (m, 1H), 4.66 (s, 2H), 4.10 (dd, <i>J</i> = 14.3, 7.1 Hz, 2H), 2.95 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.67, 146.49, 139.13, 138.76, 127.49, 127.22, 127.22, 125.67, 125.50, 125.33, 125.29, 124.59, 123.34, 121.54, 119.72, 111.05, 110.86, 57.44, 51.29, 39.09. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>NO [M + H]<sup>+</sup>, 346.1419; found, 346.1418.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2b</b>)</h3><div class="NLM_p last">Yield: 57%. <b>2b</b> was synthesized by the general procedure given above as a white solid, mp 165–166 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.13 (s, 1H), 7.82 (d, <i>J</i> = 8.1 Hz, 1H), 7.73–7.64 (m, 5H), 7.60 (d, <i>J</i> = 7.8 Hz, 1H), 7.41 (dtd, <i>J</i> = 17.8, 7.3, 1.2 Hz, 2H), 7.01 (d, <i>J</i> = 15.9 Hz, 1H), 6.59–6.47 (m, 1H), 4.61 (d, <i>J</i> = 37.0 Hz, 2H), 4.24–4.07 (m, 1H), 4.00 (s, 1H), 2.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 157.89, 155.54, 147.94, 139.07, 138.78, 130.18, 127.26, 127.26, 126.49, 125.30, 124.15, 123.48, 120.12, 119.50, 119.27, 111.52, 109.86, 57.26, 47.87, 38.56. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>NO [M + H]<sup>+</sup>, 346.1419; found, 346.1418.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>E</i>)-<i>N</i>-(benzo[<i>b</i>]thiophen-2-ylmethyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2c</b>)</h3><div class="NLM_p last">Yield: 42%. <b>2c</b> was synthesized by the general procedure given above as a white solid, mp 223–224 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.99–7.85 (m, 2H), 7.75–7.63 (m, 5H), 7.49–7.37 (m, 2H), 7.02 (d, <i>J</i> = 15.8 Hz, 1H), 6.53 (dt, <i>J</i> = 15.2, 7.4 Hz, 1H), 4.73 (s, 2H), 4.02 (s, 2H), 2.94 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 141.02, 139.18, 139.11, 138.93, 130.89, 129.50, 127.30, 127.30, 125.57, 125.51, 125.33, 125.30, 124.80, 124.12, 122.81, 122.08, 119.48, 57.18, 53.43, 38.51. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>NS [M + H]<sup>+</sup>, 362.1190; found, 360.1193.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>E</i>)-<i>N</i>-(Benzo[<i>b</i>]thiophen-3-ylmethyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2d</b>)</h3><div class="NLM_p last">Yield: 50%. <b>2d</b> was synthesized by the general procedure given above as a white solid, mp 198–200 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.02 (s, 3H), 7.68 (s, 3H), 7.50 (d, <i>J</i> = 19.3 Hz, 2H), 6.99 (d, <i>J</i> = 16.0 Hz, 1H), 6.53 (s, 1H), 4.71 (d, <i>J</i> = 53.3 Hz, 2H), 4.09 (d, <i>J</i> = 40.8 Hz, 2H), 2.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.38, 139.08, 138.87, 137.86, 131.76, 127.27, 127.27, 125.50, 125.35, 125.31, 125.27, 124.98, 124.78, 124.48, 122.81, 121.27, 119.55, 57.55, 51.26, 38.81. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>F<sub>3</sub>NS [M + H]<sup>+</sup>, 361.1112; found, 361.1114.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-2-yl)methyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2e</b>)</h3><div class="NLM_p last">Yield: 25%. <b>2e</b> was synthesized by the general procedure given above as a white oil. <sup>1</sup>H NMR (400 MHz, acetone): δ 7.98 (s, 1H), 7.71–7.64 (m, 4H), 7.59 (d, <i>J</i> = 8.0 Hz, 1H), 7.42 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (t, <i>J</i> = 7.4 Hz, 1H), 7.07 (t, <i>J</i> = 7.5 Hz, 1H), 7.00 (d, <i>J</i> = 15.8 Hz, 1H), 6.55–6.45 (m, 1H), 4.62 (t, <i>J</i> = 11.2 Hz, 1H), 4.50 (d, <i>J</i> = 13.9 Hz, 1H), 4.11 (dd, <i>J</i> = 13.1, 7.0 Hz, 1H), 3.94 (dd, <i>J</i> = 13.4, 7.7 Hz, 1H), 2.89 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 139.12, 138.76, 137.21, 127.90, 127.25, 127.25, 125.78, 125.50, 125.32, 125.28, 124.51, 122.84, 120.46, 119.80, 119.63, 111.21, 106.12, 57.05, 52.11, 38.49. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.1500; found, 344.1496.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-3-yl)methyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2f</b>)</h3><div class="NLM_p last">Yield: 78%. <b>2f</b> was synthesized by the general procedure given above as a white solid, mp 165–168 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.64 (d, <i>J</i> = 7.9 Hz, 1H), 7.62–7.54 (m, 4H), 7.35 (t, <i>J</i> = 7.5 Hz, 1H), 7.26 (s, 1H), 7.12 (dd, <i>J</i> = 11.0, 4.0 Hz, 1H), 7.05 (dd, <i>J</i> = 11.0, 3.9 Hz, 1H), 6.66 (d, <i>J</i> = 15.9 Hz, 1H), 6.48 (dt, <i>J</i> = 15.9, 6.8 Hz, 1H), 3.86 (s, 2H), 3.33 (d, <i>J</i> = 6.9 Hz, 2H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 139.09,138.51, 136.68, 128.08, 127.19, 127.05, 127.05, 126.00, 125.37, 125.33, 124.57, 122.18, 120.09, 119.94, 117.59, 111.65, 102.64, 95.65, 56.57, 50.82, 38.09. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.1500; found, 344.1499.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-4-yl)methyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2g</b>)</h3><div class="NLM_p last">Yield: 79%. <b>2g</b> was synthesized by the general procedure given above as a white solid, mp 155–157 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.24 (s, 1H), 7.54 (t, <i>J</i> = 8.8 Hz, 2H), 7.46 (d, <i>J</i> = 8.1 Hz, 2H), 7.33 (d, <i>J</i> = 7.9 Hz, 1H), 7.24–7.08 (m, 3H), 6.72 (s, 1H), 6.59 (d, <i>J</i> = 16.0 Hz, 1H), 6.50–6.37 (m, 1H), 3.85 (s, 2H), 3.28 (d, <i>J</i> = 6.4 Hz, 2H), 2.29 (d, <i>J</i> = 12.3 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 139.11, 138.48, 135.18, 128.02, 127.11, 126.85, 126.85, 126.12, 125.39, 125.31, 124.67, 123.12, 122.56, 120.01, 119.84, 117.19, 111.25, 102.59, 95.59, 56.47, 50.72, 38.01. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.1500; found, 344.1499.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-5-yl)methyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2h</b>)</h3><div class="NLM_p last">Yield: 88%. <b>2h</b> was synthesized by the general procedure given above as a white solid, mp 129–131 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.22 (s, 1H), 7.63–7.51 (m, 3H), 7.46 (d, <i>J</i> = 8.1 Hz, 2H), 7.36 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.0 Hz, 2H), 6.61–6.50 (m, 2H), 6.49–6.38 (m, 1H), 3.67 (s, 2H), 3.24 (d, <i>J</i> = 6.4 Hz, 2H), 2.28 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 138.95, 138.45, 137.11, 127.47, 127.15, 126.85, 125.78, 125.50, 125.33, 125.21, 124.89, 122.68, 120.35, 119.14, 119.53, 111.45, 106.52, 57.55, 53.45, 38.36. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.1500; found, 344.1501.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-6-yl)methyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2i</b>)</h3><div class="NLM_p last">Yield: 65%. <b>2i</b> was synthesized by the general procedure given above as a white solid, mp 134–137 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.16 (s, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 1H), 7.55 (d, <i>J</i> = 8.1 Hz, 3H), 7.46 (d, <i>J</i> = 8.1 Hz, 2H), 7.39 (s, 1H), 7.20 (s, 1H), 7.10 (d, <i>J</i> = 8.0 Hz, 1H), 6.63–6.52 (m, 2H), 6.48–6.37 (m, 1H), 3.72–3.64 (m, 2H), 3.24 (d, <i>J</i> = 6.4 Hz, 2H), 2.29 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 139.04, 138.11, 136.98, 129.03, 127.09, 126.65, 126.65, 126.01, 125.58, 125.47, 124.87, 121.88, 120.02, 118.97, 117.81, 111.94, 101.54, 95.95, 56.67, 50.98, 38.31. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.1500; found, 344.1498.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>2j</b>)</h3><div class="NLM_p last">Yield: 74%. <b>2j</b> was synthesized by the general procedure given above as a white solid, mp 146–148 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.98 (s, 1H), 7.71–7.64 (m, 4H), 7.59 (d, <i>J</i> = 8.0 Hz, 1H), 7.42 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (t, <i>J</i> = 7.4 Hz, 1H), 7.07 (t, <i>J</i> = 7.5 Hz, 1H), 7.00 (d, <i>J</i> = 12.8 Hz, 1H), 6.55–6.45 (m, 1H), 4.62 (t, <i>J</i> = 11.2 Hz, 1H), 4.50 (d, <i>J</i> = 13.9 Hz, 1H), 4.11 (dd, <i>J</i> = 13.1, 7.0 Hz, 1H), 3.94 (dd, <i>J</i> = 13.4, 7.7 Hz, 1H), 2.89 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 139.12, 138.76, 137.21, 127.90, 126.45, 126.45, 125.81, 125.47, 125.39, 125.11, 124.35, 122.74, 121.08, 119.81, 119.13, 111.23, 105.89, 57.01, 52.21, 38.39. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.1500; found, 344.1501.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>E</i>)-<i>N</i>-((3a,7a-Dihydrobenzofuran-3-yl)methyl)-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>3a</b>)</h3><div class="NLM_p last">To a solution of <b>47</b> (895.0 mg, 5 mmol) in methanol were added <b>49a</b> (1320.0 mg, 5 mmol) and K<sub>2</sub>CO<sub>3</sub> (140.0 mg, 10 mmol) in batches at room temperature. Thereafter the reaction mixture was stirred for 4 h and concentrated. The residue was poured into water and extracted with EtOAc. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and condensed. The residue was then purified via flash chromatography on silica gel, eluting with EtOAc/petroleum ether (1:1, v/v) to give the free base of <b>3a</b> as a colorless oil. <b>3a</b> was prepared using general procedure of salification as a colorless oil. Yield: 65%. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.15 (s, 1H), 7.88–7.78 (m, 1H), 7.61 (s, 1H), 7.36–7.33 (m, 2H), 6.94 (dd, <i>J</i> = 7.5, 1.0 Hz, 1H), 6.89 (d, <i>J</i> = 8.1 Hz, 1H), 6.82 (d, <i>J</i> = 23.9 Hz, 2H), 5.65 (s, 1H), 4.62 (d, <i>J</i> = 37.6 Hz, 2H), 4.03 (d, <i>J</i> = 7.2 Hz, 2H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 160.71, 155.73, 148.11, 147.99, 130.40, 128.24, 128.17, 127.69, 126.32, 126.22, 124.29, 124.25, 123.04, 121.89, 113.19, 112.78, 110.78, 76.08, 51.45. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>17</sub>F<sub>3</sub>NO [M + H]<sup>+</sup>, 332.1262; found, 332.1263.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>E</i>)-<i>N</i>-((3a,7a-Dihydrobenzofuran-3-yl)methyl)-<i>N</i>-ethyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine (<b>3b</b>)</h3><div class="NLM_p last">To a solution of the free base of <b>3a</b> (360.0 mg, 1.4 mmol) in DMF (10 mL) was added sodium hydride (52 mg, 1.4 mmol) in batches at 0 °C under a N<sub>2</sub> atmosphere. The reaction mixture was stirred for 15 min, and iodoethane (219.0 μL, 2.7 mmol) was added into the solution. The mixture was stirred at room temperature overnight, poured into water, and extracted with EtOAc. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and condensed. The residue was then purified via flash chromatography on silica gel, eluting with EtOAc/petroleum ether (1:5, v/v) to give the free base of <b>11b</b> as a colorless oil. Yield: 50%. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.15 (s, 1H), 7.80 (d, <i>J</i> = 7.6 Hz, 1H), 7.59 (d, <i>J</i> = 6.4 Hz, 2H), 7.44 (ddd, <i>J</i> = 9.5, 5.9, 2.2 Hz, 3H), 7.41–7.33 (m, 2H), 6.98 (d, <i>J</i> = 15.8 Hz, 1H), 6.51–6.33 (m, 1H), 4.63 (s, 2H), 4.06 (dd, <i>J</i> = 7.0, 3.4 Hz, 2H), 3.37 (q, <i>J</i> = 7.3 Hz, 2H), 1.47 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.48, 147.91, 140.15, 134.28, 128.57, 128.57, 127.29, 126.93, 126.46, 126.46, 125.28, 123.44, 123.11, 119.34, 119.31, 111.51, 109.83, 54.28, 48.31, 45.28, 8.22. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>21</sub>NO [M + H]<sup>+</sup>, 360.1575; found, 360.1576.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>E</i>)-<i>N</i>-((3a,7a-Dihydrobenzofuran-3-yl)methyl)-<i>N</i>-isopropyl-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-amine (<b>3c</b>)</h3><div class="NLM_p last">Yield: 50%. <b>3c</b> was synthesized using general procedure of salification as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.03 (d, <i>J</i> = 5.7 Hz, 1H), 7.82 (d, <i>J</i> = 7.3 Hz, 1H), 7.77 (d, <i>J</i> = 7.2 Hz, 1H), 7.58 (dd, <i>J</i> = 7.9, 2.4 Hz, 1H), 7.37 (dddd, <i>J</i> = 33.9, 26.7, 12.6, 5.2 Hz, 4H), 7.20 (t, <i>J</i> = 7.9 Hz, 1H), 6.92 (td, <i>J</i> = 7.1, 4.0 Hz, 1H), 6.81 (d, <i>J</i> = 8.1 Hz, 1H), 4.71–4.58 (m, 1H), 4.57–4.44 (m, 3H), 3.95–3.79 (m, 1H), 3.31 (d, <i>J</i> = 1.6 Hz, 6H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.57, 147.96, 139.62, 127.04, 127.04, 126.41, 125.86, 125.80, 125.74, 125.30, 123.47, 123.47, 123.08, 119.31, 114.63, 111.51, 109.86, 57.39, 47.54, 37.50, 37.50. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>23</sub>F<sub>3</sub>NO [M + H]<sup>+</sup>, 374.1732; found, 374.1733.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methy-2-en-1-amine Hydrochloride (<b>4a</b>)</h3><div class="NLM_p last">(<i>E</i>)-1-Bromobut-2-ene was bought from the chemical reagent company. Yield: 45%. <b>4a</b> was synthesized by the general procedure given above as a white solid, mp 171–173 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.15 (s, 1H), 7.87–7.81 (m, 1H), 7.60 (dt, <i>J</i> = 10.1, 4.9 Hz, 1H), 7.46–7.37 (m, 2H), 6.96–6.83 (m, 1H), 6.19–6.08 (m, 1H), 4.60 (dd, <i>J</i> = 17.9, 9.2 Hz, 1H), 4.49–4.42 (m, 1H), 3.91 (dt, <i>J</i> = 23.7, 11.8 Hz, 1H), 3.74 (dd, <i>J</i> = 13.1, 7.9 Hz, 1H), 2.84 (s, 3H), 1.85 (dt, <i>J</i> = 5.1, 2.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.47, 147.93, 138.69, 126.46, 125.22, 123.42, 119.40, 119.00, 111.45, 109.90, 57.37, 48.17, 38.10, 16.87. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>18</sub>NO [M + H]<sup>+</sup>, 284.2014; found, 284.2008.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methylbut-2-en-1-amine Hydrochloride (<b>4b</b>)</h3><div class="NLM_p last">Yield: 62%. <b>16a</b> was synthesized by the procedure of <b>4b</b> as a white solid, mp 154–156 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.67 (s, 1H), 7.36 (s, 1H), 7.19 (s, 1H), 7.11 (s, 1H), 6.56 (s, 1H), 6.02 (s, 1H), 5.62 (s, 1H), 4.43 (s, 2H), 3.71–6.38 (m, 2H), 2.65 (s, 3H), 1.71–1.61 (m, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 138.25, 135.47, 129.26, 125.33, 124.17, 122.18, 119.07, 118.91, 112.20, 102.02, 57.51, 55.37, 37.78, 16.73. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub> [M]<sup>+</sup>, 214.1470; found, 214.1471.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-cyclopentyl-<i>N</i>-methyprop-2-en-1-amine Hydrochloride (<b>5a</b>)</h3><div class="NLM_p last">Yield: 54%. <b>5a</b> was synthesized by the general procedure given above as a white solid, mp 154–156 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.08 (s, 1H), 7.78 (d, <i>J</i> = 7.3 Hz, 1H), 7.60 (d, <i>J</i> = 7.9 Hz, 1H), 7.47–7.34 (m, 2H), 6.07 (dd, <i>J</i> = 15.4, 7.7 Hz, 1H), 5.62 (dt, <i>J</i> = 14.8, 7.3 Hz, 1H), 4.59 (d, <i>J</i> = 14.0 Hz, 1H), 4.42 (d, <i>J</i> = 13.9 Hz, 1H), 3.99–3.84 (m, 1H), 3.77–3.62 (m, 1H), 2.82 (s, 3H), 2.59 (dd, <i>J</i> = 15.9, 8.3 Hz, 1H), 1.85 (s, 2H), 1.77–1.58 (m, 4H), 1.39 (s, 2H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.44, 148.27, 147.84, 126.39, 125.28, 123.43, 119.27, 115.81, 111.50, 109.94, 57.47, 43.10, 38.13, 32.26, 32.26, 24.71, 24.71. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>24</sub>NO [M + H]<sup>+</sup>, 270.1858; found, 270.1857.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-cyclopentyl-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>5b</b>)</h3><div class="NLM_p last">Yield: 74%. <b>5b</b> was synthesized by the general procedure given above as a white solid, mp 159–161 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.66 (d, <i>J</i> = 7.8 Hz, 1H), 7.35 (d, <i>J</i> = 2.4 Hz, 1H), 7.19 (d, <i>J</i> = 7.2 Hz, 1H), 7.10 (t, <i>J</i> = 7.6 Hz, 1H), 6.55 (d, <i>J</i> = 3.1 Hz, 1H), 5.95 (dd, <i>J</i> = 12.8, 7.7 Hz, 1H), 5.59 (dt, <i>J</i> = 8.4, 1.8 Hz, 1H), 4.40 (d, <i>J</i> = 12.1 Hz, 2H), 3.65 (d, <i>J</i> = 7.2 Hz, 2H), 2.64 (s, 3H), 2.53–2.49 (m, 1H), 1.84 (d, <i>J</i> = 8.4 Hz, 2H), 1.75–1.56 (m, 4H), 1.40–1.31 (m, 2H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 147.78, 135.48, 129.27, 125.35, 124.21, 122.21, 119.02, 115.83, 112.14, 102.03, 57.58, 55.45, 42.95, 37.79, 32.15, 32.15, 24.59, 24.59. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>26</sub>N<sub>2</sub> [M]<sup>+</sup>, 268.1939; found, 268.1940.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-cyclohexyl-<i>N</i>-methyprop-2-en-1-amine Hydrochloride (<b>6a</b>)</h3><div class="NLM_p last">Yield: 57%. <b>6a</b> was synthesized by the general procedure given above as a yellow solid. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.10 (s, 1H), 7.80 (d, <i>J</i> = 7.3 Hz, 1H), 7.58 (t, <i>J</i> = 9.1 Hz, 1H), 7.47–7.30 (m, 2H), 6.19–5.97 (m, 1H), 5.71–5.53 (m, 1H), 4.52 (d, <i>J</i> = 46.0 Hz, 2H), 3.81 (d, <i>J</i> = 66.3 Hz, 2H), 2.80 (d, <i>J</i> = 14.3 Hz, 3H), 2.65–2.51 (m, 1H), 1.85 (dt, <i>J</i> = 11.2, 6.8 Hz, 2H), 1.75–1.50 (m, 5H), 1.44–1.23 (m, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.49, 149.31, 141.84, 125.28, 123.43, 119.27, 115.81, 112.54, 111.50, 109.94, 57.78, 55.55, 40.68, 37.86, 32.01, 32.01, 25.68, 25.50, 25.50. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>26</sub>NO [M + H]<sup>+</sup>, 284.2014; found, 284.2008.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-cyclohexyl-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>6b</b>)</h3><div class="NLM_p last">Yield: 72%. <b>6b</b> was synthesized by the general procedure given above as a white solid, mp 165–167 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.69 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (d, <i>J</i> = 3.1 Hz, 1H), 7.23 (d, <i>J</i> = 7.1 Hz, 1H), 7.12 (t, <i>J</i> = 7.6 Hz, 1H), 6.56 (d, <i>J</i> = 3.1 Hz, 1H), 5.99 (d, <i>J</i> = 2.4 Hz, 1H), 5.62–5.49 (m, 1H), 4.55 (s, 2H), 3.78 (s, 2H), 2.73 (s, 3H), 2.09 (d, <i>J</i> = 6.8 Hz, 1H), 1.85–1.45 (m, 5H), 1.35–1.25 (m, 2H), 1.24–1.05 (m, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 148.94, 135.59, 129.37, 125.46, 124.35, 122.33, 119.12, 115.51, 112.20, 102.13, 57.78, 55.55, 40.68, 37.86, 32.01, 32.01, 25.68, 25.50, 25.50. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>26</sub>N<sub>2</sub> [M]<sup>+</sup>, 282.2096; found, 282.2095.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(furan-2-yl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>7a</b>)</h3><div class="NLM_p last">Yield: 35%. <b>7a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.14 (d, <i>J</i> = 20.9 Hz, 1H), 7.81 (d, <i>J</i> = 7.2 Hz, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 1H), 7.54 (s, 1H), 7.40 (ddd, <i>J</i> = 15.0, 13.9, 6.8 Hz, 2H), 6.76 (dd, <i>J</i> = 25.9, 15.6 Hz, 1H), 6.60–6.44 (m, 2H), 6.28–6.12 (m, 1H), 4.66 (d, <i>J</i> = 13.9 Hz, 1H), 4.50 (d, <i>J</i> = 13.9 Hz, 1H), 4.10 (dt, <i>J</i> = 14.4, 7.2 Hz, 1H), 3.91 (dd, <i>J</i> = 13.1, 8.3 Hz, 1H), 2.93–2.76 (m, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.53, 150.91, 147.94, 143.54, 128.41, 125.28, 125.18, 123.46, 119.29, 111.50, 111.41, 111.07, 110.98, 109.81, 57.37, 48.14, 38.26. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>18</sub>NO<sub>2</sub> [M + H]<sup>+</sup>, 268.1338; found, 268.1334.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(furan-2-yl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>7b</b>)</h3><div class="NLM_p last">Yield: 66%. <b>7b</b> was synthesized by the general procedure given above as a white solid, mp 147–149 °C. <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.53 (s, 1H), 7.36–7.21 (m, 1H), 7.28 (t, <i>J</i> = 12.2 Hz, 1H), 7.19–7.11 (m, 1H), 6.75–6.66 (m, 1H), 6.58 (d, <i>J</i> = 3.1 Hz, 1H), 6.53–6.45 (m, 2H), 6.24–6.14 (m, 1H), 4.63 (s, 2H), 4.09–3.87 (m, 2H), 2.77–2.57 (m, 1H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 150.89, 143.33, 135.50, 129.31, 128.14, 125.39, 124.26, 122.30, 119.06, 113.94, 112.00, 111.27, 110.71, 102.06, 57.47, 55.55, 37.86. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>O [M]<sup>+</sup>, 266.1419; found, 266.1418.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(thiophen-2-yl)prop-2-en-1-amine Hydrochloride (<b>8a</b>)</h3><div class="NLM_p last">Yield: 40%. <b>8a</b> was synthesized by the general procedure given above as a yellow solid. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (s, 1H), 7.80 (d, <i>J</i> = 1.2 Hz, 1H), 7.61–7.58 (m, 1H), 7.44 (dd, <i>J</i> = 7.2, 1.2 Hz, 1H), 7.39–7.35 (m, 1H), 7.25 (t, <i>J</i> = 7.6 Hz, 2H), 7.16 (d, <i>J</i> = 7.5 Hz, 1H), 6.91 (d, <i>J</i> = 15.8 Hz, 1H), 6.41–6.31 (m, 1H), 4.66 (t, <i>J</i> = 9.5 Hz, 1H), 4.54–4.46 (m, 1H), 4.11 (dt, <i>J</i> = 7.0, 5.7 Hz, 1H), 3.94 (dd, <i>J</i> = 13.1, 8.2 Hz, 1H), 2.90 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 155.42, 147.85, 140.92, 138.17, 135.09, 129.40, 128.26, 127.21, 125.16, 123.81, 123.35, 119.24, 115.81, 111.39, 57.55, 48.12, 38.27. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>18</sub>NOS [M + H]<sup>+</sup>, 360.1422; found, 360.1421.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(thiophen-2-yl)prop-2-en-1-amine Hydrochloride (<b>8b</b>)</h3><div class="NLM_p last">Yield: 43%. <b>8b</b> was synthesized by the general procedure given above as a white solid, mp 144–147 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.62 (d, <i>J</i> = 7.7 Hz, 1H), 7.35–7.30 (m, 2H), 7.16 (d, <i>J</i> = 7.1 Hz, 1H), 7.08 (d, <i>J</i> = 7.0 Hz, 2H), 7.02–6.92 (m, 1H), 6.91 (d, <i>J</i> = 4.2 Hz, 1H), 6.53 (d, <i>J</i> = 2.4 Hz, 1H), 6.19–6.07 (m, 1H), 4.29 (s, 2H), 3.66 (d, <i>J</i> = 7.2 Hz, 2H), 2.58 (d, <i>J</i> = 8.1 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.66, 135.49, 130.70, 129.00, 127.20, 126.95, 125.20, 124.98, 123.32, 121.17, 119.38, 118.96, 115.56, 101.76, 58.18, 56.84, 39.11. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>18</sub>N<sub>2</sub>S [M]<sup>+</sup>, 282.1191; found, 282.1189.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(naphthalen-1-yl)prop-2-en-1-amine Hydrochloride (<b>9a</b>)</h3><div class="NLM_p last">Yield: 46%. <b>9a</b> was synthesized by the general procedure given above as a white solid, mp 149–151 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.16 (d, <i>J</i> = 8.7 Hz, 2H), 7.94–7.87 (m, 2H), 7.86–7.73 (m, 3H), 7.61 (d, <i>J</i> = 7.8 Hz, 1H), 7.59–7.34 (m, 5H), 6.49–6.34 (m, 1H), 4.67 (d, <i>J</i> = 36.8 Hz, 2H), 4.18 (d, <i>J</i> = 49.8 Hz, 2H), 2.97 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.54, 148.00, 138.05, 133.77, 132.67, 131.01, 129.06, 128.32, 126.456, 126.27, 125.76, 125.26, 124.07, 123.48, 122.98, 122.05, 119.37, 111.51, 109.89, 57.67, 48.18, 38.48. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>22</sub>NO [M + H]<sup>+</sup>, 328.1701; found, 328.1700.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(naphthalen-1-yl)prop-2-en-1-amine Hydrochloride (<b>9b</b>)</h3><div class="NLM_p last">Yield: 39%. <b>9b</b> was synthesized by the general procedure given above as a white solid, mp 137–139 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.15 (d, <i>J</i> = 8.1 Hz, 1H), 7.88 (dd, <i>J</i> = 8.2, 7.8 Hz, 2H), 7.72–7.63 (m, 3H), 7.60–7.46 (m, 4H), 7.36 (d, <i>J</i> = 3.1 Hz, 1H), 7.24 (d, <i>J</i> = 7.1 Hz, 1H), 7.12 (t, <i>J</i> = 7.6 Hz, 1H), 6.57 (d, <i>J</i> = 3.1 Hz, 1H), 6.47–6.36 (m, 1H), 4.43 (s, 2H), 3.88 (d, <i>J</i> = 7.1 Hz, 2H), 2.71 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 136.87, 135.43, 134.87, 133.62, 133.29, 130.90, 128.88, 128.30, 128.12, 125.92, 125.49, 125.12, 124.83, 123.73, 123.34, 123.12, 123.02, 121.14, 118.88, 115.30, 58.32, 56.80, 39.18. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>2</sub> [M]<sup>+</sup>, 326.1783; found, 326.1784.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(naphthalen-2-yl)prop-2-en-1-amine Hydrochloride (<b>10a</b>)</h3><div class="NLM_p last">Yield: 51%. <b>10a</b> was synthesized by the general procedure given above as a white solid, mp 148–150 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.14 (s, 1H), 7.91–7.81 (m, 5H), 7.73 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.63–7.59 (m, 1H), 7.53–7.48 (m, 2H), 7.41 (dtd, <i>J</i> = 18.2, 7.3, 1.3 Hz, 2H), 7.12 (d, <i>J</i> = 15.7 Hz, 1H), 6.60–6.44 (m, 1H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 155.43, 147.86, 140.73, 133.63, 133.40, 132.61, 128.09, 127.78, 127.44, 127.24, 126.35, 126.27, 126.17, 125.16, 123.36, 122.87, 119.27, 116.48, 111.39, 109.81, 57.58, 47.94, 38.34. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>22</sub>NO [M + H]<sup>+</sup>, 328.1701; found, 328.1700.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(naphthalen-2-yl)prop-2-en-1-amine Hydrochloride (<b>10b</b>)</h3><div class="NLM_p last">Yield: 55%. <b>10b</b> was synthesized by the general procedure given above as a white solid, mp 173–174 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.85–7.62 (m, 4H), 7.71 (t, <i>J</i> = 6.7 Hz, 2H), 7.53–7.45 (m, 2H), 7.39 (d, <i>J</i> = 3.2 Hz, 1H), 7.30 (d, <i>J</i> = 7.1 Hz, 1H), 7.16 (t, <i>J</i> = 7.6 Hz, 1H), 7.07 (d, <i>J</i> = 6.4 Hz, 1H), 6.58 (d, <i>J</i> = 3.2 Hz, 1H), 6.53–6.42 (m, 1H), 4.80–4.56 (m, 2H), 4.21–3.97 (m, 2H), 2.86 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.82, 135.62, 133.73, 133.49, 132.73, 129.46, 128.16, 127.87, 127.53, 127.34, 126.36, 126.27, 125.54, 124.42, 122.99, 122.48, 119.20, 116.39, 112.07, 102.22, 57.91, 55.69, 38.15. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>2</sub> [M]<sup>+</sup>, 326.1783; found, 326.1786.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-phenylprop-2-en-1-amine Hydrochloride (<b>11a</b>)</h3><div class="NLM_p last">Yield: 60%. <b>11a</b> was synthesized by the general procedure given above as a white solid, mp 167–169 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (s, 1H), 7.80 (m, 1H), 7.60 (m, 1H), 7.48 (d, <i>J</i> = 23.1 Hz, 2H), 7.39 (m, 5H), 6.95 (d, <i>J</i> = 16.0 Hz, 1H), 6.40 (m, 1H), 4.68 (d, <i>J</i> = 13.7 Hz, 1H), 4.52 (d, <i>J</i> = 13.5 Hz, 1H), 4.12 (s, 1H), 3.95 (s, 1H), 2.88 (d, <i>J</i> = 17.6 Hz 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.52, 147.92, 140.80, 135.26, 128.78, 128.48, 128.48, 126.73, 126.73, 126.43, 125.26, 123.45, 119.33, 116.27, 111.49, 109.93, 57.61, 47.35, 38.39. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>20</sub>NO [M + H]<sup>+</sup>, 278.1545; found, 278.1545.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-phenylprop-2-en-1-amine Hydrochloride (<b>11b</b>)</h3><div class="NLM_p last">Yield: 76%. <b>11b</b> was synthesized by the general procedure given above as a white solid, mp 180–181 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.76–7.67 (m, 1H), 7.51 (d, <i>J</i> = 7.0 Hz, 2H), 7.40–7.25 (m, 5H), 7.16 (t, <i>J</i> = 7.6 Hz, 1H), 6.92 (d, <i>J</i> = 4.8 Hz, 1H), 6.57 (t, <i>J</i> = 6.4 Hz, 1H), 6.37–6.25 (m, 1H), 4.79–4.75 (m, 1H), 4.60–4.50 (m, 1H), 4.19–4.07 (m, 1H), 3.90–3.65 (m, 1H), 2.83 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 138.29, 135.42, 134.24, 134.12, 129.18, 128.39, 128.39, 128.05, 128.05, 125.19, 125.18, 123.87, 121.85, 119.11, 118.25, 101.97, 57.75, 55.98, 38.40. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>2</sub> [M]<sup>+</sup> 276.1626; found, 276.1625.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(4-chlorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>12a</b>)</h3><div class="NLM_p last">Yield: 51%. <b>12a</b> was synthesized by the general procedure given above as a white solid, mp 147–148 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (s, 1H), 7.80 (d, <i>J</i> = 7.4 Hz, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 1H), 7.50 (d, <i>J</i> = 8.5 Hz, 2H), 7.46–7.34 (m, 4H), 6.92 (d, <i>J</i> = 16.3 Hz, 1H), 6.39 (dd, <i>J</i> = 15.2, 7.9 Hz, 1H), 4.59 (d, <i>J</i> = 36.9 Hz, 2H), 4.02 (d, <i>J</i> = 52.6 Hz, 2H), 2.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.48, 147.94, 139.33, 134.47, 128.61, 128.61, 128.22, 128.22, 126.41, 125.33 125.29, 123.47, 119.31, 117.20, 111.51, 109.81, 57.43, 47.21, 38.43. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>ClNO [M + H]<sup>+</sup>, 312.1155; found, 312.1154.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(4-chlorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>12b</b>)</h3><div class="NLM_p last">Yield: 64%. <b>12b</b> was synthesized by the general procedure given above as a white solid, mp 159–163 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.66 (d, <i>J</i> = 7.6 Hz, 1H), 7.47 (d, <i>J</i> = 8.4 Hz, 2H), 7.42–7.35 (m, 3H), 7.22 (d, <i>J</i> = 7.0 Hz, 1H), 7.12 (t, <i>J</i> = 7.6 Hz, 1H), 6.79 (d, <i>J</i> = 2.8 Hz, 1H), 6.56 (d, <i>J</i> = 2.4 Hz, 1H), 6.44–6.33 (m, 1H), 4.41 (s, 2H), 3.79 (d, <i>J</i> = 6.7 Hz, 2H), 2.67 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 138.21, 135.45, 134.16, 134.09, 129.21, 128.42, 128.42, 128.01, 128.01, 125.24, 125.16, 123.96, 121.97, 119.00, 118.28, 101.96, 57.74, 55.99, 38.42. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>2</sub> [M]<sup>+</sup>, 310.1237; found, 310.1236.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(4-fluorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>13a</b>)</h3><div class="NLM_p last">Yield: 56%. <b>13a</b> was synthesized by the general procedure given above as a white solid, mp 162–164 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.11 (s, 1H), 7.80 (d, <i>J</i> = 7.7 Hz, 1H), 7.64–7.51 (m, 3H), 7.40 (ddd, <i>J</i> = 15.1, 13.9, 6.8 Hz, 2H), 7.12 (t, <i>J</i> = 8.7 Hz, 2H), 6.92 (d, <i>J</i> = 15.8 Hz, 1H), 6.41–6.24 (m, 1H), 4.54 (s, 2H), 4.02 (d, <i>J</i> = 51.4 Hz, 2H), 2.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.53, 147.97, 139.51, 128.77, 128.77, 128.69, 128.69, 126.37, 125.27, 123.46, 119.29, 116.17, 115.38, 115.17, 111.49, 109.88, 57.51, 47.88, 38.37. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>FNO [M + H]<sup>+</sup>, 296.1451; found, 296.1450.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(4-fluorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>13b</b>)</h3><div class="NLM_p last">Yield: 54%. <b>13b</b> was synthesized by the general procedure given above as a white solid, mp 161–163 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.68 (d, <i>J</i> = 7.9 Hz, 1H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 7.37 (d, <i>J</i> = 2.4 Hz, 1H), 7.23 (d, <i>J</i> = 4.6 Hz, 1H), 7.16–7.07 (m, 3H), 6.81 (d, <i>J</i> = 12.8 Hz, 1H), 6.57 (d, <i>J</i> = 3.1 Hz, 1H), 6.37–6.27 (m, 1H), 4.46 (s, 2H), 3.83 (d, <i>J</i> = 7.0 Hz, 2H), 2.70 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 138.96, 135.48, 131.73, 129.28, 128.61, 128.58, 125.35, 124.20, 122.20, 119.05, 118.15, 116.45, 115.19, 115.02, 112.35, 102.03, 57.69, 55.70, 38.13. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>2</sub> [M]<sup>+</sup>, 294.1532; found, 294.1531.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(4-bromophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>14a</b>)</h3><div class="NLM_p last">Yield: 43%. <b>14a</b> was synthesized by the general procedure given above as a white solid, mp 164–165 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (s, 1H), 7.81 (d, <i>J</i> = 7.4 Hz, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 1H), 7.54 (d, <i>J</i> = 8.4 Hz, 2H), 7.47–7.35 (m, 4H), 6.90 (d, <i>J</i> = 15.8 Hz, 1H), 6.51–6.31 (m, 1H), 4.58 (s, 2H), 4.01 (s, 2H), 2.89 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.50, 147.75, 139.49, 134.24, 131.64, 131.64, 128.45, 128.45, 126.39, 125.11, 123.47, 122.58, 119.29, 117.11, 111.30, 109.92, 57.43, 48.09, 38.39. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>BrNO [M + H]<sup>+</sup>, 356.0650; found, 358.0636.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(4-bromophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>14b</b>)</h3><div class="NLM_p last">Yield: 51%. <b>14b</b> was synthesized by the general procedure given above as a white solid, mp 131–134 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.63 (d, <i>J</i> = 8.0 Hz, 1H), 7.51 (d, <i>J</i> = 8.4 Hz, 2H), 7.39 (d, <i>J</i> = 8.4 Hz, 2H), 7.35 (d, <i>J</i> = 3.1 Hz, 1H), 7.18 (d, <i>J</i> = 7.0 Hz, 1H), 7.09 (t, <i>J</i> = 7.5 Hz, 1H), 6.72 (d, <i>J</i> = 6.8 Hz, 1H), 6.54 (d, <i>J</i> = 3.1 Hz, 1H), 6.46–6.35 (m, 1H), 4.29 (s, 2H), 3.67 (d, <i>J</i> = 6.9 Hz, 2H), 2.59 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 135.84, 135.38, 135.10, 131.33, 131.33, 128.79, 128.25, 128.04, 128.04, 124.73, 121.69, 121.56, 120.94, 118.83, 115.77, 58.22, 56.94, 39.31. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>BrN<sub>2</sub> [M]<sup>+</sup>, 354.0732; found, 354.0734.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(<i>p</i>-tolyl)prop-2-en-1-amine Hydrochloride (<b>15a</b>)</h3><div class="NLM_p last">Yield: 46%. <b>15a</b> was synthesized by the general procedure given above as a white solid, mp 164–165 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.13 (s, 1H), 7.83 (d, <i>J</i> = 7.2 Hz, 1H), 7.62 (dd, <i>J</i> = 15.1, 7.8 Hz, 2H), 7.40 (qd, <i>J</i> = 14.2, 6.8 Hz, 3H), 7.23–7.11 (m, 2H), 7.08 (d, <i>J</i> = 16.0 Hz, 1H), 6.59–6.38 (m, 1H), 4.61 (s, 2H), 4.09 (s, 2H), 2.91 (s, 3H), 2.38 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.53, 147.88, 140.78, 139.05, 132.50, 129.09, 129.09, 126.70, 126.70, 126.42, 125.26, 123.44, 119.33, 115.11, 111.49, 109.96, 57.75, 47.88, 38.38, 19.88. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>NO [M + H]<sup>+</sup>, 292.1701; found, 292.1702.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(<i>p</i>-tolyl)prop-2-en-1-amine Hydrochloride (<b>15b</b>)</h3><div class="NLM_p last">Yield: 76%. <b>15b</b> was synthesized by the general procedure given above as a white solid, mp 122–124 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.69 (d, <i>J</i> = 7.8 Hz, 1H), 7.46–7.35 (m, 3H), 7.25 (d, <i>J</i> = 7.2 Hz, 1H), 7.19 (d, <i>J</i> = 7.9 Hz, 2H), 7.13–7.00 (m, 2H), 6.81 (d, <i>J</i> = 15.8 Hz, 1H), 6.57 (t, <i>J</i> = 5.5 Hz, 1H), 6.37–6.26 (m, 1H), 4.52 (s, 2H), 3.88 (d, <i>J</i> = 7.3 Hz, 2H), 2.73 (s, 3H), 2.35 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 140.50, 138.87, 135.50, 132.46, 129.30, 128.95, 128.95, 126.59, 126.59, 125.38, 124.25, 122.26, 119.06, 115.04, 112.15, 102.06, 57.85, 55.57, 37.97, 19.78. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>N<sub>2</sub> [M]<sup>+</sup>, 290.1783; found, 290.1784.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(4-bromophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>16a</b>)</h3><div class="NLM_p last">Yield: 43%. <b>16a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (s, 1H), 7.85–7.74 (m, 1H), 7.60 (d, <i>J</i> = 7.8 Hz, 1H), 7.46 (d, <i>J</i> = 8.7 Hz, 2H), 7.42–7.35 (m, 2H), 6.98–6.91 (m, 2H), 6.88 (d, <i>J</i> = 15.7 Hz, 1H), 6.22 (dt, <i>J</i> = 15.5, 7.5 Hz, 1H), 4.66 (d, <i>J</i> = 13.9 Hz, 1H), 4.50 (d, <i>J</i> = 13.9 Hz, 1H), 4.10 (dd, <i>J</i> = 12.7, 7.2 Hz, 1H), 3.91 (dd, <i>J</i> = 13.0, 7.8 Hz, 1H), 3.81 (s, 3H), 2.89 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 160.61, 155.51, 147.93, 140.59, 128.18, 128.18, 127.87, 126.43, 125.25, 123.45, 119.36, 113.81, 113.81, 113.47, 111.48, 109.91, 57.84, 54.40, 48.13, 38.26. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>21</sub>NO<sub>2</sub> [M + H]<sup>+</sup>, 307.1572; found, 307.1575.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(4-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>16b</b>)</h3><div class="NLM_p last">Yield: 61%. <b>16b</b> was synthesized by the general procedure given above as a white solid, mp 152–154 °C. <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.68 (d, <i>J</i> = 7.9 Hz, 1H), 7.42 (d, <i>J</i> = 8.7 Hz, 2H), 7.36 (d, <i>J</i> = 3.1 Hz, 1H), 7.29–7.20 (m, 1H), 7.12 (t, <i>J</i> = 7.6 Hz, 1H), 6.91 (d, <i>J</i> = 4.6 Hz, 2H), 6.80 (d, <i>J</i> = 2.4 Hz, 1H), 6.56 (d, <i>J</i> = 6.4 Hz, 1H), 6.25–6.14 (m, 1H), 4.51 (s, 2H), 3.87 (d, <i>J</i> = 5.5 Hz, 2H), 3.80 (s, 3H), 2.72 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 160.42, 140.13, 135.50, 129.27, 128.04, 128.04, 127.88, 125.36, 124.26, 122.21, 119.06, 113.67, 113.67, 113.41, 112.25, 102.02, 57.94, 55.49, 54.28, 37.89. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>N<sub>2</sub>O [M]<sup>+</sup>, 306.1732; found, 306.1731.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(4-ethoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>17a</b>)</h3><div class="NLM_p last">Yield: 41%. <b>17a</b> was synthesized by the general procedure given above as a white solid, mp 153–154 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (d, <i>J</i> = 5.9 Hz, 1H), 7.81 (d, <i>J</i> = 6.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 1H), 7.47–7.34 (m, 4H), 6.96–6.79 (m, 3H), 6.30–6.14 (m, 1H), 4.66 (d, <i>J</i> = 14.0 Hz, 1H), 4.50 (d, <i>J</i> = 13.8 Hz, 1H), 4.07 (ddd, <i>J</i> = 20.8, 13.6, 7.2 Hz, 3H), 3.91 (dd, <i>J</i> = 13.0, 8.0 Hz, 1H), 2.88 (s, 3H), 1.39 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 159.90, 155.50, 147.96, 140.60, 128.18, 128.18, 127.76, 126.45, 125.25, 123.45, 119.40, 114.33, 114.33, 113.82, 111.48, 109.91, 63.19, 57.85, 47.95, 38.25, 13.70. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>24</sub>NO<sub>2</sub> [M + H]<sup>+</sup>, 322.1807; found, 322.1808.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(4-ethoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>17b</b>)</h3><div class="NLM_p last">Yield: 67%. <b>17b</b> was synthesized by the general procedure given above as a white solid, mp 148–149 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.70 (d, <i>J</i> = 7.8 Hz, 1H), 7.41 (d, <i>J</i> = 8.7 Hz, 2H), 7.36 (t, <i>J</i> = 6.6 Hz, 1H), 7.26 (d, <i>J</i> = 7.2 Hz, 1H), 7.13 (t, <i>J</i> = 7.6 Hz, 1H), 6.90 (t, <i>J</i> = 7.5 Hz, 2H), 6.83–6.81 (m, 1H), 6.57 (d, <i>J</i> = 3.2 Hz, 1H), 6.19–6.04 (m, 2H), 4.61 (s, 2H), 4.09–4.00 (m, 2H), 3.97 (d, <i>J</i> = 7.4 Hz, 2H), 2.81 (d, <i>J</i> = 27.0 Hz, 3H), 1.41–1.33 (m, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 159.83, 140.27, 135.59, 129.38, 128.13, 128.13, 127.85, 125.46, 124.31, 122.30, 119.15, 114.29, 114.29, 113.64, 112.41, 102.13, 63.17, 58.09, 55.61, 38.02, 13.70. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>24</sub>N<sub>2</sub>O [M]<sup>+</sup>, 320.1889; found, 320.1890.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(4-nitrophenyl)prop-2-en-1-amine Hydrochloride (<b>18a</b>)</h3><div class="NLM_p last">Yield: 45%. <b>18a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.25 (d, <i>J</i> = 8.5 Hz, 2H), 8.14 (s, 1H), 7.81 (t, <i>J</i> = 13.0 Hz, 1H), 7.75 (d, <i>J</i> = 8.8 Hz, 2H), 7.60 (d, <i>J</i> = 8.1 Hz, 1H), 7.41 (dq, <i>J</i> = 14.6, 7.2 Hz, 2H), 7.05 (d, <i>J</i> = 15.8 Hz, 1H), 6.63 (dd, <i>J</i> = 15.5, 7.8 Hz, 1H), 4.70 (d, <i>J</i> = 13.6 Hz, 1H), 4.57 (d, <i>J</i> = 14.0 Hz, 1H), 4.19 (dd, <i>J</i> = 13.2, 6.9 Hz, 1H), 4.06–3.94 (m, 1H), 2.92 (d, <i>J</i> = 7.7 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.51, 148.08, 147.82, 141.60, 138.11, 127.68, 127.68, 126.43, 125.28, 123.59, 123.59, 123.48, 121.35, 119.39, 111.50, 109.79, 57.12, 47.89, 38.62. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 323.1396; found, 323.1393.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(4-nitrophenyl)prop-2-en-1-amine Hydrochloride (<b>18b</b>)</h3><div class="NLM_p last">Yield: 73%. <b>18b</b> was synthesized by the general procedure given above as a white solid, mp 133–136 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.25 (d, <i>J</i> = 8.7 Hz, 2H), 7.75–7.65 (m, 3H), 7.39 (d, <i>J</i> = 2.4 Hz, 1H), 7.26 (d, <i>J</i> = 7.2 Hz, 1H), 7.14 (t, <i>J</i> = 7.6 Hz, 1H), 6.95 (d, <i>J</i> = 15.7 Hz, 1H), 6.65–6.54 (m, 2H), 4.53 (s, 2H), 3.94 (d, <i>J</i> = 5.5 Hz, 2H), 2.77 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 147.23, 142.30, 135.37, 134.98, 128.85, 127.40, 127.17, 127.17, 125.47, 124.82, 123.39, 123.39, 123.28, 121.15, 118.87, 115.33, 57.93, 56.99, 39.42. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>[M]<sup>+</sup>, 321.1477; found, 321.1478.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(4-(difluoromethyl)phenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>19a</b>)</h3><div class="NLM_p last">Yield: 55%. <b>19a</b> was synthesized by the general procedure given above as a white solid, mp 145–146 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.11 (s, 1H), 7.81 (d, <i>J</i> = 7.5 Hz, 1H), 7.67–7.53 (m, 5H), 7.47–7.35 (m, 2H), 6.98 (d, <i>J</i> = 16.1 Hz, 1H), 6.84 (d, <i>J</i> = 56.0 Hz, 1H), 6.47 (dt, <i>J</i> = 15.1, 7.5 Hz, 1H), 4.55 (s, 2H), 3.99 (s, 2H), 2.91 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.57, 147.96, 139.62, 137.66, 127.04, 127.04, 126.41, 125.86, 125.80, 125.74, 125.30, 123.47, 119.31, 118.26, 114.63, 111.51, 109.86, 57.39, 48.14, 38.50. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>20</sub>F<sub>2</sub>NO [M + H]<sup>+</sup>, 328.1513; found, 328.1512.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(4-(difluoromethyl)phenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>19b</b>)</h3><div class="NLM_p last">Yield: 64%. <b>19b</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.48–7.30 (m, 5H), 7.25 (d, <i>J</i> = 3.1 Hz, 1H), 7.03 (d, <i>J</i> = 6.9 Hz, 1H), 6.97 (t, <i>J</i> = 7.4 Hz, 1H), 6.86 (s, 1H), 6.72 (s, 1H), 6.60 (d, <i>J</i> = 16.1 Hz, 1H), 6.58–6.55 (m, 1H), 6.52–6.41 (m, 2H), 3.87 (s, 2H), 3.27 (d, <i>J</i> = 6.6 Hz, 2H), 2.28 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 139.53, 135.34, 131.99, 128.55, 128.42, 126.21, 126.21, 125.51, 125.45, 124.13, 121.62, 120.82, 119.28, 118.60, 117.24, 114.89, 101.15, 59.29, 58.82, 41.06. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>20</sub>F<sub>2</sub>N<sub>2</sub> [M]<sup>+</sup>, 326.1595; found, 326.1596.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> (<i>E</i>)-4-(3-((Benzofuran-3-ylmethyl)(methyl)amino)prop-1-en-1-yl)benzonitrile Hydrochloride (<b>20a</b>)</h3><div class="NLM_p last">Yield: 51%. <b>20a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.13 (d, <i>J</i> = 8.3 Hz, 1H), 7.83 (t, <i>J</i> = 7.1 Hz, 1H), 7.74 (d, <i>J</i> = 8.2 Hz, 3H), 7.69 (d, <i>J</i> = 8.3 Hz, 2H), 7.60 (d, <i>J</i> = 8.1 Hz, 1H), 7.47–7.35 (m, 3H), 6.99 (d, <i>J</i> = 15.7 Hz, 1H), 6.64–6.52 (m, 1H), 4.69 (d, <i>J</i> = 13.9 Hz, 1H), 4.56 (d, <i>J</i> = 14.0 Hz, 1H), 4.18 (dd, <i>J</i> = 13.3, 6.7 Hz, 1H), 4.00 (dd, <i>J</i> = 13.1, 8.1 Hz, 1H), 2.92 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 155.43, 147.86, 139.73, 138.46, 132.24, 132.24, 127.38, 127.38, 126.30, 125.19, 123.37, 120.51, 119.21, 117.95, 111.79, 111.41, 109.77, 57.08, 48.18, 38.54. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>NO [M + H]<sup>+</sup>, 303.1497; found, 303.1496.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> (<i>E</i>)-4-(3-(((1<i>H</i>-Indol-7-yl)methyl)(methyl)amino)prop-1-en-1-yl)benzonitrile Hydrochloride (<b>20b</b>)</h3><div class="NLM_p last">Yield: 52%. <b>20b</b> was synthesized by the general procedure given above as a white solid, mp 138–139 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.67 (d, <i>J</i> = 8.4 Hz, 2H), 7.60 (s, 3H), 7.31 (s, 1H), 7.12 (s, 1H), 7.04 (s, 1H), 6.75 (d, <i>J</i> = 8.6 Hz, 1H), 6.53 (d, <i>J</i> = 4.6 Hz, 2H), 4.19 (s, 2H), 3.54 (d, <i>J</i> = 2.4 Hz, 2H), 2.52 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.07, 137.69, 135.55, 132.28, 132.28, 129.34, 127.41, 127.41, 125.38, 124.13, 122.17, 121.62, 119.13, 118.11, 112.96, 111.66, 102.10, 57.59, 56.21, 38.69. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>N<sub>3</sub> [M]<sup>+</sup>, 301.1579; found, 301.1581.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(4-(<i>tert</i>-butyl)phenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>21a</b>)</h3><div class="NLM_p last">Yield: 55%. <b>21a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.16 (s, 1H), 7.85 (dd, <i>J</i> = 7.1, 1.4 Hz, 1H), 7.66–7.59 (m, 1H), 7.47–7.39 (m, 6H), 6.97–6.91 (m, 1H), 6.43–6.31 (m, 1H), 4.70 (d, <i>J</i> = 13.9 Hz, 1H), 4.54 (d, <i>J</i> = 13.9 Hz, 1H), 4.19–4.10 (m, 1H), 3.99–3.89 (m, 1H), 2.92 (s, 3H), 1.34 (s, 9H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 157.29, 155.43, 147.80, 136.07, 130.02, 127.32, 126.67, 126.67, 125.35, 125.35, 123.69, 123.35, 120.29, 119.18, 116.55, 111.40, 110.76, 109.78, 58.12, 54.50, 38.29, 38.29, 38.29. <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.47, 152.12, 147.97, 140.54, 132.54, 129.90, 129.85, 126.57, 126.57, 126.51, 125.35, 125.35, 125.21, 123.44, 119.49, 115.54, 111.45, 110.00, 57.73, 47.93, 38.32, 34.16, 30.26, 30.26, 30.26. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>28</sub>NO [M + H]<sup>+</sup>, 334.2171; found, 334.2172.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(4-(<i>tert</i>-butyl)phenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>21b</b>)</h3><div class="NLM_p last">Yield: 80%. <b>21b</b> was synthesized by the general procedure given above as a white solid, mp 119–122 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.59 (d, <i>J</i> = 7.8, 1H), 7.37 (d, <i>J</i> = 3.2 Hz, 4H), 7.32 (d, <i>J</i> = 3.2 Hz, 1H), 7.15 (d, <i>J</i> = 7.2 Hz, 1H), 7.09–7.03 (m, 1H), 6.69 (d, <i>J</i> = 12.8 Hz, 1H), 6.51 (d, <i>J</i> = 3.2 Hz, 1H), 6.31 (d, <i>J</i> = 7.2 Hz, 1H), 4.25 (d, <i>J</i> = 6.4 Hz, 2H), 3.82–3.62 (m, 2H), 2.58–2.54 (m, 2H), 1.32–1.09 (m, 9H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 151.13, 136.49, 135.48, 133.42, 128.78, 126.12, 126.12, 125.39, 125.17, 125.17, 124.94, 124.68, 122.93, 120.68, 118.86, 116.83, 58.76, 57.24, 39.59, 34.05, 30.29, 30.29, 30.29. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>28</sub>N<sub>2</sub> [M]<sup>+</sup>, 332.2252; found, 332.2253.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Methyl (<i>E</i>)-4-(3-((Benzofuran-3-ylmethyl)(methyl)amino)prop-1-en-1-yl)benzoate Hydrochloride (<b>22a</b>)</h3><div class="NLM_p last">Yield: 55%. <b>22a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.13 (s, 1H), 8.02 (d, <i>J</i> = 8.4 Hz, 2H), 7.82 (d, <i>J</i> = 7.5 Hz, 1H), 7.62 (t, <i>J</i> = 8.8 Hz, 3H), 7.48–7.30 (m, 2H), 7.00 (d, <i>J</i> = 15.8 Hz, 1H), 6.60–6.43 (m, 1H), 4.69 (d, <i>J</i> = 13.9 Hz, 1H), 4.54 (d, <i>J</i> = 13.7 Hz, 1H), 4.15 (d, <i>J</i> = 7.1 Hz, 1H), 4.04–3.94 (m, 1H), 3.91 (s, 3H), 2.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 166.60, 155.52, 148.02, 139.81, 139.38, 130.15, 129.60, 129.60, 126.82, 126.82, 126.42, 125.28, 123.47, 119.33, 111.50, 109.82, 57.32, 51.31, 48.16, 38.52. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>22</sub>NO<sub>3</sub> [M + H]<sup>+</sup>, 336.1600; found, 336.1599.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Methyl (<i>E</i>)-4-(3-(((1<i>H</i>-Indol-7-yl)methyl)(methyl)amino)prop-1-en-1-yl)benzoate Hydrochloride (<b>22b</b>)</h3><div class="NLM_p last">Yield: 73%. <b>22b</b> was synthesized by the general procedure given above as a white oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.97 (s, 2H), 7.54–7.45 (m, 3H), 7.29 (s, 1H), 7.09 (s, 1H), 7.02 (s, 1H), 6.72 (d, <i>J</i> = 6.4 Hz, 1H), 6.49 (s, 2H), 4.10 (s, 2H), 3.89 (s, 3H), 3.50 (s, 2H), 2.45 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 135.59, 133.26, 132.91, 129.46, 129.46, 127.14, 126.58, 126.58, 125.24, 124.18, 123.18, 122.35, 121.98, 119.02, 105.24, 102.01, 57.73, 56.16, 51.18, 38.62. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub> [M]<sup>+</sup>, 334.1681; found, 334.1682.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> (<i>E</i>)-3-([1,1′-Biphenyl]-4-yl)-<i>N</i>-(benzofuran-3-ylmethyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>23a</b>)</h3><div class="NLM_p last">Yield: 61%. <b>23a</b> was synthesized by the general procedure given above as a white solid, mp 157–158 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.13 (s, 1H), 7.86–7.77 (m, 1H), 7.67–7.58 (m, 7H), 7.41 (dddd, <i>J</i> = 23.2, 15.9, 9.3, 4.8 Hz, 5H), 6.99 (d, <i>J</i> = 15.7 Hz, 1H), 6.50–6.34 (m, 1H), 4.68–4.44 (m, 2H), 4.06 (d, <i>J</i> = 55.9 Hz, 2H), 2.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO): δ 155.03, 148.79, 140.67, 139.90, 138.50, 135.09, 129.47, 129.47, 128.16, 127.91, 127.91, 127.43, 127.43, 127.40, 127.04, 127.04, 125.58, 123.79, 121.03, 118.87, 112.12, 110.51, 56.77, 47.37, 38.73. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>NO [M + H]<sup>+</sup>, 354.1858; found, 354.1857.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-([1,1′-biphenyl]-4-yl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>23b</b>)</h3><div class="NLM_p last">Yield: 69%. <b>23b</b> was synthesized by the general procedure given above as a white solid, mp 199–200 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72 (d, <i>J</i> = 7.7 Hz, 1H), 7.67–7.57 (m, 6H), 7.44 (t, <i>J</i> = 7.6 Hz, 2H), 7.40 (d, <i>J</i> = 3.2 Hz, 1H), 7.34 (t, <i>J</i> = 7.4 Hz, 1H), 7.29 (d, <i>J</i> = 7.2 Hz, 1H), 7.16 (t, <i>J</i> = 7.6 Hz, 1H), 6.94 (d, <i>J</i> = 15.7 Hz, 1H), 6.59 (d, <i>J</i> = 3.2 Hz, 1H), 6.46–6.34 (m, 1H), 4.67 (s, 2H), 4.05 (d, <i>J</i> = 6.2 Hz, 2H), 2.83 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.23, 140.15, 135.61, 134.28, 129.45, 128.57, 128.57, 127.38, 127.28, 127.28, 126.92, 126.92, 126.44, 126.44, 125.52, 124.35, 122.44, 119.20, 116.16, 115.62, 112.18, 102.23, 57.92, 55.74, 38.16. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>2</sub> [M]<sup>+</sup>, 352.1939; found, 352.1937.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(2-chlorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>24a</b>)</h3><div class="NLM_p last">Yield: 43%. <b>24a</b> was synthesized by the general procedure given above as a white solid, mp 145–146 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.11 (s, 1H), 7.82 (d, <i>J</i> = 7.2 Hz, 1H), 7.74–7.69 (m, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 1H), 7.42 (dd, <i>J</i> = 17.3, 7.5 Hz, 3H), 7.37–7.29 (m, 3H), 6.40 (dt, <i>J</i> = 15.4, 7.6 Hz, 1H), 4.58 (s, 2H), 4.04 (s, 2H), 2.91 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.53, 148.02, 136.42, 133.33, 133.09, 130.03, 129.52, 127.27, 127.11, 126.41, 125.29, 123.49, 119.77, 119.34, 111.51, 109.81, 57.35, 48.16, 38.48. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>ClNO [M + H]<sup>+</sup>, 312.1155; found, 312.1156.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(2-chlorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>24b</b>)</h3><div class="NLM_p last">Yield: 80%. <b>24b</b> was synthesized by the general procedure given above as a white solid, mp 185–188 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.66 (d, <i>J</i> = 7.9 Hz, 2H), 7.43 (d, <i>J</i> = 6.4 Hz, 1H), 7.37 (d, <i>J</i> = 2.4 Hz, 1H), 7.32 (d, <i>J</i> = 7.8 Hz, 2H), 7.21 (t, <i>J</i> = 6.4 Hz, 2H), 7.12 (t, <i>J</i> = 4.8 Hz, 1H), 6.56 (d, <i>J</i> = 2.4 Hz, 1H), 6.45–6.34 (m, 1H), 4.40 (s, 2H), 3.82 (d, <i>J</i> = 6.9 Hz, 2H), 2.68 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 135.65, 135.47, 133.36, 132.91, 129.76, 129.36, 129.28, 127.14, 126.94, 125.33, 124.18, 122.18, 120.29, 119.04, 112.49, 102.04, 57.64, 55.95, 38.34. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>ClN<sub>2</sub> [M]<sup>+</sup>, 310.1237; found, 310.1233.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(2-fluorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>25a</b>)</h3><div class="NLM_p last">Yield: 47%. <b>25a</b> was synthesized by the general procedure given above as a white solid, mp 140–141 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (s, 1H), 7.85–7.76 (m, 1H), 7.68–7.54 (m, 2H), 7.49–7.29 (m, 3H), 7.27–6.99 (m, 3H), 6.56–6.40 (m, 1H), 4.61 (d, <i>J</i> = 45.6 Hz, 2H), 4.08 (d, <i>J</i> = 69.5 Hz, 2H), 2.91 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.56, 148.07, 136.47, 134.12, 133.08, 130.23, 129.49, 127.25, 127.15, 126.44, 125.21, 123.39, 119.69, 119.29, 111.48, 109.77, 57.32, 48.14, 38.51. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>FNO [M + H]<sup>+</sup>, 296.1451; found, 296.1452.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(2-fluorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>25b</b>)</h3><div class="NLM_p last">Yield: 54%. <b>25b</b> was synthesized by the general procedure given above as a white solid, mp 167–168 °C. <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.72 (d, <i>J</i> = 7.8 Hz, 1H), 7.64–7.58 (m, 1H), 7.39 (d, <i>J</i> = 3.2 Hz, 1H), 7.36 (d, <i>J</i> = 12.4 Hz, 1H), 7.29 (d, <i>J</i> = 7.2 Hz, 1H), 7.20 (t, <i>J</i> = 7.5 Hz, 1H), 7.17–7.10 (m, 2H), 7.05 (s, 1H), 6.59 (d, <i>J</i> = 3.1 Hz, 1H), 6.50–6.42 (m, 1H), 4.66 (s, 2H), 4.15–3.96 (m, 2H), 2.83 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 135.49, 132.57, 130.34, 130.27, 129.31, 127.84, 125.39, 124.29, 124.17, 122.31, 119.39, 119.06, 115.41, 115.23, 112.08, 102.06, 57.89, 55.78, 38.12. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>2</sub> [M]<sup>+</sup>, 294.1532; found, 294.1532.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(<i>o</i>-tolyl)prop-2-en-1-amine Hydrochloride (<b>26a</b>)</h3><div class="NLM_p last">Yield: 32%. <b>26a</b> was synthesized by the general procedure given above as a white solid, mp 164–165 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.70 (dd, <i>J</i> = 15.7, 7.5 Hz, 1H), 7.56 (d, <i>J</i> = 8.7 Hz, 1H), 7.47 (t, <i>J</i> = 7.1 Hz, 2H), 7.32–7.27 (m, 1H), 7.26–7.22 (m, 1H), 7.18–7.11 (m, 3H), 6.77 (d, <i>J</i> = 15.7 Hz, 1H), 6.20 (dt, <i>J</i> = 15.7, 6.6 Hz, 1H), 3.71 (s, 2H), 3.27 (d, <i>J</i> = 6.6 Hz, 2H), 2.34 (s, 3H), 2.32 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.50, 147.99, 138.61, 135.96, 134.24, 130.13, 128.59, 126.49, 125.98, 125.66, 125.24, 123.45, 119.37, 117.66, 111.48, 109.88, 57.71, 47.88, 38.34, 18.38. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>NO [M + H]<sup>+</sup>, 292.1701; found, 292.1702.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(<i>o</i>-tolyl)prop-2-en-1-amine Hydrochloride (<b>26b</b>)</h3><div class="NLM_p last">Yield: 73%. <b>26b</b> was synthesized by the general procedure given above as a white solid, mp 167–169 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.67 (d, <i>J</i> = 7.5 Hz, 1H), 7.54–7.48 (m, 1H), 7.36 (d, <i>J</i> = 3.2 Hz, 1H), 7.23 (d, <i>J</i> = 7.2 Hz, 1H), 7.20–7.15 (m, 3H), 7.10 (d, <i>J</i> = 8.6 Hz, 2H), 6.56 (d, <i>J</i> = 3.2 Hz, 1H), 6.27–6.16 (m, 1H), 4.48 (s, 2H), 3.87 (d, <i>J</i> = 6.6 Hz, 2H), 2.72 (d, <i>J</i> = 6.8 Hz, 3H), 2.35 (d, <i>J</i> = 3.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 136.99, 135.71, 135.56, 134.63, 130.03, 129.13, 128.25, 125.91, 125.60, 125.48, 125.13, 123.85, 121.74, 119.65, 119.04, 113.93, 58.26, 56.33, 38.69, 18.40. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>N<sub>2</sub> [M]<sup>+</sup>, 290.1783; found, 290.1784.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(2-nitrophenyl)prop-2-en-1-amine Hydrochloride (<b>27a</b>)</h3><div class="NLM_p last">Yield: 32%. <b>27a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.14 (s, 1H), 8.07–8.02 (m, 1H), 7.85–7.80 (m, 1H), 7.76–7.71 (m, 2H), 7.63–7.56 (m, 2H), 7.46–7.34 (m, 3H), 6.38–6.27 (m, 1H), 4.70 (d, <i>J</i> = 13.9 Hz, 1H), 4.56 (d, <i>J</i> = 13.2 Hz, 1H), 4.17 (d, <i>J</i> = 7.3 Hz, 1H), 4.04 (d, <i>J</i> = 8.0 Hz, 1H), 2.95 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.50, 148.11, 147.96, 136.34, 133.44, 130.93, 129.47, 129.06, 126.44, 125.26, 124.26, 123.48, 121.62, 119.43, 111.48, 109.77, 57.01, 48.14, 38.57. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 323.1396; found, 323.1397.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(2-nitrophenyl)prop-2-en-1-amine Hydrochloride (<b>27b</b>)</h3><div class="NLM_p last">Yield: 69%. <b>27b</b> was synthesized by the general procedure given above as a white solid, mp 179–181 °C. <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.99 (d, <i>J</i> = 8.0 Hz, 1H), 7.68 (dd, <i>J</i> = 14.9, 7.2 Hz, 2H), 7.58–7.51 (m, 2H), 7.36 (d, <i>J</i> = 3.1 Hz, 1H), 7.30–7.20 (m, 2H), 7.10 (d, <i>J</i> = 6.8 Hz, 1H), 6.55 (d, <i>J</i> = 2.4 Hz, 1H), 6.38–6.27 (m, 1H), 4.53 (d, <i>J</i> = 7.2 Hz, 2H), 3.90 (d, <i>J</i> = 6.7 Hz, 2H), 2.74 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 147.74, 135.42, 134.13, 133.16, 133.16, 131.06, 128.82, 128.82, 125.07, 124.02, 124.02, 121.69, 118.99, 118.99, 113.82, 101.85, 57.55, 56.43, 38.85. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub> [M]<sup>+</sup>, 321.1477; found, 321.1476.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(2-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>28a</b>)</h3><div class="NLM_p last">Yield: 43%. <b>28a</b> was synthesized by the general procedure given above as a white solid, mp 144–146 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.15 (d, <i>J</i> = 5.1 Hz, 1H), 7.89–7.75 (m, 3H), 7.61 (dt, <i>J</i> = 15.2, 7.7 Hz, 3H), 7.40 (dt, <i>J</i> = 18.9, 7.3 Hz, 2H), 7.01 (d, <i>J</i> = 15.8 Hz, 1H), 6.62–6.46 (m, 1H), 4.70 (d, <i>J</i> = 14.0 Hz, 1H), 4.56 (d, <i>J</i> = 13.7 Hz, 1H), 4.17 (dd, <i>J</i> = 12.9, 7.1 Hz, 1H), 3.99 (dd, <i>J</i> = 12.8, 7.8 Hz, 1H), 2.92 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 155.44, 147.80, 136.00, 134.12, 132.24, 128.59, 127.83, 126.30, 125.45, 125.41, 125.30, 125.17, 123.36, 121.75, 119.20, 111.40, 109.84, 57.18, 48.21, 38.42. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>NO [M + H]<sup>+</sup>, 346.1419; found, 346.1418.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(2-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>28b</b>)</h3><div class="NLM_p last">Yield: 83%. <b>28b</b> was synthesized by the general procedure given above as a white solid, mp 179–180 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.66 (d, <i>J</i> = 7.8 Hz, 2H), 7.56 (t, <i>J</i> = 7.6 Hz, 1H), 7.50 (d, <i>J</i> = 7.7 Hz, 1H), 7.40 (t, <i>J</i> = 7.6 Hz, 1H), 7.25 (d, <i>J</i> = 3.2 Hz, 1H), 7.04 (d, <i>J</i> = 7.0 Hz, 1H), 7.01–6.96 (m, 1H), 6.93 (d, <i>J</i> = 6.8 Hz, 1H), 6.46 (d, <i>J</i> = 3.2 Hz, 1H), 6.41–6.31 (m, 1H), 3.91 (s, 2H), 3.32 (d, <i>J</i> = 4.6 Hz, 2H), 2.30 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 136.02, 135.33, 131.96, 131.48, 128.66, 128.42, 127.46, 127.15, 125.22, 125.16, 124.12, 122.54, 121.61, 120.73, 119.31, 118.60, 101.13, 59.34, 58.88, 41.03. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.1500; found, 344.1498.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(2-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>29a</b>)</h3><div class="NLM_p last">Yield: 53%. <b>29a</b> was synthesized by the general procedure given above as a white solid, mp 151–152 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (s, 1H), 7.81 (d, <i>J</i> = 7.6 Hz, 1H), 7.60 (d, <i>J</i> = 7.9 Hz, 1H), 7.52 (dd, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.46–7.29 (m, 3H), 7.21 (d, <i>J</i> = 15.9 Hz, 1H), 7.02 (d, <i>J</i> = 8.3 Hz, 1H), 6.96 (t, <i>J</i> = 7.5 Hz, 1H), 6.40 (dt, <i>J</i> = 15.1, 7.5 Hz, 1H), 4.58 (d, <i>J</i> = 50.9 Hz, 2H), 4.18–3.90 (m, 2H), 3.87 (s, 3H), 2.90 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 157.29, 155.43, 147.80, 136.07, 130.02, 127.32, 126.29, 125.17, 123.69, 123.35, 120.29, 119.18, 116.55, 111.40, 110.76, 109.78, 58.12, 54.50, 48.12, 38.29. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>NO<sub>2</sub> [M + H]<sup>+</sup>, 308.1651; found, 308.1649.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(2-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>29b</b>)</h3><div class="NLM_p last">Yield: 74%. <b>29b</b> was synthesized by the general procedure given above as a white solid, mp 154–155 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.67 (d, <i>J</i> = 5.2 Hz, 1H), 7.50 (s, 1H), 7.36 (s, 1H), 7.26 (d, <i>J</i> = 2.4 Hz, 2H), 7.12 (d, <i>J</i> = 4.8 Hz, 2H), 7.04–6.87 (m, 2H), 6.56 (s, 1H), 6.37 (s, 1H), 4.48 (s, 1H), 3.86–3.25 (m, 6H), 2.71 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 157.19, 135.57, 134.44, 129.74, 129.14, 127.16, 125.17, 124.18, 123.96, 121.84, 120.34, 119.07, 118.40, 113.66, 110.77, 101.97, 58.64, 56.12, 54.59, 38.51. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>N<sub>2</sub>O [M]<sup>+</sup>, 306.1732; found, 306.1733.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(3-chlorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>30a</b>)</h3><div class="NLM_p last">Yield: 53%. <b>30a</b> was synthesized by the general procedure given above as a white solid, mp 136–137 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.14 (s, 1H), 7.83 (d, <i>J</i> = 7.0 Hz, 1H), 7.63–7.54 (m, 2H), 7.43 (t, <i>J</i> = 8.1 Hz, 2H), 7.40–7.32 (m, 3H), 6.91 (d, <i>J</i> = 15.8 Hz, 1H), 6.52–6.36 (m, 1H), 4.61 (d, <i>J</i> = 36.8 Hz, 2H), 4.04 (d, <i>J</i> = 55.0 Hz, 2H), 2.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.51, 147.98, 139.02, 137.38, 134.43, 129.99, 128.53, 128.04, 126.46, 125.25, 125.23, 123.45, 119.39, 118.29, 111.48, 109.90, 57.32, 48.11, 38.50. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>ClNO [M + H]<sup>+</sup>, 312.1155; found, 312.1154.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(3-chlorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>30b</b>)</h3><div class="NLM_p last">Yield: 64%. <b>30b</b> was synthesized by the general procedure given above as a white solid, mp 186–190 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.46 (s, 1H), 7.36–7.24 (m, 5H), 7.13 (d, <i>J</i> = 6.9 Hz, 1H), 7.08–7.02 (m, 1H), 6.67 (d, <i>J</i> = 12.8 Hz, 1H), 6.51 (d, <i>J</i> = 3.2 Hz, 1H), 6.40 (d, <i>J</i> = 7.2 Hz, 1H), 4.22 (d, <i>J</i> = 12.0 Hz, 2H), 3.58 (d, <i>J</i> = 7.5 Hz, 2H), 2.51 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 138.89, 137.41, 135.58, 134.42, 129.96, 129.43, 128.50, 126.42, 125.50, 125.23, 124.36, 122.43, 119.18, 118.24, 112.20, 102.20, 57.59, 55.83, 38.31. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>ClN<sub>2</sub> [M]<sup>+</sup>, 310.1237; found, 310.1234.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(3-fluorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>31a</b>)</h3><div class="NLM_p last">Yield: 43%. <b>31a</b> was synthesized by the general procedure given above as a white solid, mp 161–162 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.11 (s, 1H), 7.81 (d, <i>J</i> = 7.5 Hz, 1H), 7.64–7.58 (m, 2H), 7.45–7.34 (m, 3H), 7.24–7.11 (m, 2H), 7.08 (d, <i>J</i> = 15.9 Hz, 1H), 6.56–6.41 (m, 1H), 4.58 (s, 2H), 4.02 (s, 2H), 2.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.45, 147.81, 138.59, 136.98, 134.41, 129.45, 128.49, 128.64, 126.45, 125.15, 125.35, 123.58, 119.28, 118.36, 111.31, 109.79, 57.82, 47.89, 38.51. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>FNO [M + H]<sup>+</sup>, 296.1451; found, 296.1452.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(3-fluorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>31b</b>)</h3><div class="NLM_p last">Yield: 52%. <b>31b</b> was synthesized by the general procedure given above as a white solid, mp 186–187 °C. <sup>1</sup>H NMR (500 MHz, MeOD): δ 7.72 (d, <i>J</i> = 7.9 Hz, 1H), 7.43–7.35 (m, 2H), 7.34–7.26 (m, 3H), 7.16 (t, <i>J</i> = 7.6 Hz, 1H), 7.11–7.05 (m, 1H), 6.90 (d, <i>J</i> = 6.8 Hz, 1H), 6.59 (d, <i>J</i> = 3.1 Hz, 1H), 6.46–6.37 (m, 1H), 4.67 (s, 2H), 4.15–3.94 (m, 2H), 2.82 (d, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 139.05, 137.69, 135.49, 130.14, 129.32, 125.39, 124.32, 122.83, 122.80, 122.32, 119.07, 118.00, 115.25, 112.88, 112.05, 102.06, 57.45, 55.71, 38.14. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>2</sub> [M]<sup>+</sup>, 294.1532; found, 294.1533.</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(<i>m</i>-tolyl)prop-2-en-1-amine Hydrochloride (<b>32a</b>)</h3><div class="NLM_p last">Yield: 47%. <b>13c</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.12 (s, 1H), 7.81 (d, <i>J</i> = 7.2 Hz, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 1H), 7.47–7.33 (m, 4H), 7.19 (d, <i>J</i> = 7.9 Hz, 2H), 6.90 (d, <i>J</i> = 15.8 Hz, 1H), 6.32 (dt, <i>J</i> = 15.5, 7.6 Hz, 1H), 4.67 (d, <i>J</i> = 13.9 Hz, 1H), 4.51 (d, <i>J</i> = 13.9 Hz, 1H), 4.11 (dd, <i>J</i> = 13.0, 7.0 Hz, 1H), 3.93 (dd, <i>J</i> = 12.9, 7.9 Hz, 1H), 2.89 (s, 3H), 2.34 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.53, 147.95, 139.12, 137.35, 134.23, 129.87, 128.54, 128.29, 126.39, 125.27, 125.14, 123.25, 119.45, 118.15, 111.36, 109.84, 57.45, 48.19, 38.75, 18.29. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>NO [M + H]<sup>+</sup>, 292.1701; found, 292.1702.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(<i>m</i>-tolyl)prop-2-en-1-amine Hydrochloride (<b>32b</b>)</h3><div class="NLM_p last">Yield: 78%. <b>32b</b> was synthesized by the general procedure given above as a white solid, mp 196–197 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.61 (d, <i>J</i> = 7.1 Hz, 1H), 7.33 (d, <i>J</i> = 3.2 Hz, 1H), 7.29–7.14 (m, 4H), 7.13–7.04 (m, 2H), 6.71 (d, <i>J</i> = 6.8 Hz, 1H), 6.53 (d, <i>J</i> = 3.2 Hz, 1H), 6.39–6.28 (m, 1H), 4.29 (s, 2H), 3.67 (d, <i>J</i> = 6.4 Hz, 2H), 2.57 (s, 3H), 2.33 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 138.02, 137.31, 136.03, 135.49, 130.95, 128.86, 128.70, 128.20, 126.98, 124.77, 123.56, 123.11, 121.11, 120.78, 118.90, 116.21, 58.61, 57.07, 39.43, 19.99. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>N<sub>2</sub> [M]<sup>+</sup>, 290.1783; found, 290.1784.</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(3-nitrophenyl)prop-2-en-1-amine Hydrochloride (<b>33a</b>)</h3><div class="NLM_p last">Yield: 35%. <b>33a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.37 (t, <i>J</i> = 1.8 Hz, 1H), 8.19 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 8.11 (s, 1H), 7.91 (d, <i>J</i> = 7.8 Hz, 1H), 7.85–7.80 (m, 1H), 7.63 (t, <i>J</i> = 8.0 Hz, 1H), 7.58 (d, <i>J</i> = 7.5 Hz, 1H), 7.44–7.33 (m, 2H), 7.01 (d, <i>J</i> = 15.7 Hz, 1H), 6.64–6.53 (m, 1H), 4.55 (s, 2H), 4.04 (t, <i>J</i> = 14.6 Hz, 2H), 2.88 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 155.42, 148.61, 147.52, 137.35, 137.20, 132.46, 129.64, 126.45, 125.07, 123.26, 122.81, 121.01, 120.67, 119.30, 111.33, 110.39, 57.22, 48.27, 38.77. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 323.1396; found, 323.1399.</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(3-nitrophenyl)prop-2-en-1-amine Hydrochloride (<b>33b</b>)</h3><div class="NLM_p last">Yield: 86%. <b>33b</b> was synthesized by the general procedure given above as a white solid, mp 186–188 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.23 (t, <i>J</i> = 1.9 Hz, 1H), 8.08 (d, <i>J</i> = 6.9 Hz, 1H), 7.78 (d, <i>J</i> = 7.8 Hz, 1H), 7.58–7.46 (m, 2H), 7.26 (d, <i>J</i> = 3.2 Hz, 1H), 7.04 (d, <i>J</i> = 6.6 Hz, 1H), 6.98 (d, <i>J</i> = 3.6 Hz, 1H), 6.67 (d, <i>J</i> = 6.4 Hz, 1H), 6.54 (d, <i>J</i> = 6.6 Hz, 1H), 6.47–6.43 (m, 1H), 3.91 (s, 2H), 3.32 (d, <i>J</i> = 6.4 Hz, 1H), 2.31 (d, <i>J</i> = 8.0 Hz, 4H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 148.50, 138.66, 135.23, 134.46, 131.84, 131.15, 129.28, 129.10, 128.34, 124.10, 121.75, 121.53, 120.31, 119.89, 119.49, 118.56, 58.85, 58.56, 40.86. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub> [M]<sup>+</sup>, 321.1477; found, 321.1476.</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-<i>N</i>-methyl-3-(3-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>34a</b>)</h3><div class="NLM_p last">Yield: 58%. <b>34a</b> was synthesized by the general procedure given above as a white solid, mp 121–123 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.15 (d, <i>J</i> = 5.1 Hz, 1H), 7.88–7.73 (m, 3H), 7.61 (dt, <i>J</i> = 15.2, 7.7 Hz, 3H), 7.40 (dt, <i>J</i> = 18.9, 7.3 Hz, 2H), 7.01 (d, <i>J</i> = 15.8 Hz, 1H), 6.62–6.45 (m, 1H), 4.70 (d, <i>J</i> = 14.0 Hz, 1H), 4.56 (d, <i>J</i> = 13.7 Hz, 1H), 4.23–4.13 (m, 1H), 3.99 (dd, <i>J</i> = 12.8, 7.8 Hz, 1H), 2.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.48, 148.06, 138.84, 136.41, 130.64, 130.24, 129.35, 126.48, 125.47, 125.23, 125.03, 123.44, 123.34, 119.46, 118.89, 111.46, 109.88, 57.28, 48.14, 38.52. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>NO [M + H]<sup>+</sup>, 346.1419; found, 346.1418.</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-<i>N</i>-methyl-3-(3-(trifluoromethyl)phenyl)prop-2-en-1-amine Hydrochloride (<b>34b</b>)</h3><div class="NLM_p last">Yield: 82%. <b>34b</b> was synthesized by the general procedure given above as a white solid, mp 129–131 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.65 (s, 2H), 7.49 (dd, <i>J</i> = 7.5, 3.8 Hz, 3H), 7.25 (d, <i>J</i> = 3.1 Hz, 1H), 7.03 (d, <i>J</i> = 7.2 Hz, 1H), 6.97 (t, <i>J</i> = 7.4 Hz, 1H), 6.63 (d, <i>J</i> = 15.8 Hz, 1H), 6.53–6.42 (m, 2H), 3.88 (s, 2H), 3.28 (s, 2H), 2.31–2.10 (m, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 138.12, 135.33, 131.38, 129.40, 128.98, 128.43, 125.15, 124.13, 123.51, 123.47, 122.53, 122.49, 121.61, 120.78, 119.28, 118.58, 101.12, 59.26, 58.88, 41.11. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>F<sub>3</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.1500; found, 344.1503.</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(3-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>35a</b>)</h3><div class="NLM_p last">Yield: 23%. <b>35a</b> was synthesized by the general procedure given above as a white solid, mp 153–154 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.13 (s, 1H), 7.82 (d, <i>J</i> = 7.3 Hz, 1H), 7.60 (d, <i>J</i> = 8.2 Hz, 1H), 7.49–7.34 (m, 2H), 7.29 (t, <i>J</i> = 7.9 Hz, 1H), 7.08 (dd, <i>J</i> = 10.7, 4.8 Hz, 2H), 6.95–6.86 (m, 2H), 6.47–6.29 (m, 1H), 4.68 (d, <i>J</i> = 14.0 Hz, 1H), 4.52 (d, <i>J</i> = 13.7 Hz, 1H), 4.13 (dd, <i>J</i> = 12.9, 7.2 Hz, 1H), 4.01–3.89 (m, 1H), 3.81 (s, 3H), 2.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 160.13, 155.51, 147.99, 140.75, 136.62, 129.48, 128.45, 126.43, 125.26, 123.45, 119.31, 116.50, 114.31, 112.05, 111.49, 109.86, 57.55, 54.36, 48.05, 38.38. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>NO<sub>2</sub> [M + H]<sup>+</sup>, 308.1651; found, 308.1652.</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(3-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>35b</b>)</h3><div class="NLM_p last">Yield: 75%. <b>35b</b> was synthesized by the general procedure given above as a white solid, mp 154–155 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.71 (d, <i>J</i> = 7.9 Hz, 1H), 7.39 (d, <i>J</i> = 3.2 Hz, 1H), 7.27 (t, <i>J</i> = 7.7 Hz, 2H), 7.14 (t, <i>J</i> = 7.6 Hz, 1H), 7.07 (d, <i>J</i> = 7.7 Hz, 1H), 7.04 (s, 1H), 6.88 (s, 2H), 6.58 (d, <i>J</i> = 3.2 Hz, 1H), 6.40–6.29 (m, 1H), 4.64 (s, 2H), 4.01 (d, <i>J</i> = 7.2 Hz, 2H), 2.81 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 160.09, 140.35, 136.72, 135.60, 129.43, 129.37, 125.47, 124.38, 122.32, 119.26, 119.16, 116.83, 114.22, 112.39, 112.00, 102.12, 57.80, 55.77, 54.36, 38.17. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>22</sub>N<sub>2</sub>O [M]<sup>+</sup>, 306.1732; found, 306.1733.</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(2,4-dichlorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>36a</b>)</h3><div class="NLM_p last">Yield: 46%. <b>36a</b> was synthesized by the general procedure given above as a white solid, mp 146–148 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.13 (s, 1H), 7.82 (d, <i>J</i> = 7.5 Hz, 1H), 7.71 (d, <i>J</i> = 8.5 Hz, 1H), 7.60 (d, <i>J</i> = 7.7 Hz, 1H), 7.53 (d, <i>J</i> = 2.0 Hz, 1H), 7.40 (ddt, <i>J</i> = 9.9, 8.5, 4.1 Hz, 3H), 7.27 (d, <i>J</i> = 15.7 Hz, 1H), 6.43 (dt, <i>J</i> = 15.6, 7.7 Hz, 1H), 4.69 (d, <i>J</i> = 13.9 Hz, 1H), 4.55 (d, <i>J</i> = 13.8 Hz, 1H), 4.19 (dd, <i>J</i> = 13.3, 6.8 Hz, 1H), 4.02 (dd, <i>J</i> = 13.5, 7.8 Hz, 1H), 2.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.51, 148.05, 135.04, 134.90, 133.74, 132.20, 129.12, 128.39, 127.44, 126.42, 125.27, 123.48, 120.65, 119.37, 111.49, 109.79, 57.20, 48.15, 38.53. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>18</sub>Cl<sub>2</sub>NO [M + H]<sup>+</sup>, 346.0765; found, 346.0763.</div></div><div id="sec4_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(2,4-dichlorophenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>36b</b>)</h3><div class="NLM_p last">Yield: 68%. <b>36b</b> was synthesized by the general procedure given above as a white solid, mp 176–177 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.61 (d, <i>J</i> = 8.5 Hz, 1H), 7.56 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (s, 1H), 7.35–7.29 (m, 2H), 7.12 (d, <i>J</i> = 7.0 Hz, 1H), 7.04 (t, <i>J</i> = 3.6 Hz, 1H), 6.98 (s, 1H), 6.50 (d, <i>J</i> = 3.2 Hz, 1H), 6.46–6.35 (m, 1H), 4.09 (s, 2H), 3.50 (s, 2H), 2.46 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 135.38, 134.20, 133.35, 133.12, 132.51, 128.88, 128.88, 128.09, 128.09, 127.18, 127.18, 125.22, 124.35, 123.41, 121.32, 118.88, 57.96, 56.76, 39.18. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>2</sub> [M]<sup>+</sup>, 344.0847; found, 344.0838.</div></div><div id="sec4_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i125" class="anchor-spacer"></div><h3 class="article-section__title" id="_i125"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(2-fluoro-4-(trifluoromethyl)phenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>37a</b>)</h3><div class="NLM_p last">Yield: 35%. <b>37a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.15 (d, <i>J</i> = 5.1 Hz, 1H), 7.89–7.75 (m, 3H), 7.61 (dt, <i>J</i> = 15.2, 7.7 Hz, 3H), 7.40 (dt, <i>J</i> = 18.9, 7.3 Hz, 2H), 7.01 (d, <i>J</i> = 15.8 Hz, 1H), 6.61–6.46 (m, 1H), 4.70 (d, <i>J</i> = 14.0 Hz, 1H), 4.56 (d, <i>J</i> = 13.7 Hz, 1H), 4.23–4.12 (m, 1H), 3.99 (dd, <i>J</i> = 12.8, 7.8 Hz, 1H), 2.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.54, 148.05, 135.04, 133.74, 132.20, 129.89, 129.12, 128.35, 127.44, 126.42, 125.27, 124.58, 123.48, 120.65, 119.39, 111.49, 109.79, 57.20, 48.19, 38.53. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>F<sub>4</sub>NO [M + H]<sup>+</sup>, 364.1325; found, 364.1326.</div></div><div id="sec4_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i126" class="anchor-spacer"></div><h3 class="article-section__title" id="_i126"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(2-fluoro-4-(trifluoromethyl)phenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>37b</b>)</h3><div class="NLM_p last">Yield: 69%. <b>37b</b> was synthesized by the general procedure given above as a white solid, mp 154–155 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.76 (t, <i>J</i> = 8.0 Hz, 1H), 7.61 (d, <i>J</i> = 7.7 Hz, 1H), 7.47 (s, 2H), 7.33 (d, <i>J</i> = 3.2 Hz, 1H), 7.16 (d, <i>J</i> = 7.2 Hz, 1H), 7.07 (t, <i>J</i> = 7.6 Hz, 1H), 6.92 (d, <i>J</i> = 6.4 Hz, 1H), 6.64–6.54 (m, 1H), 6.52 (d, <i>J</i> = 3.2 Hz, 1H), 4.29 (s, 2H), 3.71 (s, 2H), 2.56 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 160.91, 158.42, 135.44, 128.82, 128.58, 128.54, 127.00, 124.71, 124.36, 122.96, 120.94, 120.81, 118.87, 116.57, 112.87, 112.61, 101.63, 58.56, 57.52, 39.86. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>F<sub>4</sub>N<sub>2</sub> [M]<sup>+</sup> 362.1406; found, 362.1408.</div></div><div id="sec4_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i127" class="anchor-spacer"></div><h3 class="article-section__title" id="_i127"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(3-fluoro-4-(trifluoromethyl)phenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>38a</b>)</h3><div class="NLM_p last">Yield: 42%. <b>38a</b> was synthesized by the general procedure given above as a white solid, mp 166–168 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.07 (s, 1H), 7.80 (d, <i>J</i> = 7.1 Hz, 1H), 7.69 (t, <i>J</i> = 7.6 Hz, 1H), 7.58 (d, <i>J</i> = 8.0 Hz, 1H), 7.54–7.34 (m, 4H), 6.92 (d, <i>J</i> = 16.4 Hz, 1H), 6.63–6.50 (m, 1H), 4.63 (s, 2H), 4.49 (s, 1H), 3.96 (s, 1H), 3.48 (s, 1H), 2.83 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.52, 148.08, 137.63, 128.58, 127.30, 126.42, 125.28, 124.71, 123.48, 123.06, 123.02, 121.21, 119.32, 114.62, 114.41, 111.50, 109.78, 56.97, 47.52, 38.62. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>F<sub>4</sub>NO [M + H]<sup>+</sup>, 364.1325; found, 364.1326.</div></div><div id="sec4_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i128" class="anchor-spacer"></div><h3 class="article-section__title" id="_i128"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(3-fluoro-4-(trifluoromethyl)phenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>38b</b>)</h3><div class="NLM_p last">Yield: 35%. <b>38b</b> was synthesized by the general procedure given above as a white solid, mp 119–120 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.69–7.56 (m, 2H), 7.41 (d, <i>J</i> = 12.4 Hz, 2H), 7.32 (d, <i>J</i> = 3.2 Hz, 1H), 7.15 (d, <i>J</i> = 7.2 Hz, 1H), 7.06 (t, <i>J</i> = 7.5 Hz, 1H), 6.77 (d, <i>J</i> = 6.8 Hz, 1H), 6.55 (s, 1H), 6.51 (t, <i>J</i> = 7.4 Hz, 1H), 4.26 (s, 2H), 3.67 (d, <i>J</i> = 6.7 Hz, 2H), 2.55 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 160.71, 158.40, 135.37, 128.77, 128.51, 128.42, 127.01, 124.69, 124.28, 122.92, 120.91, 120.79, 118.83, 116.53, 112.82, 112.59, 101.61, 58.53, 57.49, 39.81. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>F<sub>4</sub>N<sub>2</sub> [M]<sup>+</sup>, 362.1406; found, 362.1405.</div></div><div id="sec4_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(2-fluoro-4-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>39a</b>)</h3><div class="NLM_p last">Yield: 47%. <b>39a</b> was synthesized by the general procedure given above as a white solid, mp 150–151 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.14 (s, 1H), 7.83 (d, <i>J</i> = 7.3 Hz, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 1H), 7.39 (tt, <i>J</i> = 17.3, 8.7 Hz, 2H), 7.32–7.21 (m, 1H), 7.08 (dd, <i>J</i> = 9.8, 5.0 Hz, 2H), 6.93 (s, 1H), 6.47–6.31 (m, 1H), 4.60 (d, <i>J</i> = 43.9 Hz, 2H), 3.99 (dd, <i>J</i> = 41.1, 32.3 Hz, 2H), 3.82 (d, <i>J</i> = 6.1 Hz, 3H), 2.91 (d, <i>J</i> = 9.1 Hz, 3H). <sup>13</sup>C NMR (126 MHz, MeOD): δ 160.03, 155.41, 147.87, 140.65, 136.52, 129.38, 126.33, 125.15, 123.35, 119.26, 119.15, 116.40, 114.21, 111.95, 111.38, 109.76, 57.45, 54.26, 47.91, 38.29. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>21</sub>FNO<sub>2</sub> [M + H]<sup>+</sup>, 326.1556; found, 326.1554.</div></div><div id="sec4_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(2-fluoro-4-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>39b</b>)</h3><div class="NLM_p last">Yield: 45%. <b>39b</b> was synthesized by the general procedure given above as a white solid, mp 108–111 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.52 (t, <i>J</i> = 8.7 Hz, 1H), 7.39–7.31 (m, 1H), 7.27 (d, <i>J</i> = 7.2 Hz, 1H), 7.14 (t, <i>J</i> = 7.6 Hz, 1H), 6.95 (d, <i>J</i> = 15.9 Hz, 1H), 6.75–6.60 (m, 2H), 6.58 (d, <i>J</i> = 3.2 Hz, 1H), 6.35–6.25 (m, 1H), 4.64 (s, 2H), 4.05 (d, <i>J</i> = 6.7 Hz, 2H), 3.81 (s, 3H), 2.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 135.60, 132.71, 129.40, 128.63, 125.48, 124.37, 122.38, 119.16, 116.48, 115.40, 115.28, 112.21, 110.48, 102.15, 101.20, 100.94, 58.23, 55.70, 54.85, 38.05. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>21</sub>FN<sub>2</sub>O [M]<sup>+</sup>, 324.1638; found, 324.1635.</div></div><div id="sec4_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i131" class="anchor-spacer"></div><h3 class="article-section__title" id="_i131"> (<i>E</i>)-<i>N</i>-(Benzofuran-3-ylmethyl)-3-(3-fluoro-4-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>40a</b>)</h3><div class="NLM_p last">Yield: 51%. <b>40a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.07 (s, 1H), 7.80 (d, <i>J</i> = 7.1 Hz, 1H), 7.69 (t, <i>J</i> = 7.6 Hz, 1H), 7.58 (d, <i>J</i> = 8.0 Hz, 1H), 7.54–7.34 (m, 4H), 6.92 (d, <i>J</i> = 16.4 Hz, 1H), 6.63–6.50 (m, 1H), 4.63 (s, 2H), 4.49 (s, 1H), 3.96 (s, 1H), 3.48 (s, 1H), 2.83 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.51, 148.15, 148.09, 146.41, 136.73, 130.94, 129.29, 128.47, 126.96, 124.83, 123.32, 123.01, 119.50, 113.21, 113.03, 111.25, 58.13, 55.29, 48.53, 39.36. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>F<sub>4</sub>NO [M + H]<sup>+</sup>, 364.1325; found, 364.1326.</div></div><div id="sec4_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i132" class="anchor-spacer"></div><h3 class="article-section__title" id="_i132"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-(3-fluoro-4-methoxyphenyl)-<i>N</i>-methylprop-2-en-1-amine Hydrochloride (<b>40b</b>)</h3><div class="NLM_p last">Yield: 64%. <b>40b</b> was synthesized by the general procedure given above as a white solid, mp 117–118 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.49 (d, <i>J</i> = 7.7 Hz, 1H), 7.26 (d, <i>J</i> = 3.2 Hz, 1H), 7.19 (d, <i>J</i> = 8.8 Hz, 1H), 7.11 (d, <i>J</i> = 8.6 Hz, 1H), 7.00 (t, <i>J</i> = 6.6 Hz, 2H), 6.47 (s, 3H), 6.20–6.04 (m, 2H), 3.90 (s, 2H), 3.84 (s, 3H), 3.28 (d, <i>J</i> = 6.9 Hz, 2H), 2.30 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 147.42, 135.39, 133.16, 130.24, 128.52, 124.31, 123.55, 122.76, 122.72, 122.17, 119.84, 119.16, 118.71, 113.14, 112.95, 112.77, 59.03, 58.09, 55.27, 40.42. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>21</sub>FN<sub>2</sub>O [M]<sup>+</sup>, 324.1638; found, 324.1637.</div></div><div id="sec4_90" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> 3-([1,1′-Biphenyl]-4-yl)-<i>N</i>-(benzofuran-3-ylmethyl)-<i>N</i>-methylprop-2-yn-1-amine Hydrochloride (<b>41a</b>)</h3><div class="NLM_p last">Yield: 51%. <b>41a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.70–7.56 (m, 7H), 7.46 (dd, <i>J</i> = 10.3, 4.8 Hz, 2H), 7.37 (dd, <i>J</i> = 8.3, 6.4 Hz, 1H), 7.32 (dd, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.27–7.18 (m, 1H), 6.97–6.82 (m, 2H), 5.64 (t, <i>J</i> = 9.1 Hz, 2H), 4.41 (s, 2H), 2.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.37, 145.47, 140.35, 138.70, 135.72, 134.56, 130.25, 130.25, 129.31, 129.31, 127.51, 127.51, 126.24, 127.17, 126.34, 126.34, 126.08, 126.08, 124.30, 124.27, 85.24, 82.59, 65.58, 59.64, 39.89. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>21</sub>NO [M]<sup>+</sup>, 351.1623; found, 351.1624.</div></div><div id="sec4_91" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134"> N-((1<i>H</i>-Indol-7-yl)methyl)-3-([1,1′-biphenyl]-4-yl)-<i>N</i>-methylprop-2-yn-1-amine Hydrochloride (<b>41b</b>)</h3><div class="NLM_p last">Yield: 29%. <b>41b</b> was synthesized by the general procedure given above as a white solid, mp 163–167 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.71–7.59 (m, 7H), 7.46 (t, <i>J</i> = 7.6 Hz, 2H), 7.40–7.34 (m, 2H), 7.27 (d, <i>J</i> = 7.1 Hz, 1H), 7.13 (t, <i>J</i> = 7.6 Hz, 1H), 6.57 (d, <i>J</i> = 3.2 Hz, 1H), 4.59 (s, 2H), 4.20 (s, 2H), 2.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.69, 140.29, 137.28, 136.44, 130.87, 130.32, 130.32, 130.27, 130.27, 129.76, 128.89, 127.75, 127.75, 127.80, 127.80, 127.32, 126.58, 123.21, 120.27, 114.15, 85.49, 82.56, 56.72, 39.68, 18.80. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>22</sub>N<sub>2</sub> [M]<sup>+</sup>, 350.1783; found, 350.1782.</div></div><div id="sec4_92" class="NLM_sec NLM_sec_level_2"><div id="ac_i135" class="anchor-spacer"></div><h3 class="article-section__title" id="_i135"> 3-([1,1′-Biphenyl]-4-yl)-<i>N</i>-(benzofuran-3-ylmethyl)-<i>N</i>-methylpropan-1-amine Hydrochloride (<b>42a</b>)</h3><div class="NLM_p last">Yield: 35%. <b>42a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.62–7.53 (m, 4H), 7.43 (t, <i>J</i> = 7.6 Hz, 2H), 7.23 (dddd, <i>J</i> = 13.9, 11.2, 9.5, 4.5 Hz, 5H), 6.88–6.81 (m, 2H), 4.62 (s, 1H), 4.27 (s, 1H), 3.17–3.02 (m, 2H), 2.78 (s, 3H), 2.69 (dd, <i>J</i> = 9.4, 5.6 Hz, 2H), 2.12–1.94 (m, 2H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.28, 145.41, 140.31, 137.70, 135.59, 134.21, 128.56, 128.56, 127.51, 127.51, 126.24, 127.17, 126.34, 126.34, 126.08, 126.08, 124.30, 124.27, 112.03, 110.25, 65.58, 59.64, 39.89, 31.58, 28.56. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>25</sub>NO [M]<sup>+</sup>, 355.1936; found, 355.1936.</div></div><div id="sec4_93" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136"> N-((1<i>H</i>-Indol-7-yl)methyl)-3-([1,1′-biphenyl]-4-yl)-<i>N</i>-methylpropan-1-amine Hydrochloride (<b>42b</b>)</h3><div class="NLM_p last">Yield: 42%. <b>42b</b> was synthesized by the general procedure given above as a white solid, mp 154–155 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.64–7.61 (m, 1H), 7.59–7.56 (m, 2H), 7.52–7.48 (m, 2H), 7.42 (d, <i>J</i> = 6.8 Hz, 2H), 7.32 (d, <i>J</i> = 6.9 Hz, 2H), 7.21 (d, <i>J</i> = 8.3 Hz, 2H), 7.13 (d, <i>J</i> = 7.3 Hz, 1H), 7.05 (dd, <i>J</i> = 8.7, 6.4 Hz, 1H), 6.53 (d, <i>J</i> = 3.2 Hz, 1H), 4.38 (s, 2H), 3.05–2.99 (m, 2H), 2.70 (d, <i>J</i> = 7.5 Hz, 2H), 2.68 (s, 3H), 2.09–2.03 (m, 2H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.81, 140.39, 137.18, 136.24, 130.87, 130.19, 130.19, 129.76, 129.28, 129.28, 128.89, 128.05, 128.05, 127.32, 126.58, 124.39, 123.21, 120.27, 114.15, 102.41, 56.72, 42.15, 39.68, 31.89, 27.58. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>22</sub>N<sub>2</sub> [M]<sup>+</sup>, 354.2096; found, 354.2097.</div></div><div id="sec4_94" class="NLM_sec NLM_sec_level_2"><div id="ac_i137" class="anchor-spacer"></div><h3 class="article-section__title" id="_i137"> (<i>E</i>)-3-([1,1′-Biphenyl]-4-yl)-<i>N</i>-(benzofuran-3-ylmethyl)-N,2-dimethylprop-2-en-1-amine Hydrochloride (<b>43a</b>)</h3><div class="NLM_p last">Yield: 41%. <b>43a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72–7.57 (m, 5H), 7.44 (dd, <i>J</i> = 7.9, 6.3 Hz, 5H), 7.37–7.31 (m, 2H), 7.29–7.22 (m, 1H), 6.92 (ddd, <i>J</i> = 12.5, 9.5, 4.6 Hz, 1H), 6.82 (d, <i>J</i> = 24.1 Hz, 1H), 2.89 (s, 3H), 2.04 (dd, <i>J</i> = 39.4, 1.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 154.35, 140.47, 140.30, 138.70, 135.78, 134.90, 130.26, 130.20, 129.31, 129.31, 128.56, 128.56, 127.24, 127.17, 126.54, 126.54, 126.49, 126.49, 124.30, 120.22, 115.59, 65.25, 59.54, 39.76, 15.74. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>25</sub>NO [M]<sup>+</sup>, 367.1936; found, 367.1938.</div></div><div id="sec4_95" class="NLM_sec NLM_sec_level_2"><div id="ac_i138" class="anchor-spacer"></div><h3 class="article-section__title" id="_i138"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-3-([1,1′-biphenyl]-4-yl)-<i>N</i>,2-dimethylprop-2-en-1-amine Hydrochloride (<b>43b</b>)</h3><div class="NLM_p last">Yield: 38%. <b>43b</b> was synthesized by the general procedure given above as a white solid, mp 164–165 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.73 (d, <i>J</i> = 7.9 Hz, 1H), 7.63 (t, <i>J</i> = 7.2 Hz, 4H), 7.47–7.38 (m, 5H), 7.37–7.30 (m, 2H), 7.17 (t, <i>J</i> = 7.6 Hz, 1H), 6.82 (s, 1H), 6.57 (t, <i>J</i> = 8.0 Hz, 1H), 4.72 (s, 2H), 3.99–2.90 (m, 2H), 2.87 (s, 3H), 2.02 (d, <i>J</i> = 6.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.79, 140.31, 137.24, 136.42, 135.55, 130.85, 130.32, 130.32, 130.27, 130.27, 129.76, 128.89, 127.86, 127.86, 127.80, 127.80, 126.58, 123.21, 120.25, 114.20, 103.07, 65.89, 56.72, 39.68, 18.80. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>22</sub>N<sub>2</sub> [M]<sup>+</sup>, 366.2096; found, 366.2097.</div></div><div id="sec4_96" class="NLM_sec NLM_sec_level_2"><div id="ac_i139" class="anchor-spacer"></div><h3 class="article-section__title" id="_i139"> (<i>E</i>)-4-([1,1′-Biphenyl]-4-yl)-<i>N</i>-(benzofuran-3-ylmethyl)-<i>N</i>-methylbut-3-en-1-amine Hydrochloride (<b>44a</b>)</h3><div class="NLM_p last">Yield: 32%. <b>44a</b> was synthesized by the general procedure given above as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72 (d, <i>J</i> = 7.9 Hz, 1H), 7.64–7.55 (m, 4H), 7.49–7.37 (m, 5H), 7.35–7.24 (m, 2H), 7.15 (t, <i>J</i> = 7.6 Hz, 1H), 6.58–6.35 (m, 2H), 6.28–6.15 (m, 1H), 4.65 (s, 2H), 3.37 (t, <i>J</i> = 6.4 Hz, 2H), 2.92–2.82 (m, 3H), 2.72–2.62 (m, 2H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.16, 135.59, 135.70, 133.16, 129.29, 129.29, 128.50, 127.98, 127.98, 127.83, 127.83, 126.94, 126.94, 126.44, 126.36, 125.50, 124.43, 123.38, 122.41, 119.18, 112.14, 102.19, 57.89, 53.59, 41.28, 31.28. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>25</sub>NO [M + H]<sup>+</sup>, 367.1936; found, 367.1937.</div></div><div id="sec4_97" class="NLM_sec NLM_sec_level_2"><div id="ac_i140" class="anchor-spacer"></div><h3 class="article-section__title" id="_i140"> (<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-4-([1,1′-biphenyl]-4-yl)-<i>N</i>-methylbut-3-en-1-amine Hydrochloride (<b>44b</b>)</h3><div class="NLM_p last">Yield: 64%. <b>44b</b> was synthesized by the general procedure given above as a white solid, mp 169–172 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72 (d, <i>J</i> = 7.9 Hz, 1H), 7.64–7.55 (m, 4H), 7.49–7.37 (m, 5H), 7.35–7.24 (m, 2H), 7.15 (t, <i>J</i> = 7.6 Hz, 1H), 6.58–6.35 (m, 2H), 6.28–6.15 (m, 1H), 4.65 (s, 2H), 3.37 (t, <i>J</i> = 6.4 Hz, 2H), 2.92–2.82 (m, 3H), 2.72–2.62 (m, 2H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 140.44, 140.36, 135.77, 135.70, 133.16, 129.40, 128.50, 128.50, 127.03, 126.74, 126.74, 126.44, 126.44, 126.36, 126.36, 125.50, 124.43, 123.38, 122.41, 119.18, 112.14, 102.19, 56.46, 55.22, 38.87, 27.76. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>2</sub> [M]<sup>+</sup>, 366.2096; found, 366.2090.</div></div><div id="sec4_98" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141"> (2<i>E</i>,4<i>E</i>)-5-([1,1′-Biphenyl]-4-yl)-<i>N</i>-(benzofuran-3-ylmethyl)-<i>N</i>-methylpenta-2,4-dien-1-amine Hydrochloride (<b>45a</b>)</h3><div class="NLM_p last">Yield: 52%. <b>45a</b> was synthesized by the general procedure given above as a yellow solid, mp 155–158 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.60 (m, 5H), 7.51 (d, <i>J</i> = 8.1 Hz, 2H), 7.42 (t, <i>J</i> = 7.5 Hz, 2H), 7.33 (d, <i>J</i> = 7.6 Hz, 1H), 7.14 (dd, <i>J</i> = 20.8, 7.8 Hz, 2H), 6.97–6.88 (m, 1H), 6.75 (d, <i>J</i> = 7.6 Hz, 2H), 6.64 (d, <i>J</i> = 16.0 Hz, 1H), 6.55–6.40 (m, 1H), 5.94 (s, 1H), 4.61 (s, 2H), 3.38 (d, <i>J</i> = 6.5 Hz, 2H), 2.42 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 155.47, 147.93, 138.69, 135.74, 135.59, 135.46, 129.44, 128.55, 128.51, 127.11, 126.95, 126.95, 126.87, 126.87, 126.58, 126.18, 126.18, 125.53, 124.40, 122.46, 119.27, 119.18, 112.01, 102.21, 57.37, 48.17, 38.10. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>25</sub>NO [M]<sup>+</sup>, 379.1936; found, 379.1937.</div></div><div id="sec4_99" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142"> (2<i>E</i>,4<i>E</i>)-<i>N</i>-((1<i>H</i>-Indol-7-yl)methyl)-5-([1,1′-biphenyl]-4-yl)-<i>N</i>-methylpenta-2,4-dien-1-amine Hydrochloride (<b>45b</b>)</h3><div class="NLM_p last">Yield: 33%. <b>45b</b> was synthesized by the general procedure given above as a white solid, mp 193–199 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.72 (d, <i>J</i> = 7.7 Hz, 1H), 7.67–7.59 (m, 4H), 7.56 (d, <i>J</i> = 8.3 Hz, 2H), 7.46–7.38 (m, 3H), 7.33 (t, <i>J</i> = 7.3 Hz, 1H), 7.28 (d, <i>J</i> = 7.1 Hz, 1H), 7.16 (t, <i>J</i> = 7.6 Hz, 1H), 7.00 (dd, <i>J</i> = 12.6, 10.5 Hz, 1H), 6.80 (d, <i>J</i> = 12.8 Hz, 1H), 6.73 (dd, <i>J</i> = 15.0, 10.5 Hz, 1H), 6.59 (d, <i>J</i> = 3.2 Hz, 1H), 5.94 (dt, <i>J</i> = 15.2, 7.7 Hz, 1H), 4.63–4.38 (m, 4H), 2.80 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD): δ 141.27, 141.00, 140.30, 135.64, 135.59, 135.86, 129.44, 128.53, 128.53, 127.18, 126.97, 126.97, 126.88, 126.88, 126.58, 126.38, 126.38, 125.53, 124.40, 122.46, 119.26, 119.18, 112.03, 102.21, 57.59, 55.51, 37.98. HRMS (EI): <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>26</sub>N<sub>2</sub> [M]<sup>+</sup>, 378.2096; found, 378.2098.</div></div><div id="sec4_100" class="NLM_sec NLM_sec_level_2"><div id="ac_i143" class="anchor-spacer"></div><h3 class="article-section__title" id="_i143"> 1-(3a,7a-Dihydrobenzofuran-2-yl)-<i>N</i>-methylmethanamine (<b>48a</b>)</h3><div class="NLM_p last">To a solution of 3a,7a-dihydrobenzofuran-3-carbaldehyde (18.2 g, 123 mmol) in methanol (20 mL) was slowly treated with methanamine (31g, 33%, in methanol), and then the reaction was stirred at room temperature for 4 h. Thereafter, NaBH<sub>4</sub> (9.4 g, 246 mmol) was added in batches at 0 °C, and the reaction was heated to rt. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and condensed. The residue was then purified via flash chromatography on silica gel, eluting with EtOAc/petroleum ether (1:25, v/v) to give <b>48a</b> as a yellow oil. Yield: 42%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (dt, <i>J</i> = 15.3, 4.5 Hz, 1H), 7.58 (s, 1H), 7.34–7.27 (m, 1H), 7.26–7.24 (m, 1H), 3.90 (d, <i>J</i> = 0.9 Hz, 2H), 2.51(d, <i>J</i> = 4.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO): δ 157.06, 145.21, 143.44, 130.15, 129.52, 124.73, 118.02, 117.62, 55.59, 33.90.</div></div><div id="sec4_101" class="NLM_sec NLM_sec_level_2"><div id="ac_i144" class="anchor-spacer"></div><h3 class="article-section__title" id="_i144"> (<i>E</i>)-3-(4-(Trifluoromethyl)phenyl)prop-2-en-1-ol (<b>49a</b>)</h3><div class="NLM_p last">A solution of cinnamaldehyde (400.0 mg, 2 mmol) in methanol (10 mL) was treated with sodium borohydride (76.0 mg, 2 mmol) in batches at 0 °C. The reaction mixture was stirred at room temperature for 15 min and concentrated. The residue was poured into water and extracted with EtOAc. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and condensed. The crude material was used for the next step without further separation giving the title compound <b>49a</b> as a yellow oil. Yield: 59%. <sup>1</sup>H NMR (400 MHz, DMSO): δ 7.65 (m, 4H), 6.67 (d, <i>J</i> = 16.1 Hz, 1H), 6.58 (dt, <i>J</i> = 16.0, 4.4 Hz, 1H), 5.14–4.92 (m, 1H), 4.18 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO): δ 141.50, 134.67, 127.14, 127.14, 127.11, 127.11, 125.88, 125.85, 124.35, 61.69.</div></div><div id="sec4_102" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> (<i>E</i>)-1-(3-Bromoprop-1-en-1-yl)-4-(trifluoromethyl)benzene (<b>51a</b>)</h3><div class="NLM_p last">A solution of <b>49a</b> (303.0 mg, 1.5 mmol) in anhydrous ether (20 mL) was treated with phosphorus tribromide (84.0 μL, 0.9 mmol) at 0 °C under a N<sub>2</sub> atmosphere. The reaction mixture was stirred at room temperature overnight and poured into ice water containing sodium bicarbonate. The mixture was partitioned between EtOAc and water. The combined organic layers were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and condensed at 30 °C. The crude was used for next step without further purification, affording <b>51a</b> as a white solid. Yield: 85%. <sup>1</sup>H NMR (400 MHz, DMSO): δ 7.82 (d, <i>J</i> = 8.0 Hz, 2H), 7.77–7.73 (d, 2H), 6.99 (d, <i>J</i> = 21.3, 12.3 Hz, 1H), 6.61–6.55 (m, 1H), 4.38 (d, <i>J</i> = 7.6 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO): δ 138.72, 134.70, 127.56, 127.47, 127.47, 127.12, 127.12, 125.90, 119.51, 61.65.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i146"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01300">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01300" class="ext-link">10.1021/acs.jmedchem.7b01300</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures and characterizations of derivatives, bacterial growth assays of <i>S. aureus</i> Newman and MRSA strains, the hERG inhibition assay, MIC values of derivatives against MRSA strains, pigment inhibition assay, CrtN enzyme inhibition assay, hydrogen peroxide killing and human whole blood killing, <i>S. aureus</i> systemic infection models, antifungal assay, cytochrome P450 inhibition assay, pharmacokinetic methods (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf">jm7b01300_si_001.pdf (252.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_002.csv">jm7b01300_si_002.csv (6.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01300" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lefu Lan</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5551-5496" title="Orcid link">http://orcid.org/0000-0002-5551-5496</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#432f2f222d03302a2e2e6d22206d202d"><span class="__cf_email__" data-cfemail="b1ddddd0dff1c2d8dcdc9fd0d29fd2df">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Li</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School
of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7521-8798" title="Orcid link">http://orcid.org/0000-0002-7521-8798</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e9838088878580a98c8a9c9a9dc78c8d9cc78a87"><span class="__cf_email__" data-cfemail="a1cbc8c0cfcdc8e1c4c2d4d2d58fc4c5d48fc2cf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Baoli Li</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School
of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuaishuai Ni</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School
of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fei Mao</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School
of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feifei Chen</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7251-1956" title="Orcid link">http://orcid.org/0000-0002-7251-1956</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yifu Liu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School
of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hanwen Wei</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School
of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenhua Chen</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School
of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Zhu</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, School
of Pharmacy, East China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3934-0312" title="Orcid link">http://orcid.org/0000-0003-3934-0312</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>These authors contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d222e10558-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i148">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The financial support for this research was provided by the National Key R&D Program of China (Grant no. 2017YFB0202600), the National Natural Science Foundation of China (Grant no. 21672064), and the “Shu Guang” project supported by the Shanghai Municipal Education Commission and Shanghai Education Development Foundation (Grant no. 14SG28). The Fundamental Research Funds for the Central Universities are gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i149" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i149"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i150" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i150"> Abbreviations Used</h2><tr><td class="NLM_term"><i>S. aureus</i></td><td class="NLM_def"><p class="first last"><i>Staphylococcus aureus</i></p></td></tr><tr><td class="NLM_term">MRSA</td><td class="NLM_def"><p class="first last">methicillin-resistant <i>Staphylococcus aureus</i></p></td></tr><tr><td class="NLM_term">STX</td><td class="NLM_def"><p class="first last">staphyloxanthin</p></td></tr><tr><td class="NLM_term">CrtN</td><td class="NLM_def"><p class="first last">diapophytoene desaturases</p></td></tr><tr><td class="NLM_term">ND4BB</td><td class="NLM_def"><p class="first last">New Drugs for Bad Bugs</p></td></tr><tr><td class="NLM_term">CrtM</td><td class="NLM_def"><p class="first last">dehydrosqualene synthase</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass chromatography</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony-forming unit</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">CH<sub>2</sub>Cl<sub>2</sub></td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i151">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 35 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lepri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buonerba, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goracci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velilla, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzziconi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaatz, G. W.</span><span> </span><span class="NLM_article-title">G Cruciani. Indole based weapons to fight antibiotic: a structure-activity relationship study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=867-891&author=S.+Lepriauthor=F.+Buonerbaauthor=L.+Goracciauthor=I.+Velillaauthor=R.+Ruzziconiauthor=B.+D.+Schindlerauthor=S.+M.+Seoauthor=G.+W.+Kaatz&title=G+Cruciani.+Indole+based+weapons+to+fight+antibiotic%3A+a+structure-activity+relationship+study&doi=10.1021%2Facs.jmedchem.5b01219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01219%26sid%3Dliteratum%253Aachs%26aulast%3DLepri%26aufirst%3DS.%26aulast%3DBuonerba%26aufirst%3DF.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DVelilla%26aufirst%3DI.%26aulast%3DRuzziconi%26aufirst%3DR.%26aulast%3DSchindler%26aufirst%3DB.%2BD.%26aulast%3DSeo%26aufirst%3DS.%2BM.%26aulast%3DKaatz%26aufirst%3DG.%2BW.%26atitle%3DG%2520Cruciani.%2520Indole%2520based%2520weapons%2520to%2520fight%2520antibiotic%253A%2520a%2520structure-activity%2520relationship%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D867%26epage%3D891%26doi%3D10.1021%2Facs.jmedchem.5b01219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lowy, F. D.</span><span> </span><span class="NLM_article-title"><i>Staphylococcus aureus</i> infections</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span><span class="refDoi"> DOI: 10.1056/NEJM199808203390806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1056%2FNEJM199808203390806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=9709046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A280%3ADyaK1czmtlKltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=520-532&author=F.+D.+Lowy&title=Staphylococcus+aureus+infections&doi=10.1056%2FNEJM199808203390806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Staphylococcus aureus infections</span></div><div class="casAuthors">Lowy F D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">520-32</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTK9d0Jprpbc56KlWarZTAzfW6udTcc2eaZMHZBuUuwkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czmtlKltw%253D%253D&md5=210aac522def7325e264aec01d7e8d9a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJM199808203390806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199808203390806%26sid%3Dliteratum%253Aachs%26aulast%3DLowy%26aufirst%3DF.%2BD.%26atitle%3DStaphylococcus%2520aureus%2520infections%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D520%26epage%3D532%26doi%3D10.1056%2FNEJM199808203390806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">O’Connell, K. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgkinson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sore, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmond, G. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spring, D. R.</span><span> </span><span class="NLM_article-title">Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">10706</span><span class="NLM_x">–</span> <span class="NLM_lpage">10733</span><span class="refDoi"> DOI: 10.1002/anie.201209979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1002%2Fanie.201209979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=24038605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=10706-10733&author=K.+M.+G.+O%E2%80%99Connellauthor=J.+T.+Hodgkinsonauthor=H.+F.+Soreauthor=M.+Welchauthor=G.+P.+C.+Salmondauthor=D.+R.+Spring&title=Combating+multidrug-resistant+bacteria%3A+current+strategies+for+the+discovery+of+novel+antibacterials&doi=10.1002%2Fanie.201209979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Combating Multidrug-Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials</span></div><div class="casAuthors">O'Connell, Kieron M. G.; Hodgkinson, James T.; Sore, Hannah F.; Welch, Martin; Salmond, George P. C.; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10706-10733</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The introduction of effective antibacterial therapies for infectious diseases in the mid-20th century completely revolutionized clin. practices and helped to facilitate the development of modern medicine.  Many potentially life-threatening conditions became easily curable, greatly reducing the incidence of death or disability resulting from bacterial infections.  This overwhelming historical success makes it very difficult to imagine life without effective antibacterials; however, the inexorable rise of antibiotic resistance has made this a very real and disturbing possibility for some infections.  The ruthless selection for resistant bacteria, coupled with insufficient investment in antibacterial research, has led to a steady decline in the efficacy of existing therapies and a paucity of novel structural classes with which to replace them, or complement their use.  This situation has resulted in a very pressing need for the discovery of novel antibiotics and treatment strategies, the development of which is likely to be a key challenge to 21st century medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJpKYdiujdvrVg90H21EOLACvtfcHk0ljE3oQJIYwdNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtbfI&md5=797c2b503a9ee729093192ae216c0b20</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fanie.201209979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201209979%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DK.%2BM.%2BG.%26aulast%3DHodgkinson%26aufirst%3DJ.%2BT.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DSalmond%26aufirst%3DG.%2BP.%2BC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DCombating%2520multidrug-resistant%2520bacteria%253A%2520current%2520strategies%2520for%2520the%2520discovery%2520of%2520novel%2520antibacterials%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D10706%26epage%3D10733%26doi%3D10.1002%2Fanie.201209979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kawatkar, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breen, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guler, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentemann, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Botella, G.</span><span> </span><span class="NLM_article-title">Antibacterial inhibitors of gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding region</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4584</span><span class="NLM_x">–</span> <span class="NLM_lpage">4597</span><span class="refDoi"> DOI: 10.1021/jm500463c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500463c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4584-4597&author=S.+P.+Kawatkarauthor=T.+A.+Keatingauthor=N.+B.+Olivierauthor=J.+N.+Breenauthor=O.+M.+Greenauthor=S.+Y.+Gulerauthor=M.+F.+Hentemannauthor=J.+T.+Lochauthor=A.+R.+McKenzieauthor=J.+V.+Newmanauthor=L.+G.+Ottersonauthor=G.+Mart%C3%ADnez-Botella&title=Antibacterial+inhibitors+of+gram-positive+thymidylate+kinase%3A+structure-activity+relationships+and+chiral+preference+of+a+new+hydrophobic+binding+region&doi=10.1021%2Fjm500463c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm500463c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500463c%26sid%3Dliteratum%253Aachs%26aulast%3DKawatkar%26aufirst%3DS.%2BP.%26aulast%3DKeating%26aufirst%3DT.%2BA.%26aulast%3DOlivier%26aufirst%3DN.%2BB.%26aulast%3DBreen%26aufirst%3DJ.%2BN.%26aulast%3DGreen%26aufirst%3DO.%2BM.%26aulast%3DGuler%26aufirst%3DS.%2BY.%26aulast%3DHentemann%26aufirst%3DM.%2BF.%26aulast%3DLoch%26aufirst%3DJ.%2BT.%26aulast%3DMcKenzie%26aufirst%3DA.%2BR.%26aulast%3DNewman%26aufirst%3DJ.%2BV.%26aulast%3DOtterson%26aufirst%3DL.%2BG.%26aulast%3DMart%25C3%25ADnez-Botella%26aufirst%3DG.%26atitle%3DAntibacterial%2520inhibitors%2520of%2520gram-positive%2520thymidylate%2520kinase%253A%2520structure-activity%2520relationships%2520and%2520chiral%2520preference%2520of%2520a%2520new%2520hydrophobic%2520binding%2520region%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4584%26epage%3D4597%26doi%3D10.1021%2Fjm500463c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Fischbach, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span> </span><span class="NLM_article-title">Antibiotics for emerging pathogens</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1093</span><span class="refDoi"> DOI: 10.1126/science.1176667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1126%2Fscience.1176667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=19713519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVersrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=1089-1093&author=M.+A.+Fischbachauthor=C.+T.+Walsh&title=Antibiotics+for+emerging+pathogens&doi=10.1126%2Fscience.1176667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics for Emerging Pathogens</span></div><div class="casAuthors">Fischbach, Michael A.; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5944</span>),
    <span class="NLM_cas:pages">1089-1093</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Antibiotic-resistant strains of pathogenic bacteria are increasingly prevalent in hospitals and the community.  New antibiotics are needed to combat these bacterial pathogens, but progress in developing them has been slow.  Historically, most antibiotics have come from a small set of mol. scaffolds whose functional lifetimes have been extended by generations of synthetic tailoring.  The emergence of multidrug resistance among the latest generation of pathogens suggests that the discovery of new scaffolds should be a priority.  Promising approaches to scaffold discovery are emerging; they include mining underexplored microbial niches for natural products, designing screens that avoid rediscovering old scaffolds, and repurposing libraries of synthetic mols. for use as antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZw1IG5S90IbVg90H21EOLACvtfcHk0liGZ4eTbBZ9Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVersrzK&md5=96d902c55376951663e06dcddf0d571d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1176667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1176667%26sid%3Dliteratum%253Aachs%26aulast%3DFischbach%26aufirst%3DM.%2BA.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DAntibiotics%2520for%2520emerging%2520pathogens%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D1089%26epage%3D1093%26doi%3D10.1126%2Fscience.1176667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Payne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwynn, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span> </span><span class="NLM_article-title">Drugs for bad bugs: confronting the challenges of antibacterial discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1038/nrd2201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnrd2201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=17159923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGktbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=29-40&author=D.+J.+Payneauthor=M.+N.+Gwynnauthor=D.+J.+Holmesauthor=D.+L.+Pompliano&title=Drugs+for+bad+bugs%3A+confronting+the+challenges+of+antibacterial+discovery&doi=10.1038%2Fnrd2201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs for bad bugs: confronting the challenges of antibacterial discovery</span></div><div class="casAuthors">Payne, David J.; Gwynn, Michael N.; Holmes, David J.; Pompliano, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-40</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope for antibacterial drug discoverers, who now had the tools to search entire genomes for new antibacterial targets.  Several companies, including GlaxoSmithKline, moved back into the antibacterials area and embraced a genomics-derived, target-based approach to screen for new classes of drugs with novel modes of action.  Here, we share our experience of evaluating more than 300 genes and 70 high-throughput screening campaigns over a period of 7 years, and look at what we learned and how that has influenced GlaxoSmithKline's antibacterials strategy going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH1tM2BSZbWLVg90H21EOLACvtfcHk0li2yDJoxuFbuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGktbfM&md5=18100253f9868af578ea621ab98a5c86</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd2201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2201%26sid%3Dliteratum%253Aachs%26aulast%3DPayne%26aufirst%3DD.%2BJ.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26aulast%3DHolmes%26aufirst%3DD.%2BJ.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26atitle%3DDrugs%2520for%2520bad%2520bugs%253A%2520confronting%2520the%2520challenges%2520of%2520antibacterial%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D29%26epage%3D40%26doi%3D10.1038%2Fnrd2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Liu, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span> </span><span class="NLM_article-title">Color me bad: microbial pigments as virulence factors</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1016/j.tim.2009.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2Fj.tim.2009.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=19726196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFajtrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=406-413&author=G.+Y.+Liuauthor=V.+Nizet&title=Color+me+bad%3A+microbial+pigments+as+virulence+factors&doi=10.1016%2Fj.tim.2009.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Color me bad: Microbial pigments as virulence factors</span></div><div class="casAuthors">Liu, George Y.; Nizet, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">406-413</span>CODEN:
                <span class="NLM_cas:coden">TRMIEA</span>;
        ISSN:<span class="NLM_cas:issn">0966-842X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A hallmark feature of several pathogenic microbes is the distinctive color of their colonies when propagated in the clin. lab.  Such pigmentation comes in a variety of hues, and has often proven useful in presumptive clin. diagnosis.  Recent advances in microbial pigment biochem. and the genetic basis of pigment prodn. have sometimes revealed a more sinister aspect to these curious materials that change the color of reflected light by selective light absorbance.  In many cases, the microbial pigment contributes to disease pathogenesis by interfering with host immune clearance mechanisms or by exhibiting pro-inflammatory or cytotoxic properties.  We review several examples of pigments that promote microbial virulence, including the golden staphyloxanthin of Staphylococcus aureus, the blue-green pyocyanin of Pseudomonas spp., and the dark brown or black melanin pigments of Cryptococcus neoformans and Aspergillus spp.  Targeted pigment neutralisation might represent a viable concept to enhance treatment of certain difficult infectious disease conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgjrCf7qVLxLVg90H21EOLACvtfcHk0li2yDJoxuFbuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFajtrnE&md5=f9ccbcb067f7c379db9189e5a2810d19</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tim.2009.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tim.2009.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%2BY.%26aulast%3DNizet%26aufirst%3DV.%26atitle%3DColor%2520me%2520bad%253A%2520microbial%2520pigments%2520as%2520virulence%2520factors%26jtitle%3DTrends%2520Microbiol.%26date%3D2009%26volume%3D17%26spage%3D406%26epage%3D413%26doi%3D10.1016%2Fj.tim.2009.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">David, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glikman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle-Vavra, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daum, S.</span><span> </span><span class="NLM_article-title">What is community-associated methicillin-resistant <i>Staphylococcus aureus</i>?</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span><span class="refDoi"> DOI: 10.1086/533502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1086%2F533502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=18422435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A280%3ADC%252BD1c3mtlWktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2008&pages=1235-1243&author=M.+Z.+Davidauthor=D.+Glikmanauthor=S.+E.+Crawfordauthor=J.+Pengauthor=K.+J.+Kingauthor=M.+A.+Hostetlerauthor=S.+R.+Boyle-Vavraauthor=S.+Daum&title=What+is+community-associated+methicillin-resistant+Staphylococcus+aureus%3F&doi=10.1086%2F533502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">What is community-associated methicillin-resistant Staphylococcus aureus?</span></div><div class="casAuthors">David Michael Z; Glikman Daniel; Crawford Susan E; Peng Jie; King Kimberly J; Hostetler Mark A; Boyle-Vavra Susan; Daum Robert S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1235-43</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">BACKGROUND:  A community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection has been defined as an MRSA infection in a patient who lacks specific risk factors for healthcare exposure.  We sought to determine whether the absence or presence of these risk factors still predicts the phenotypic or genotypic characteristics of MRSA strains.  METHODS:  All clinical MRSA isolates were prospectively collected at the University of Chicago Hospitals from July 2004 through June 2005.  Patients were interviewed and/or their medical records were reviewed.  Isolates underwent genotyping and susceptibility testing.  Data on patients and isolates were stratified in accordance with 8 frequently cited criteria for the identification of CA-MRSA and compared for concordance.  RESULTS:  Among 616 unique patients from whom MRSA isolates were recovered, 404 (65.6%) had risk factors for healthcare exposure.  Of the 404 isolates recovered from these patients, 166 (41.1%) were clindamycin susceptible, 190 (47.0%) carried staphylococcal cassette chromosome mec (SCCmec) type IV, 145 (35.9%) carried the Panton-Valentine leukocidin genes (PVL+), and 162 (40.1%) were identified as sequence type (ST) 8 by multilocus sequence typing (MLST), all of which are characteristics commonly attributed to CA-MRSA strains.  CONCLUSIONS:  Association with the healthcare environment now has little predictive value for distinguishing patients with infection due to multidrug resistant MRSA isolates from those infected by CA-MRSA isolates, that is, isolates that are clindamycin-susceptible, PVL+, ST8, and/or contain SCCmec type IV.  Defining CA-MRSA by the absence of risk factors for healthcare exposure greatly underestimates the burden of epidemic CA-MRSA disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHXzIjMB2CYPcsfMJQC1ZdfW6udTcc2eZOw1X299GGorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3mtlWktQ%253D%253D&md5=024dbe20816d05655d1a68ec91ef3f60</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1086%2F533502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F533502%26sid%3Dliteratum%253Aachs%26aulast%3DDavid%26aufirst%3DM.%2BZ.%26aulast%3DGlikman%26aufirst%3DD.%26aulast%3DCrawford%26aufirst%3DS.%2BE.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DK.%2BJ.%26aulast%3DHostetler%26aufirst%3DM.%2BA.%26aulast%3DBoyle-Vavra%26aufirst%3DS.%2BR.%26aulast%3DDaum%26aufirst%3DS.%26atitle%3DWhat%2520is%2520community-associated%2520methicillin-resistant%2520Staphylococcus%2520aureus%253F%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D197%26spage%3D1235%26epage%3D1243%26doi%3D10.1086%2F533502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wulf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, A.</span><span> </span><span class="NLM_article-title">MRSA in livestock animals—an epidemic waiting to happen?</span> <span class="citation_source-journal">Clin. Microbiol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">521</span><span class="refDoi"> DOI: 10.1111/j.1469-0691.2008.01970.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1111%2Fj.1469-0691.2008.01970.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=18325034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A280%3ADC%252BD1c3pvFOqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=519-521&author=M.+Wulfauthor=A.+Voss&title=MRSA+in+livestock+animals%E2%80%94an+epidemic+waiting+to+happen%3F&doi=10.1111%2Fj.1469-0691.2008.01970.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MRSA in livestock animals-an epidemic waiting to happen?</span></div><div class="casAuthors">Wulf M; Voss A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">519-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Screening of pig farmers and pigs in The Netherlands has revealed that >20% of pig farmers and 39% of slaughterhouse pigs are positive for an unusual strain of methicillin-resistant Staphylococcus aureus (MRSA) belonging to sequence type (ST) 398.  It is now clear that the emergence of ST398 is not just a Dutch problem, with human infections being described in several European countries, Canada and Singapore.  Furthermore, some human isolates have now acquired the genes encoding Panton-Valentine leukocidin.  Livestock may become an important source of community-acquired MRSA.  A concerted effort on the part of clinicians, infection control practitioners and veterinarians will be required to prevent further spread of this novel strain of MRSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOzzNumf7fWr7NkxioyDXTfW6udTcc2eZZUF9PzJV6X7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3pvFOqtw%253D%253D&md5=8b52f14cb981912289d6890b6021cbcf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2008.01970.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2008.01970.x%26sid%3Dliteratum%253Aachs%26aulast%3DWulf%26aufirst%3DM.%26aulast%3DVoss%26aufirst%3DA.%26atitle%3DMRSA%2520in%2520livestock%2520animals%25E2%2580%2594an%2520epidemic%2520waiting%2520to%2520happen%253F%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2008%26volume%3D14%26spage%3D519%26epage%3D521%26doi%3D10.1111%2Fj.1469-0691.2008.01970.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Van Cleef, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnet, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krziwanek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allerberger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struelens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemlickova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuopio-Varkila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiliopoulou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paszti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardardottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantosti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller-Premru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson-Liljequist, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbarth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluytmans, J. A.</span><span> </span><span class="NLM_article-title">Livestock-associated methicillin-resistant <i>Staphylococcus aureus</i> in humans, Europe</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span><span class="refDoi"> DOI: 10.3201/eid1703.101036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.3201%2Feid1703.101036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=21392444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A280%3ADC%252BC3MvkslyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=502-505&author=B.+A.+Van+Cleefauthor=D.+L.+Monnetauthor=A.+Vossauthor=K.+Krziwanekauthor=F.+Allerbergerauthor=M.+Struelensauthor=H.+Zemlickovaauthor=R.+L.+Skovauthor=J.+Vuopio-Varkilaauthor=C.+Cunyauthor=A.+W.+Friedrichauthor=I.+Spiliopoulouauthor=J.+Pasztiauthor=H.+Hardardottirauthor=A.+Rossneyauthor=A.+Panauthor=A.+Pantostiauthor=M.+Borgauthor=H.+Grundmannauthor=M.+Mueller-Premruauthor=B.+Olsson-Liljequistauthor=A.+Widmerauthor=S.+Harbarthauthor=A.+Schweigerauthor=S.+Unalauthor=J.+A.+Kluytmans&title=Livestock-associated+methicillin-resistant+Staphylococcus+aureus+in+humans%2C+Europe&doi=10.3201%2Feid1703.101036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe</span></div><div class="casAuthors">van Cleef Brigitte A G L; Monnet Dominique L; Voss Andreas; Krziwanek Karina; Allerberger Franz; Struelens Marc; Zemlickova Helena; Skov Robert L; Vuopio-Varkila Jaana; Cuny Christiane; Friedrich Alexander W; Spiliopoulou Iris; Paszti Judit; Hardardottir Hjordis; Rossney Angela; Pan Angelo; Pantosti Annalisa; Borg Michael; Grundmann Hajo; Mueller-Premru Manica; Olsson-Liljequist Barbro; Widmer Andreas; Harbarth Stephan; Schweiger Alexander; Unal Serhat; Kluytmans Jan A J W</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">502-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To estimate the proportion of methicillin-resistant Staphylococcus aureus (MRSA) isolates from humans that were sequence type (ST) 398, we surveyed 24 laboratories in 17 countries in Europe in 2007.  Livestock-associated MRSA ST398 accounted for only a small proportion of MRSA isolates from humans; most were from the Netherlands, Belgium, Denmark, and Austria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjctboFGiEHnwOGIfWJ7-GfW6udTcc2eZZUF9PzJV6X7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvkslyrsQ%253D%253D&md5=fa02a6b1f75d33934f3cf975904bd54b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3201%2Feid1703.101036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid1703.101036%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BCleef%26aufirst%3DB.%2BA.%26aulast%3DMonnet%26aufirst%3DD.%2BL.%26aulast%3DVoss%26aufirst%3DA.%26aulast%3DKrziwanek%26aufirst%3DK.%26aulast%3DAllerberger%26aufirst%3DF.%26aulast%3DStruelens%26aufirst%3DM.%26aulast%3DZemlickova%26aufirst%3DH.%26aulast%3DSkov%26aufirst%3DR.%2BL.%26aulast%3DVuopio-Varkila%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DC.%26aulast%3DFriedrich%26aufirst%3DA.%2BW.%26aulast%3DSpiliopoulou%26aufirst%3DI.%26aulast%3DPaszti%26aufirst%3DJ.%26aulast%3DHardardottir%26aufirst%3DH.%26aulast%3DRossney%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DPantosti%26aufirst%3DA.%26aulast%3DBorg%26aufirst%3DM.%26aulast%3DGrundmann%26aufirst%3DH.%26aulast%3DMueller-Premru%26aufirst%3DM.%26aulast%3DOlsson-Liljequist%26aufirst%3DB.%26aulast%3DWidmer%26aufirst%3DA.%26aulast%3DHarbarth%26aufirst%3DS.%26aulast%3DSchweiger%26aufirst%3DA.%26aulast%3DUnal%26aufirst%3DS.%26aulast%3DKluytmans%26aufirst%3DJ.%2BA.%26atitle%3DLivestock-associated%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520in%2520humans%252C%2520Europe%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D2011%26volume%3D17%26spage%3D502%26epage%3D505%26doi%3D10.3201%2Feid1703.101036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Nicholson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frana, T. S.</span><span> </span><span class="NLM_article-title">Livestock-associated methicillin-resistant <i>Staphylococcus aureus</i> (LA-MRSA) isolates of swine origin form robust biofilms</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e73376</span><span class="refDoi"> DOI: 10.1371/journal.pone.0073376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1371%2Fjournal.pone.0073376" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e73376&author=T.+L.+Nicholsonauthor=S.+M.+Shoreauthor=T.+C.+Smithauthor=T.+S.+Frana&title=Livestock-associated+methicillin-resistant+Staphylococcus+aureus+%28LA-MRSA%29+isolates+of+swine+origin+form+robust+biofilms&doi=10.1371%2Fjournal.pone.0073376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073376%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DT.%2BL.%26aulast%3DShore%26aufirst%3DS.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BC.%26aulast%3DFrana%26aufirst%3DT.%2BS.%26atitle%3DLivestock-associated%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528LA-MRSA%2529%2520isolates%2520of%2520swine%2520origin%2520form%2520robust%2520biofilms%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De73376%26doi%3D10.1371%2Fjournal.pone.0073376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Barber, M.</span><span> </span><span class="NLM_article-title">Editorial</span> <span class="citation_source-journal">J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1136/jcp.14.4.385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1136%2Fjcp.14.4.385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=13686776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADyaF38Xps1Oq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1961&pages=385-393&author=M.+Barber&title=Editorial&doi=10.1136%2Fjcp.14.4.385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Methicillin-resistant staphylococci</span></div><div class="casAuthors">Barber, Mary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">385-93</span>CODEN:
                <span class="NLM_cas:coden">JCPAAK</span>;
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    </div><div class="casAbstract">After repeated passage on Celbenin (Methicillin) ditch plates, 18 strains of Staphylococcus aureus showed an increase in resistance to Celbenin; resistance was of the drug-tolerant type and Celbenin was not inactivated.  There was an assocd. increase in tolerance to benzylpenicillin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyNOtS6b7CebVg90H21EOLACvtfcHk0lgt1OCzXR5qWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38Xps1Oq&md5=2001b633999fdd8b159f3ceee6277604</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1136%2Fjcp.14.4.385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.14.4.385%26sid%3Dliteratum%253Aachs%26aulast%3DBarber%26aufirst%3DM.%26atitle%3DEditorial%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D1961%26volume%3D14%26spage%3D385%26epage%3D393%26doi%3D10.1136%2Fjcp.14.4.385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span> <span class="citation_source-book">Antibiotic Resistance Threats in the United States</span>; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Antibiotic+Resistance+Threats+in+the+United+States%3B+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DAntibiotic%2520Resistance%2520Threats%2520in%2520the%2520United%2520States%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Rex, J. H.</span><span> </span><span class="NLM_article-title">ND4BB: addressing the antimicrobial resistance crisis</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1038/nrmicro3245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnrmicro3245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVyrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=231-232&author=J.+H.+Rex&title=ND4BB%3A+addressing+the+antimicrobial+resistance+crisis&doi=10.1038%2Fnrmicro3245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">ND4BB: addressing the antimicrobial resistance crisis</span></div><div class="casAuthors">Rex, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Innovative Medicines Initiative (IMI) recently launched its third public-private partnership, ENABLE (European Gram-neg. Antibacterial Engine), to tackle the shortage of effective antimicrobial agents for Gram-neg. pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXa_dkTisl6LVg90H21EOLACvtfcHk0lgt1OCzXR5qWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVyrsb0%253D&md5=67453f4239e7f1c55762751a8a854efd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3245%26sid%3Dliteratum%253Aachs%26aulast%3DRex%26aufirst%3DJ.%2BH.%26atitle%3DND4BB%253A%2520addressing%2520the%2520antimicrobial%2520resistance%2520crisis%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2014%26volume%3D12%26spage%3D231%26epage%3D232%26doi%3D10.1038%2Fnrmicro3245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span> <span class="citation_source-book">National Action Plan for Combating Antibiotic-resistant Bacteria</span>; <span class="NLM_publisher-name">White House</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Action+Plan+for+Combating+Antibiotic-resistant+Bacteria%3B+White+House%3A+Washington%2C+DC%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DNational%2520Action%2520Plan%2520for%2520Combating%2520Antibiotic-resistant%2520Bacteria%26pub%3DWhite%2520House%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Appelbaum, P. C.</span><span> </span><span class="NLM_article-title">The emergence of vancomycin-intermediate and vancomycin-resistant <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Clin. Microbiol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1111/j.1469-0691.2006.01344.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1111%2Fj.1469-0691.2006.01344.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=16445720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFOrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=16-23&author=P.+C.+Appelbaum&title=The+emergence+of+vancomycin-intermediate+and+vancomycin-resistant+Staphylococcus+aureus&doi=10.1111%2Fj.1469-0691.2006.01344.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Appelbaum, P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology and Infection</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">16-23</span>CODEN:
                <span class="NLM_cas:coden">CMINFM</span>;
        ISSN:<span class="NLM_cas:issn">1198-743X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Methicillin-resistant Staphylococcus aureus (MRSA) is well-recognized as a major cause of infection in the healthcare setting but, even more worryingly, is now emerging in the community.  The glycopeptides - notably vancomycin - have traditionally been the mainstay of treatment of MRSA but overuse has led to the emergence of vancomycin-intermediate and vancomycin-resistant MRSA (VISA and VRSA, resp.).  Although the mechanisms underlying vancomycin resistance are not yet fully understood, changes to the bacterial cell wall - the site of action of the glycopeptides - are believed to be key.  Recent evidence also supports the transfer of genetic material among bacteria as contributing to the development of VRSA.  Based on the cases identified to date, risk factors for the development of VRSA may include older age, compromised blood flow to the lower limbs, and the presence of chronic ulcers.  The true extent of the problem, however, remains to be detd. - it is likely that many cases of VISA and VRSA infection go undetected because of suboptimal screening programs and possible limitations of automated and non-automated detection methods.  Effective screening directed at those patients considered to be most at risk should therefore be a priority.  Not surprisingly, the spread of MRSA from the hospital to the community setting, coupled with the emergence of VISA and VRSA, has become a major cause of concern among clinicians and microbiologists.  The treatment options available for these infections are now severely compromised and thus new classes of antimicrobial agents effective against MRSA, VISA and VRSA are urgently required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdTpzSqp0FNLVg90H21EOLACvtfcHk0liaTxovHZQOTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFOrur0%253D&md5=e4cfd011e9834649da5733a4b8edc02e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2006.01344.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2006.01344.x%26sid%3Dliteratum%253Aachs%26aulast%3DAppelbaum%26aufirst%3DP.%2BC.%26atitle%3DThe%2520emergence%2520of%2520vancomycin-intermediate%2520and%2520vancomycin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2006%26volume%3D12%26spage%3D16%26epage%3D23%26doi%3D10.1111%2Fj.1469-0691.2006.01344.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Tsiodras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoulas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliopoulos, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennersten, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moellering, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraro, J.</span><span> </span><span class="NLM_article-title">Linezolid resistance in a clinical isolate of <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span><span class="refDoi"> DOI: 10.1016/S0140-6736(01)05410-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2FS0140-6736%2801%2905410-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=11476839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlymsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=207-208&author=S.+Tsiodrasauthor=H.+S.+Goldauthor=G.+Sakoulasauthor=G.+M.+Eliopoulosauthor=C.+Wennerstenauthor=L.+Venkataramanauthor=R.+C.+Moelleringauthor=J.+Ferraro&title=Linezolid+resistance+in+a+clinical+isolate+of+Staphylococcus+aureus&doi=10.1016%2FS0140-6736%2801%2905410-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid resistance in a clinical isolate of Staphylococcus aureus</span></div><div class="casAuthors">Tsiodras, S.; Gold, H. S.; Sakoulas, G.; Eliopoulos, G. M.; Wennersten, C.; Venkataraman, L.; Moellering, R. C.; Ferraro, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">9277</span>),
    <span class="NLM_cas:pages">207-208</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various Gram-pos. bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).  Although instances of linezolid resistance in VRE have been reported, resistance has not been encountered among clin. isolates of S aureus.  The authors have characterized an MRSA isolate resistant to linezolid that was recovered from a patient treated with this agent for dialysis-assocd. peritonitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRryTK5F9tc7Vg90H21EOLACvtfcHk0liaTxovHZQOTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlymsr8%253D&md5=d8574bd50d0f1129cbc8d5dae0ac8127</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2801%2905410-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252801%252905410-1%26sid%3Dliteratum%253Aachs%26aulast%3DTsiodras%26aufirst%3DS.%26aulast%3DGold%26aufirst%3DH.%2BS.%26aulast%3DSakoulas%26aufirst%3DG.%26aulast%3DEliopoulos%26aufirst%3DG.%2BM.%26aulast%3DWennersten%26aufirst%3DC.%26aulast%3DVenkataraman%26aufirst%3DL.%26aulast%3DMoellering%26aufirst%3DR.%2BC.%26aulast%3DFerraro%26aufirst%3DJ.%26atitle%3DLinezolid%2520resistance%2520in%2520a%2520clinical%2520isolate%2520of%2520Staphylococcus%2520aureus%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D207%26epage%3D208%26doi%3D10.1016%2FS0140-6736%2801%2905410-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Prystowsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chosay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinabarger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millichap, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noskin, A. G.</span><span> </span><span class="NLM_article-title">Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2154</span><span class="NLM_x">–</span> <span class="NLM_lpage">2156</span><span class="refDoi"> DOI: 10.1128/AAC.45.7.2154-2156.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FAAC.45.7.2154-2156.2001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=2154-2156&author=J.+Prystowskyauthor=F.+Siddiquiauthor=J.+Chosayauthor=D.+L.+Shinabargerauthor=J.+Millichapauthor=L.+R.+Petersonauthor=A.+G.+Noskin&title=Resistance+to+linezolid%3A+characterization+of+mutations+in+rRNA+and+comparison+of+their+occurrences+in+vancomycin-resistant+enterococci&doi=10.1128%2FAAC.45.7.2154-2156.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.7.2154-2156.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.7.2154-2156.2001%26sid%3Dliteratum%253Aachs%26aulast%3DPrystowsky%26aufirst%3DJ.%26aulast%3DSiddiqui%26aufirst%3DF.%26aulast%3DChosay%26aufirst%3DJ.%26aulast%3DShinabarger%26aufirst%3DD.%2BL.%26aulast%3DMillichap%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DL.%2BR.%26aulast%3DNoskin%26aufirst%3DA.%2BG.%26atitle%3DResistance%2520to%2520linezolid%253A%2520characterization%2520of%2520mutations%2520in%2520rRNA%2520and%2520comparison%2520of%2520their%2520occurrences%2520in%2520vancomycin-resistant%2520enterococci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D2154%26epage%3D2156%26doi%3D10.1128%2FAAC.45.7.2154-2156.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Silverman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span> </span><span class="NLM_article-title">Resistance studies with daptomycin</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1799</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span><span class="refDoi"> DOI: 10.1128/AAC.45.6.1799-1802.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FAAC.45.6.1799-1802.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=11353628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslyqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=1799-1802&author=J.+A.+Silvermanauthor=N.+Oliverauthor=T.+Andrewauthor=T.+Li&title=Resistance+studies+with+daptomycin&doi=10.1128%2FAAC.45.6.1799-1802.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance studies with daptomycin</span></div><div class="casAuthors">Silverman, Jared A.; Oliver, Nicole; Andrew, Ted; Li, Tongchuan</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1799-1802</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The authors studied the in vitro emergence of resistance to daptomycin using 3 methods; spontaneous resistance incidence, serial passage in the presence of increasing drug concns., and chem. mutagenesis.  No spontaneously resistant mutants were obtained for any organism tested (<10-10 for Staphylococcus aureus, <10-9 for Staphylococcus epidermidis, <10-9 for Enterococcus faecalis, <10-9 for Enterococcus faecium, <10-8 for Streptococcus pneumoniae).  Population anal. demonstrated that bacterial susceptibility to daptomycin is heterogeneous.  Assay results were sensitive to Ca concn. and culture d., both of which can affect apparent resistance rates.  Stable S. aureus mutants were isolated by both serial passage in liq. media and chem. mutagenesis.  The daptomycin MICs for these isolates were 8- to 32-fold higher than for the parental strain.  Many mutants with high MICs (>12.5 μg/mL) had growth defects but did not display phenotypes typical of S. aureus small colony variants.  The voltage component (Δψ) of the bacterial membrane potential was increased in 3 independent resistant isolates.  In vivo data showed that some daptomycin-resistant mutants had lost virulence.  For other mutants, the degree of in vitro resistance was greater than the change in in vivo susceptibility.  These results suggest that infection with some daptomycin-resistant organisms may still be easily treatable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4J9V61A8j0rVg90H21EOLACvtfcHk0liaTxovHZQOTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslyqsLc%253D&md5=37ec8b901b719a3d373b139a1de0901d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.6.1799-1802.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.6.1799-1802.2001%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DJ.%2BA.%26aulast%3DOliver%26aufirst%3DN.%26aulast%3DAndrew%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DT.%26atitle%3DResistance%2520studies%2520with%2520daptomycin%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D1799%26epage%3D1802%26doi%3D10.1128%2FAAC.45.6.1799-1802.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sabol, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadena, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, J. H.</span><span> </span><span class="NLM_article-title">Emergence of daptomycin resistance in enterococcus faecium during daptomycin therapy</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1665</span><span class="refDoi"> DOI: 10.1128/AAC.49.4.1664-1665.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FAAC.49.4.1664-1665.2005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1664-1665&author=K.+Sabolauthor=J.+E.+Pattersonauthor=J.+S.+Lewisauthor=A.+Owensauthor=J.+Cadenaauthor=J.+H.+Jorgensen&title=Emergence+of+daptomycin+resistance+in+enterococcus+faecium+during+daptomycin+therapy&doi=10.1128%2FAAC.49.4.1664-1665.2005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.4.1664-1665.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.4.1664-1665.2005%26sid%3Dliteratum%253Aachs%26aulast%3DSabol%26aufirst%3DK.%26aulast%3DPatterson%26aufirst%3DJ.%2BE.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DOwens%26aufirst%3DA.%26aulast%3DCadena%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DJ.%2BH.%26atitle%3DEmergence%2520of%2520daptomycin%2520resistance%2520in%2520enterococcus%2520faecium%2520during%2520daptomycin%2520therapy%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D1664%26epage%3D1665%26doi%3D10.1128%2FAAC.49.4.1664-1665.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mendes, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsakris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sader, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGhee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbaum, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosowska-Shick, K.</span><span> </span><span class="NLM_article-title">Charaterization of methicillin-resistant <i>Staphylococcus aureus</i> displaying increased MICs of ceftaroline</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span><span class="refDoi"> DOI: 10.1093/jac/dks069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1093%2Fjac%2Fdks069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=22398650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2qt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=1321-1324&author=R.+E.+Mendesauthor=A.+Tsakrisauthor=H.+S.+Saderauthor=R.+N.+Jonesauthor=D.+Biekauthor=P.+McGheeauthor=P.+C.+Appelbaumauthor=K.+Kosowska-Shick&title=Charaterization+of+methicillin-resistant+Staphylococcus+aureus+displaying+increased+MICs+of+ceftaroline&doi=10.1093%2Fjac%2Fdks069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline</span></div><div class="casAuthors">Mendes, Rodrigo E.; Tsakris, Athanassios; Sader, Helio S.; Jones, Ronald N.; Biek, Donald; McGhee, Pamela; Appelbaum, Peter C.; Kosowska-Shick, Klaudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1321-1324</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The objective of this study was to characterize the mechanisms responsible for elevated MICs of ceftaroline for methicillin-resistant Staphylococcus aureus (MRSA).  During the 2008 Assessing Worldwide Antimicrobial Resistance Evaluation ( AWARE') surveillance program, four S. aureus collected from sep. patients in Athens, Greece, demonstrated ceftaroline MICs of 4 mg/L.  These isolates were clonally related and one strain (13101) was selected for further characterization.  Two strains (4981 and 4977) displaying ceftaroline MICs of 1 and 2 mg/L, resp., were included for comparison.  All strains originated from the same hospital.  Penicillin-binding protein (PBP) affinities for ceftaroline and comparators were detd.  Strains were typed by single-locus typing (i.e. spa typing), multilocus sequence typing ( MLST') and by multiple-locus variable-no. tandem repeat fingerprinting (MLVF).  The presence of Pantone-Valentine leucocidin and the staphylococcal cassette chromosome mec types was assessed.  The authors also performed nucleotide sequencing of the mecA (encoding PBP2a) promoter and ribosomal binding site (rbs) regions and mecR1.  Ceftaroline demonstrated the highest PBP2a affinity with strain 4981 (ST5-MRSA-II) (IC50 0.06 mg/L; MIC 1 mg/L).  Strains 4977 and 13101 (both ST239-MRSA-III) showed indistinguishable MLVF profiles.  Ceftaroline PBP2a binding affinity in strains 4977 (IC50 0.25 mg/L; MIC 2 mg/L) and 13101 (IC50 1 mg/L; MIC 4 mg/L) was 4- and 16-fold lower than 4981, resp.  Strain 4981 contains a wild-type PBP2a, while strains 4977 and 13101 have N146K and E150K alterations in the non-penicillin-binding domain.  Addnl., 13101 has one substitution (H351N) in the transpeptidase domain.  Alterations in the mecR1, mecA promoter or rbs regions were not obsd.  Thus, increased ceftaroline MICs were assocd. with decreased PBP2a binding affinity and reflected alterations in PBP2a.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKfKJDYcNUfLVg90H21EOLACvtfcHk0lhirRVSG-Xh4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2qt7g%253D&md5=24f80a4d1cb592fd498d1aa09a7809f0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks069%26sid%3Dliteratum%253Aachs%26aulast%3DMendes%26aufirst%3DR.%2BE.%26aulast%3DTsakris%26aufirst%3DA.%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DJones%26aufirst%3DR.%2BN.%26aulast%3DBiek%26aufirst%3DD.%26aulast%3DMcGhee%26aufirst%3DP.%26aulast%3DAppelbaum%26aufirst%3DP.%2BC.%26aulast%3DKosowska-Shick%26aufirst%3DK.%26atitle%3DCharaterization%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520displaying%2520increased%2520MICs%2520of%2520ceftaroline%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D1321%26epage%3D1324%26doi%3D10.1093%2Fjac%2Fdks069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jameson-Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OttoWang, M.</span><span> </span><span class="NLM_article-title"><i>Staphylococcus</i> epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1510</span><span class="NLM_x">–</span> <span class="NLM_lpage">1514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnm1656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=17994102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtl2gs7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1510-1514&author=R.+Wangauthor=B.+Khanauthor=G.+Cheungauthor=T.+Bachauthor=M.+Jameson-Leeauthor=K.+Kongauthor=S.+Queckauthor=M.+OttoWang&title=Staphylococcus+epidermidis+surfactant+peptides+promote+biofilm+maturation+and+dissemination+of+biofilm-associated+infection+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA</span></div><div class="casAuthors">Wang, Rong; Braughton, Kevin R.; Kretschmer, Dorothee; Bach, Thanh-Huy L.; Queck, Shu Y.; Li, Min; Kennedy, Adam D.; Dorward, David W.; Klebanoff, Seymour J.; Peschel, Andreas; DeLeo, Frank R.; Otto, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1510-1514</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Methicillin-resistant Staphylococcus aureus (MRSA) remains a major human pathogen.  Traditionally, MRSA infections occurred exclusively in hospitals and were limited to immunocompromised patients or individuals with predisposing risk factors.  However, recently there has been an alarming epidemic caused by community-assocd. (CA)-MRSA strains, which can cause severe infections that can result in necrotizing fasciitis or even death in otherwise healthy adults outside of healthcare settings.  In the US, CA-MRSA is now the cause of the majority of infections that result in trips to the emergency room.  It is unclear what makes CA-MRSA strains more successful in causing human disease compared with their hospital-assocd. counterparts.  Here we describe a class of secreted staphylococcal peptides that have a remarkable ability to recruit, activate and subsequently lyse human neutrophils, thus eliminating the main cellular defense against S. aureus infection.  These peptides are produced at high concns. by std. CA-MRSA strains and contribute significantly to the strains' ability to cause disease in animal models of infection.  Our study reveals a previously uncharacterized set of S. aureus virulence factors that account at least in part for the enhanced virulence of CA-MRSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYAQsZnMB2cLVg90H21EOLACvtfcHk0lhirRVSG-Xh4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtl2gs7fN&md5=0d0178f9f2e78c40f2686ca916f0f3e0</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1038%2Fnm1656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1656%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DG.%26aulast%3DBach%26aufirst%3DT.%26aulast%3DJameson-Lee%26aufirst%3DM.%26aulast%3DKong%26aufirst%3DK.%26aulast%3DQueck%26aufirst%3DS.%26aulast%3DOttoWang%26aufirst%3DM.%26atitle%3DStaphylococcus%2520epidermidis%2520surfactant%2520peptides%2520promote%2520biofilm%2520maturation%2520and%2520dissemination%2520of%2520biofilm-associated%2520infection%2520in%2520mice%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1510%26epage%3D1514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_contrib-group">Escaich, S.</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2008.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2Fj.cbpa.2008.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=18639647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2jsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Escaich%2C+S.Curr.+Opin.+Chem.+Biol.+2008%2C+12%2C+400%E2%80%93408+10.1016%2Fj.cbpa.2008.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antivirulence as a new antibacterial approach for chemotherapy</span></div><div class="casAuthors">Escaich, Sonia</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">400-408</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Bacterial resistance to antibiotics is an issue that has led to the search for new antibacterial approaches.  Drugs targeting virulence is an alternative approach to treat infections due to resistant bacteria.  There is extensive literature and knowledge in the field of bacterial pathogenesis and genomic determinant of virulence.  As therapeutic targets, virulence factors have been primarily addressed in the vaccine field to prevent infection by specific pathogens.  Recently novel strategies to identify virulence inhibitors have been numerous and several new compds. were recently reported.  This review emphasizes the new virulence inhibitors that have shown a biol. activity and have made a proof of concept that disarming bacteria lead to the inhibition of bacterial infection in exptl. models in vivo.  Moreover, some of these new anti-virulence compds. are able to inhibit the virulence of different related pathogenic species, indicating that it is possible to target common virulence mechanisms.  The progress reported recently with proof of concept for anti-virulence mols. at the preclin. stages should allow the anti-virulence concept to become a reality as a new antibacterial approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJbkQsVpfmtrVg90H21EOLACvtfcHk0lhirRVSG-Xh4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2jsrvI&md5=6563c3f594233a0960cb2de36309c657</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DEscaich%26aufirst%3DS.%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D400%26epage%3D408%26doi%3D10.1016%2Fj.cbpa.2008.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Clauditz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götz, F.</span><span> </span><span class="NLM_article-title">Staphyloxanthin plays a role in the fitness of <i>Staphylococcus aureus</i> and its ability to cope with oxidative stress</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">4950</span><span class="NLM_x">–</span> <span class="NLM_lpage">4953</span><span class="refDoi"> DOI: 10.1128/IAI.00204-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FIAI.00204-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=16861688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvFWqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2006&pages=4950-4953&author=A.+Clauditzauthor=A.+Reschauthor=K.+Wielandauthor=A.+Peschelauthor=F.+G%C3%B6tz&title=Staphyloxanthin+plays+a+role+in+the+fitness+of+Staphylococcus+aureus+and+its+ability+to+cope+with+oxidative+stress&doi=10.1128%2FIAI.00204-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress</span></div><div class="casAuthors">Clauditz, Alexandra; Resch, Alexandra; Wieland, Karsten-Peter; Peschel, Andreas; Goetz, Friedrich</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4950-4953</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Staphyloxanthin is a membrane-bound carotenoid of Staphylococcus aureus.  Here we studied the interaction of staphyloxanthin with reactive oxygen substances (ROS) and showed by comparative anal. of the wild type (WT) and an isogenic crtM mutant that the WT is more resistant to hydrogen peroxide, superoxide radical, hydroxyl radical, hypochlorite, and neutrophil killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIqSybpc3xXLVg90H21EOLACvtfcHk0lgVAyAATtzqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvFWqt74%253D&md5=3a6cc24dd4e751718645378006170103</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FIAI.00204-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00204-06%26sid%3Dliteratum%253Aachs%26aulast%3DClauditz%26aufirst%3DA.%26aulast%3DResch%26aufirst%3DA.%26aulast%3DWieland%26aufirst%3DK.%26aulast%3DPeschel%26aufirst%3DA.%26aulast%3DG%25C3%25B6tz%26aufirst%3DF.%26atitle%3DStaphyloxanthin%2520plays%2520a%2520role%2520in%2520the%2520fitness%2520of%2520Staphylococcus%2520aureus%2520and%2520its%2520ability%2520to%2520cope%2520with%2520oxidative%2520stress%26jtitle%3DInfect.%2520Immun.%26date%3D2006%26volume%3D74%26spage%3D4950%26epage%3D4953%26doi%3D10.1128%2FIAI.00204-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, L.</span><span> </span><span class="NLM_article-title">Small molecule targeting of a diapophytoene desaturase inhibits <i>S. aureus</i> virulence</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1038/nchembio.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnchembio.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=26780405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=174-179&author=F.+Chenauthor=H.+Diauthor=Y.+Wangauthor=Q.+Caoauthor=B.+Xuauthor=X.+Zhangauthor=N.+Yangauthor=G.+Liuauthor=C.+G.+Yangauthor=Y.+Xuauthor=H.+Jiangauthor=F.+Lianauthor=N.+Zhangauthor=J.+Liauthor=L.+Lan&title=Small+molecule+targeting+of+a+diapophytoene+desaturase+inhibits+S.+aureus+virulence&doi=10.1038%2Fnchembio.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</span></div><div class="casAuthors">Chen, Feifei; Di, Hongxia; Wang, Youxin; Cao, Qiao; Xu, Bin; Zhang, Xue; Yang, Nana; Liu, Guijie; Yang, Cai-Guang; Xu, Yong; Jiang, Hualiang; Lian, Fulin; Zhang, Naixia; Li, Jian; Lan, Lefu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">174-179</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The surge of antibiotic resistance in Staphylococcus aureus has created a dire need for innovative anti-infective agents that attack new targets, to overcome resistance.  In S. aureus, carotenoid pigment is an important virulence factor because it shields the bacterium from host oxidant killing.  Here we show that naftifine, a US Food and Drug Administration (FDA)-approved antifungal drug, blocks biosynthesis of carotenoid pigment at nanomolar concns.  This effect is mediated by competitive inhibition of S. aureus diapophytoene desaturase (CrtN), an essential enzyme for carotenoid pigment synthesis.  We found that naftifine attenuated the virulence of a variety of clin. S. aureus isolates, including methicillin-resistant S. aureus (MRSA) strains, in mouse infection models.  Specifically, we detd. that naftifine is a lead compd. for potent CrtN inhibitors.  In sum, these findings reveal that naftifine could serve as a chem. probe to manipulate CrtN activity, providing proof of concept that CrtN is a druggable target against S. aureus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3544UnQ977LVg90H21EOLACvtfcHk0lgVAyAATtzqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D&md5=77be3d6b1b252ea24f011b711f348130</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DC.%2BG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLian%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26atitle%3DSmall%2520molecule%2520targeting%2520of%2520a%2520diapophytoene%2520desaturase%2520inhibits%2520S.%2520aureus%2520virulence%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D174%26epage%3D179%26doi%3D10.1038%2Fnchembio.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span> </span><span class="NLM_article-title">A cholesterol biosynthesis inhibitor blocks <i>Staphylococcus aureus</i> virulence</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">1391</span><span class="NLM_x">–</span> <span class="NLM_lpage">1394</span><span class="refDoi"> DOI: 10.1126/science.1153018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1126%2Fscience.1153018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=18276850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislSkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=1391-1394&author=C.+Liuauthor=G.+Liuauthor=Y.+Songauthor=F.+Yinauthor=M.+Henslerauthor=W.+Jengauthor=V.+Nizetauthor=A.+Wangauthor=E.+Oldfield&title=A+cholesterol+biosynthesis+inhibitor+blocks+Staphylococcus+aureus+virulence&doi=10.1126%2Fscience.1153018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence</span></div><div class="casAuthors">Liu, Chia-I.; Liu, George Y.; Song, Yongcheng; Yin, Fenglin; Hensler, Mary E.; Jeng, Wen-Yih; Nizet, Victor; Wang, Andrew H.-J.; Oldfield, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5868</span>),
    <span class="NLM_cas:pages">1391-1394</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Staphylococcus aureus produces hospital- and community-acquired infections, with methicillin-resistant S. aureus posing a serious public health threat.  The golden carotenoid pigment of S. aureus, staphyloxanthin, promotes resistance to reactive oxygen species and host neutrophil-based killing, and early enzymic steps in staphyloxanthin prodn. resemble those for cholesterol biosynthesis.  The authors detd. the crystal structures of S. aureus dehydrosqualene synthase (CrtM) at 1.58 angstrom resoln., finding structural similarity to human squalene synthase (SQS).  They screened nine SQS inhibitors and detd. the structures of three, bound to CrtM.  One, previously tested for cholesterol-lowering activity in humans, blocked staphyloxanthin biosynthesis in vitro (median inhibitory concn. ∼100 nM), resulting in colorless bacteria with increased susceptibility to killing by human blood and to innate immune clearance in a mouse infection model.  This finding represents proof of principle for a virulence factor-based therapy against S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSU79aY2tk2LVg90H21EOLACvtfcHk0lgVAyAATtzqWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislSkt78%253D&md5=dc5cad808833e6fb2d0c5ef65dd21013</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.1153018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1153018%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DF.%26aulast%3DHensler%26aufirst%3DM.%26aulast%3DJeng%26aufirst%3DW.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DA%2520cholesterol%2520biosynthesis%2520inhibitor%2520blocks%2520Staphylococcus%2520aureus%2520virulence%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D1391%26epage%3D1394%26doi%3D10.1126%2Fscience.1153018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poveda, C. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukkamala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacanowska, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span> </span><span class="NLM_article-title">Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in <i>staphylococcus aureus</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1021/jm801023u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801023u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=976-988&author=Y.+Songauthor=F.+Linauthor=F.+Yinauthor=M.+Henslerauthor=C.+A.+R.+Povedaauthor=D.+Mukkamalaauthor=R.+Caoauthor=H.+Wangauthor=C.+Moritaauthor=D.+G.+Pacanowskaauthor=V.+Nizetauthor=E.+Oldfield&title=Phosphonosulfonates+are+potent%2C+selective+inhibitors+of+dehydrosqualene+synthase+and+staphyloxanthin+biosynthesis+in+staphylococcus+aureus&doi=10.1021%2Fjm801023u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm801023u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801023u%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DYin%26aufirst%3DF.%26aulast%3DHensler%26aufirst%3DM.%26aulast%3DPoveda%26aufirst%3DC.%2BA.%2BR.%26aulast%3DMukkamala%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMorita%26aufirst%3DC.%26aulast%3DPacanowska%26aufirst%3DD.%2BG.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DPhosphonosulfonates%2520are%2520potent%252C%2520selective%2520inhibitors%2520of%2520dehydrosqualene%2520synthase%2520and%2520staphyloxanthin%2520biosynthesis%2520in%2520staphylococcus%2520aureus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D976%26epage%3D988%26doi%3D10.1021%2Fjm801023u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span> </span><span class="NLM_article-title">Head-to-head prenyl tranferases: anti-infective drug targets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4367</span><span class="NLM_x">–</span> <span class="NLM_lpage">4372</span><span class="refDoi"> DOI: 10.1021/jm300208p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300208p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4367-4372&author=F.+Linauthor=Y.+Liuauthor=K.+Liauthor=R.+Caoauthor=W.+Zhuauthor=J.+Axelsonauthor=R.+Pangauthor=E.+Oldfield&title=Head-to-head+prenyl+tranferases%3A+anti-infective+drug+targets&doi=10.1021%2Fjm300208p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300208p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300208p%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DAxelson%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DR.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DHead-to-head%2520prenyl%2520tranferases%253A%2520anti-infective%2520drug%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4367%26epage%3D4372%26doi%3D10.1021%2Fjm300208p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Discovery of potent benzofuran-derived diapophytoene desaturase (CrtN) inhibitors with enhanced oral bioavailability for the treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) Infections</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3215</span><span class="NLM_x">–</span> <span class="NLM_lpage">3230</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3215-3230&author=Y.+Wangauthor=F.+Chenauthor=H.+Diauthor=Y.+Xuauthor=Q.+Xiaoauthor=X.+Wangauthor=H.+Weiauthor=Y.+Luauthor=L.+Zhangauthor=J.+Zhuauthor=C.+Shengauthor=L.+Lanauthor=J.+Li&title=Discovery+of+potent+benzofuran-derived+diapophytoene+desaturase+%28CrtN%29+inhibitors+with+enhanced+oral+bioavailability+for+the+treatment+of+methicillin-resistant+Staphylococcus+aureus+%28MRSA%29+Infections&doi=10.1021%2Facs.jmedchem.5b01984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections</span></div><div class="casAuthors">Wang, Youxin; Chen, Feifei; Di, Hongxia; Xu, Yong; Xiao, Qiang; Wang, Xuehai; Wei, Hanwen; Lu, Yanli; Zhang, Lingling; Zhu, Jin; Sheng, Chunquan; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3215-3230</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blocking the staphyloxanthin biosynthesis process has emerged as a new promising antivirulence strategy.  Previously, we first revealed that CrtN is a druggable target against infections caused by pigmented Staphylococcus aureus (S. aureus) and that naftifine was an effective CrtN inhibitor.  Here, we identify a new type of benzofuran-derived CrtN inhibitor with submicromolar IC50 values that is based on the naftifine scaffold.  The most potent analog, 5m, inhibits the pigment prodn. of S. aureus Newman and three MRSA strains, with IC50 values of 0.38-5.45 nM, without any impact on the survival of four strains (up to 200 μM).  Notably, compd. 5m (1 μM) could significantly sensitize four strains to immune clearance and could effectively attenuate the virulence of three strains in vivo.  Moreover, 5m was detd. to be a weak antifungal reagent (MIC > 16 μg/mL).  Combined with good oral bioavailability (F = 42.2%) and excellent safety profiles, these data demonstrate that 5m may be a good candidate for the treatment of MRSA infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqahz7Kq8Z-k7Vg90H21EOLACvtfcHk0lhHqExePHV82g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCisLo%253D&md5=109908ff78289f118ced8c8883622f02</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01984%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520benzofuran-derived%2520diapophytoene%2520desaturase%2520%2528CrtN%2529%2520inhibitors%2520with%2520enhanced%2520oral%2520bioavailability%2520for%2520the%2520treatment%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3215%26epage%3D3230%26doi%3D10.1021%2Facs.jmedchem.5b01984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">David, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daum, R. S.</span><span> </span><span class="NLM_article-title">Community-associated methicillin-resistant <i>Staphylococcus aureus</i>: epidemiology and clinical consequences of an emerging epidemic</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">687</span><span class="refDoi"> DOI: 10.1128/CMR.00081-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FCMR.00081-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=20610826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWgtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=616-687&author=M.+Z.+Davidauthor=R.+S.+Daum&title=Community-associated+methicillin-resistant+Staphylococcus+aureus%3A+epidemiology+and+clinical+consequences+of+an+emerging+epidemic&doi=10.1128%2FCMR.00081-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic</span></div><div class="casAuthors">David, Michael Z.; Daum, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-687</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Staphylococcus aureus is an important cause of skin and soft-tissue infections (SSTIs), endovascular infections, pneumonia, septic arthritis, endocarditis, osteomyelitis, foreign-body infections, and sepsis.  Methicillin-resistant S. aureus (MRSA) isolates were once confined largely to hospitals, other health care environments, and patients frequenting these facilities.  Since the mid-1990s, however, there has been an explosion in the no. of MRSA infections reported in populations lacking risk factors for exposure to the health care system.  This increase in the incidence of MRSA infection has been assocd. with the recognition of new MRSA clones known as community-assocd. MRSA (CA-MRSA).  CA-MRSA strains differ from the older, health care-assocd. MRSA strains; they infect a different group of patients, they cause different clin. syndromes, they differ in antimicrobial susceptibility patterns, they spread rapidly among healthy people in the community, and they frequently cause infections in health care environments as well.  This review details what is known about the epidemiol. of CA-MRSA strains and the clin. spectrum of infectious syndromes assocd. with them that ranges from a commensal state to severe, overwhelming infection.  It also addresses the therapy of these infections and strategies for their prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdAu5V8JgWQrVg90H21EOLACvtfcHk0lhHqExePHV82g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWgtLnN&md5=09da2efa326503462593abd5367dff30</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FCMR.00081-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00081-09%26sid%3Dliteratum%253Aachs%26aulast%3DDavid%26aufirst%3DM.%2BZ.%26aulast%3DDaum%26aufirst%3DR.%2BS.%26atitle%3DCommunity-associated%2520methicillin-resistant%2520Staphylococcus%2520aureus%253A%2520epidemiology%2520and%2520clinical%2520consequences%2520of%2520an%2520emerging%2520epidemic%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2010%26volume%3D23%26spage%3D616%26epage%3D687%26doi%3D10.1128%2FCMR.00081-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">de Matos, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalcante, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iorio, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamon, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Santos, K. R.</span><span> </span><span class="NLM_article-title">Molecular markers of antimicrobial resistance in methicillin-resistant <i>staphylococcus aureus</i> SCCmec IV presenting different genetic backgrounds</span> <span class="citation_source-journal">Microb. Drug. Resist.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1089%2Fmdr.2015.0255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=700-706&author=P.+D.+de+Matosauthor=T.+L.+de+Oliveiraauthor=F.+S.+Cavalcanteauthor=D.+C.+Ferreiraauthor=N.+L.+Iorioauthor=E.+M.+Pereiraauthor=R.+C.+Chamonauthor=K.+R.+Dos+Santos&title=Molecular+markers+of+antimicrobial+resistance+in+methicillin-resistant+staphylococcus+aureus+SCCmec+IV+presenting+different+genetic+backgrounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1089%2Fmdr.2015.0255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fmdr.2015.0255%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMatos%26aufirst%3DP.%2BD.%26aulast%3Dde%2BOliveira%26aufirst%3DT.%2BL.%26aulast%3DCavalcante%26aufirst%3DF.%2BS.%26aulast%3DFerreira%26aufirst%3DD.%2BC.%26aulast%3DIorio%26aufirst%3DN.%2BL.%26aulast%3DPereira%26aufirst%3DE.%2BM.%26aulast%3DChamon%26aufirst%3DR.%2BC.%26aulast%3DDos%2BSantos%26aufirst%3DK.%2BR.%26atitle%3DMolecular%2520markers%2520of%2520antimicrobial%2520resistance%2520in%2520methicillin-resistant%2520staphylococcus%2520aureus%2520SCCmec%2520IV%2520presenting%2520different%2520genetic%2520backgrounds%26jtitle%3DMicrob.%2520Drug.%2520Resist.%26date%3D2016%26volume%3D5%26spage%3D700%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kuroda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuzawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanamori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumaru, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani-Ui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekimizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuzaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanehisa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasawara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, K.</span><span> </span><span class="NLM_article-title">Whole genome sequencing of meticillin-resistant <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1240</span><span class="refDoi"> DOI: 10.1016/S0140-6736(00)04403-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2FS0140-6736%2800%2904403-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=11418146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvVClur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=1225-1240&author=M.+Kurodaauthor=T.+Ohtaauthor=I.+Uchiyamaauthor=T.+Babaauthor=H.+Yuzawaauthor=I.+Kobayashiauthor=L.+Cuiauthor=A.+Oguchiauthor=K.-i.+Aokiauthor=Y.+Nagaiauthor=J.+Lianauthor=T.+Itoauthor=M.+Kanamoriauthor=H.+Matsumaruauthor=A.+Maruyamaauthor=H.+Murakamiauthor=A.+Hosoyamaauthor=Y.+Mizutani-Uiauthor=N.+Takahashiauthor=R.+Sawanoauthor=i.+Inoueauthor=C.+Kaitoauthor=K.+Sekimizuauthor=H.+Hirakawaauthor=S.+Kuharaauthor=S.+Gotoauthor=J.+Yabuzakiauthor=M.+Kanehisaauthor=A.+Yamashitaauthor=K.+Oshimaauthor=K.+Furuyaauthor=C.+Yoshinoauthor=T.+Shibaauthor=M.+Hattoriauthor=N.+Ogasawaraauthor=H.+Hayashiauthor=K.+Hiramatsu&title=Whole+genome+sequencing+of+meticillin-resistant+Staphylococcus+aureus&doi=10.1016%2FS0140-6736%2800%2904403-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Whole genome sequencing of meticillin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Kuroda, Makoto; Ohta, Toshiko; Uchiyama, Ikuo; Baba, Tadashi; Yuzawa, Harumi; Kobayashi, Ichizo; Cui, Longzhu; Oguchi, Akio; Aoki, Ken-ichi; Nagai, Yoshimi; Lian, JianQi; Ito, Teruyo; Kanamori, Mutsumi; Matsumaru, Hiroyuki; Maruyama, Atsushi; Murakami, Hiroyuki; Hosoyama, Akira; Mizutani-Ui, Yoko; Takahashi, Noriko K.; Sawano, Toshihiko; Inoue, Ryu-ichi; Kaito, Chikara; Sekimizu, Kazuhisa; Hirakawa, Hideki; Kuhara, Satoru; Goto, Susumu; Yabuzaki, Junko; Kanehisa, Minoru; Yamashita, Atsushi; Oshima, Kenshiro; Furuya, Keiko; Yoshino, Chie; Shiba, Tadayoshi; Hattori, Masahira; Ogasawara, Naotake; Hayashi, Hideo; Hiramatsu, Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9264</span>),
    <span class="NLM_cas:pages">1225-1240</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">Staphylococcus aureus is one of the major causes of community-acquired and hospital-acquired infections.  It produces numerous toxins including superantigens that cause unique disease entities such as toxic-shock syndrome and staphylococcal scarlet fever, and has acquired resistance to practically all antibiotics.  Whole genome anal. is a necessary step towards future development of countermeasures against this organism.  Whole genome sequences of two related S aureus strains (N315 and Mu50) were detd. by shot-gun random sequencing.  N315 is a meticillin-resistant S aureus (MRSA) strain isolated in 1982, and Mu50 is an MRSA strain with vancomycin resistance isolated in 1997.  The open reading frames were identified by use of GAMBLER and GLIMMER programs, and annotation of each was done with a BLAST homol. search, motif anal., and protein localization prediction.  The Staphylococcus genome was composed of a complex mixt. of genes, many of which seem to have been acquired by lateral gene transfer.  Most of the antibiotic resistance genes were carried either by plasmids or by mobile genetic elements including a unique resistance island.  Three classes of new pathogenicity islands were identified in the genome: a toxic shock syndrome toxin island family, exotoxin islands, and enterotoxin islands.  In the latter two pathogenicity islands, clusters of exotoxin and enterotoxin genes were found closely linked with other gene clusters encoding putative pathogenic factors.  The anal. also identified 70 candidates for new virulence factors.  The remarkable ability of S aureus to acquire useful genes from various organisms was revealed through the observation of genome complexity and evidence of lateral gene transfer.  Repeated duplication of genes encoding superantigens explains why S aureus is capable of infecting humans of diverse genetic backgrounds, eliciting severe immune reactions.  Investigation of many newly identified gene products, including the 70 putative virulence factors, will greatly improve our understanding of the biol. of staphylococci and the processes of infectious diseases caused by S aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpU6n9OxpCX7Vg90H21EOLACvtfcHk0lhtR5MPnpcKQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvVClur0%253D&md5=3b46b4b35182e65e5794bd2e689b740b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2800%2904403-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252800%252904403-2%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DI.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DYuzawa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DI.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DOguchi%26aufirst%3DA.%26aulast%3DAoki%26aufirst%3DK.-i.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DLian%26aufirst%3DJ.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKanamori%26aufirst%3DM.%26aulast%3DMatsumaru%26aufirst%3DH.%26aulast%3DMaruyama%26aufirst%3DA.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DHosoyama%26aufirst%3DA.%26aulast%3DMizutani-Ui%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DSawano%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3Di.%26aulast%3DKaito%26aufirst%3DC.%26aulast%3DSekimizu%26aufirst%3DK.%26aulast%3DHirakawa%26aufirst%3DH.%26aulast%3DKuhara%26aufirst%3DS.%26aulast%3DGoto%26aufirst%3DS.%26aulast%3DYabuzaki%26aufirst%3DJ.%26aulast%3DKanehisa%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DA.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DFuruya%26aufirst%3DK.%26aulast%3DYoshino%26aufirst%3DC.%26aulast%3DShiba%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DM.%26aulast%3DOgasawara%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DWhole%2520genome%2520sequencing%2520of%2520meticillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D1225%26epage%3D1240%26doi%3D10.1016%2FS0140-6736%2800%2904403-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wilson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walesby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, M.</span><span> </span><span class="NLM_article-title">Linezolid resistance in clinical isolates of <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1093/jac/dkg104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1093%2Fjac%2Fdkg104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=12493812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslOgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=186-188&author=P.+Wilsonauthor=J.+Andrewsauthor=R.+Charlesworthauthor=R.+Walesbyauthor=M.+Singerauthor=D.+J.+Farrelauthor=M.+Robbins&title=Linezolid+resistance+in+clinical+isolates+of+Staphylococcus+aureus&doi=10.1093%2Fjac%2Fdkg104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid resistance in clinical isolates of Staphylococcus aureus</span></div><div class="casAuthors">Wilson, Peter; Andrews, J. A.; Charlesworth, R.; Walesby, R.; Singer, M.; Farrell, D. J.; Robbins, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">186-188</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A 52-yr-old man underwent thoracotomy and drainage of right-sided empyema and showed a second clin. infection due to a resistant methicillin-resistant Staphylococcus aureus (MRSA) that developed from a susceptible isolate during treatment.  Eleven isolates of MRSA from this patient were collected during his hospital stay and were tested in parallel by BSAC disk testing.  The linezolid-resistant isolate was first detected in a sample 20 days after linezolid treatment was over.  Phage typing of susceptible and resistant isolates showed them to be indistinguishable E-MRSA 15.  An isolate with an MIC for linezolid of 8 mg/L had a G2576T mutation in two of six alleles, but the mutation was in five of six alleles in an isolate with an MIC of 32 mg/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTjVV7YpQN7LVg90H21EOLACvtfcHk0lhtR5MPnpcKQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslOgtL0%253D&md5=c90fd768194f976ffc8e5582eb6a8819</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg104%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DAndrews%26aufirst%3DJ.%26aulast%3DCharlesworth%26aufirst%3DR.%26aulast%3DWalesby%26aufirst%3DR.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DFarrel%26aufirst%3DD.%2BJ.%26aulast%3DRobbins%26aufirst%3DM.%26atitle%3DLinezolid%2520resistance%2520in%2520clinical%2520isolates%2520of%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26spage%3D186%26epage%3D188%26doi%3D10.1093%2Fjac%2Fdkg104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span> </span><span class="NLM_article-title">Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China</span> <span class="citation_source-journal">BMC Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1186/s12866-014-0292-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1186%2Fs12866-014-0292-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=25420718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Kgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=292-307&author=Y.+Tianauthor=T.+Liauthor=Y.+Zhuauthor=B.+Wangauthor=X.+Zouauthor=M.+Li&title=Mechanisms+of+linezolid+resistance+in+staphylococci+and+enterococci+isolated+from+two+teaching+hospitals+in+Shanghai%2C+China&doi=10.1186%2Fs12866-014-0292-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China</span></div><div class="casAuthors">Tian, Yueru; Li, Tianming; Zhu, Yuanjun; Wang, Bei; Zou, Xue; Li, Min</div><div class="citationInfo"><span class="NLM_cas:title">BMC Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">292/1-292/27, 27 pp.</span>CODEN:
                <span class="NLM_cas:coden">BMMIBC</span>;
        ISSN:<span class="NLM_cas:issn">1471-2180</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Linezolid is one of the most effective treatments against Gram-pos. pathogens.  However, linezolid-resistant/intermediate strains have recently emerged worldwide.  The purpose of this study was to analyze the prevalence and resistance mechanisms of linezolid-resistant/intermediate staphylococci and enterococci in Shanghai, China.  Thirty-two linezolid-resistant/intermediate strains, including 14 Staphylococcus capitis, three Staphylococcus aureus, 14 Enterococcus faecalis and one Enterococcus faecium clin. isolates, were collected in this study which displayed linezolid MICs of 8 to 512 μg/mL, 8-32 μg/mL, 4-8 μg/mL and 4 μg/mL, resp.  All linezolid-resistant S. capitis isolates had a novel C2131T mutation and a G2603T mutation in the 23S rRNA region, and some had a C316T (Arg106Cys) substitution in protein L4 and/or harbored cfr.  Linezolid-resistant S. aureus isolates carried a C389G (Ala130Gly) substitution in protein L3, and/or harbored cfr.  The cfr gene was flanked by two copies of the IS256-like element, with a downstream orf1 gene.  Linezolid-resistant/intermediate enterococci lacked major resistance mechanisms.  The semi-quant. biofilm assay showed that 14 linezolid-resistant E. faecalis isolates produced a larger biofilm than linezolid-susceptible E. faecalis strains. (P < 0.0001, two-tailed t-test).  TEM showed the cell walls of linezolid-resistant/intermediate strains were thicker than linezolid-susceptible strains.  Thus, major resistance mechanisms, such as mutations in 23S rRNA and ribosomal proteins L3 and L4, along with cfr acquisition, played an important role in linezolid resistance.  Secondary resistance mechanisms, such as biofilm formation and cell wall thickness, should also be taken into account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjD-V4j1nZl7Vg90H21EOLACvtfcHk0ljiIfNJrTBAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Kgt70%253D&md5=24c54d66de4344515f35d5c5c012d175</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2Fs12866-014-0292-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12866-014-0292-5%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520linezolid%2520resistance%2520in%2520staphylococci%2520and%2520enterococci%2520isolated%2520from%2520two%2520teaching%2520hospitals%2520in%2520Shanghai%252C%2520China%26jtitle%3DBMC%2520Microbiol.%26date%3D2014%26volume%3D14%26spage%3D292%26epage%3D307%26doi%3D10.1186%2Fs12866-014-0292-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villaruz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diep, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, Ml.</span><span> </span><span class="NLM_article-title">MRSA epidemic linked to a quickly spreading colonization and virulence determinant</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span><span class="refDoi"> DOI: 10.1038/nm.2692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnm.2692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=22522561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVKlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=816-819&author=M.+Liauthor=X.+Duauthor=E.+Villaruzauthor=A.+Diepauthor=D.+Wangauthor=Y.+Songauthor=Y.+Tianauthor=J.+Huauthor=F.+Yuauthor=Y.+Luauthor=Ml.+Otto&title=MRSA+epidemic+linked+to+a+quickly+spreading+colonization+and+virulence+determinant&doi=10.1038%2Fnm.2692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">MRSA epidemic linked to a quickly spreading colonization and virulence determinant</span></div><div class="casAuthors">Li, Min; Du, Xin; Villaruz, Amer E.; Diep, Binh An; Wang, Decheng; Song, Yan; Tian, Yueru; Hu, Jinhui; Yu, Fangyou; Lu, Yuan; Otto, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">816-819</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mol. processes underlying epidemic waves of methicillin-resistant Staphylococcus aureus (MRSA) infection are poorly understood.  Although a major role has been attributed to the acquisition of virulence determinants by horizontal gene transfer, there are insufficient epidemiol. and functional data supporting that concept.  The authors report the spread of clones contg. a previously extremely rare mobile genetic element-encoded gene, sasX.  They demonstrate that sasX has a key role in MRSA colonization and pathogenesis, substantially enhancing nasal colonization, lung disease and abscess formation and promoting mechanisms of immune evasion.  Moreover, the authors obsd. the recent spread of sasX from sequence type 239 (ST239) to invasive clones belonging to other sequence types.  Thus, this study identifies sasX as a quickly spreading crucial determinant of MRSA pathogenic success and a promising target for therapeutic interference.  The results provide proof of principle that horizontal gene transfer of key virulence determinants drives MRSA epidemic waves.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppHNhvCumCTLVg90H21EOLACvtfcHk0ljiIfNJrTBAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVKlt78%253D&md5=01b8b38ddfd81fcfc65b8e3f7153b54f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnm.2692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2692%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DVillaruz%26aufirst%3DE.%26aulast%3DDiep%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DOtto%26aufirst%3DMl.%26atitle%3DMRSA%2520epidemic%2520linked%2520to%2520a%2520quickly%2520spreading%2520colonization%2520and%2520virulence%2520determinant%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D816%26epage%3D819%26doi%3D10.1038%2Fnm.2692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, X.</span><span> </span><span class="NLM_article-title">First report of a sequence type 239 vancomycin-intermediate <i>Staphylococcus aureus</i> isolate in Mainland China</span> <span class="citation_source-journal">Diagn. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1016/j.diagmicrobio.2013.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2Fj.diagmicrobio.2013.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=23876353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCqs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2013&pages=64-68&author=X.+Zhangauthor=Q.+Huauthor=W.+Yuanauthor=W.+Shangauthor=H.+Chengauthor=J.+Yuanauthor=J.+Zhuauthor=Z.+Huauthor=S.+Liauthor=W.+Chenauthor=X.+Huauthor=X.+Rao&title=First+report+of+a+sequence+type+239+vancomycin-intermediate+Staphylococcus+aureus+isolate+in+Mainland+China&doi=10.1016%2Fj.diagmicrobio.2013.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">First report of a sequence type 239 vancomycin-intermediate Staphylococcus aureus isolate in Mainland China</span></div><div class="casAuthors">Zhang, Xia; Hu, Qiwen; Yuan, Wenchang; Shang, Weilong; Cheng, Hang; Yuan, Jizhen; Zhu, Junmin; Hu, Zhen; Li, Shu; Chen, Wei; Hu, Xiaomei; Rao, Xiancai</div><div class="citationInfo"><span class="NLM_cas:title">Diagnostic Microbiology and Infectious Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-68</span>CODEN:
                <span class="NLM_cas:coden">DMIDDZ</span>;
        ISSN:<span class="NLM_cas:issn">0732-8893</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen that causes a wide range of both hospital- and community-acquired infections.  The high prevalence of MRSA and the extensive use of vancomycin in Mainland China may lead to the emergence of vancomycin-intermediate S. aureus (VISA) isolates.  In this case, we report a VISA isolate from a 34-yr-old male patient with steam burn.  The isolate was detd. to be sequence type 239 staphylococcal cassette chromosome mec type III, the most prevalent MRSA clone in Mainland China.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI3w10l06J5LVg90H21EOLACvtfcHk0ljiIfNJrTBAmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCqs7zJ&md5=caae96c840204893eb13c82f56e59c7d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.diagmicrobio.2013.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diagmicrobio.2013.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DShang%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DRao%26aufirst%3DX.%26atitle%3DFirst%2520report%2520of%2520a%2520sequence%2520type%2520239%2520vancomycin-intermediate%2520Staphylococcus%2520aureus%2520isolate%2520in%2520Mainland%2520China%26jtitle%3DDiagn.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D77%26spage%3D64%26epage%3D68%26doi%3D10.1016%2Fj.diagmicrobio.2013.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ruoxi Li, Dazheng Ling, Tongke Tang, Zhenghui Huang, Manjiong Wang, Yan Ding, Taiping Liu, Hanwen Wei, Wenyue Xu, Fei Mao, Jin Zhu, Xiaokang Li, Lubin Jiang, <span class="NLM_string-name hlFld-ContribAuthor">Jian Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2254-2271. <a href="https://doi.org/10.1021/acs.jmedchem.0c02104" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02104</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02104%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BPlasmodium%252Bfalciparum%252BHDAC1%252BInhibitors%252Bwith%252BDual-Stage%252BAntimalarial%252BPotency%252Band%252BImproved%252BSafety%252BBased%252Bon%252Bthe%252BClinical%252BAnticancer%252BDrug%252BCandidate%252BQuisinostat%26aulast%3DLi%26aufirst%3DRuoxi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05122020%26date%3D04022021%26volume%3D64%26issue%3D4%26spage%3D2254%26epage%3D2271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shuimu Lin, Hongxia Li, Yiwen Tao, Jiayong Liu, Wenchang Yuan, Yongzhi Chen, Ying Liu, <span class="NLM_string-name hlFld-ContribAuthor">Shouping Liu</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5797-5815. <a href="https://doi.org/10.1021/acs.jmedchem.0c00053" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252BMembrane-Active%252BFlavone%252BAmphiphiles%25253A%252BSemisynthetic%252BKaempferol-Derived%252BAntimicrobials%252Bagainst%252BDrug-Resistant%252BGram-Positive%252BBacteria%26aulast%3DLin%26aufirst%3DShuimu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10012020%26date%3D26052020%26date%3D13052020%26volume%3D63%26issue%3D11%26spage%3D5797%26epage%3D5815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Toshiki Akiyama, Yuki Wada, Kellie Jenkinson, Tetsuo Honma, Kazuki Tsuruta, Yusuke Tamenori, Hitoshi Haneoka, Tsunayoshi Takehara, Takeyuki Suzuki, Kenichi Murai, Hiromichi Fujioka, Yoshihiro Sato, Andrew E. H. Wheatley, <span class="NLM_string-name hlFld-ContribAuthor">Mitsuhiro Arisawa</span>. </span><span class="cited-content_cbyCitation_article-title">Reusable Immobilized Iron(II) Nanoparticle Precatalysts for Ligand-Free Kumada Coupling. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Nano Materials</span><span> <strong>2018,</strong> <em>1 </em>
                                    (12)
                                     , 6950-6958. <a href="https://doi.org/10.1021/acsanm.8b01742" title="DOI URL">https://doi.org/10.1021/acsanm.8b01742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsanm.8b01742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsanm.8b01742%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Nano%2520Materials%26atitle%3DReusable%252BImmobilized%252BIron%252528II%252529%252BNanoparticle%252BPrecatalysts%252Bfor%252BLigand-Free%252BKumada%252BCoupling%26aulast%3DAkiyama%26aufirst%3DToshiki%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04102018%26date%3D09112018%26date%3D12122018%26date%3D09112018%26volume%3D1%26issue%3D12%26spage%3D6950%26epage%3D6958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Di  Song</span>, <span class="hlFld-ContribAuthor ">Nan  Zhang</span>, <span class="hlFld-ContribAuthor ">Panpan  Zhang</span>, <span class="hlFld-ContribAuthor ">Na  Zhang</span>, <span class="hlFld-ContribAuthor ">Weijin  Chen</span>, <span class="hlFld-ContribAuthor ">Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Ting  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaotong  Gu</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113480. <a href="https://doi.org/10.1016/j.ejmech.2021.113480" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113480%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B9-arylalkyl-10-methylacridinium%252Bderivatives%252Bas%252Bhighly%252Bpotent%252BFtsZ-targeting%252Bantibacterial%252Bagents%26aulast%3DSong%26aufirst%3DDi%26date%3D2021%26volume%3D221%26spage%3D113480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiangxiang  Zhao</span>, <span class="hlFld-ContribAuthor ">John R.  Cappiello</span>, <span class="hlFld-ContribAuthor ">Yi  Yang</span>, <span class="hlFld-ContribAuthor ">Yunfei  Cheng</span>, <span class="hlFld-ContribAuthor ">Guang  Liu</span>, <span class="hlFld-ContribAuthor ">Wenjing  Fang</span>, <span class="hlFld-ContribAuthor ">Yinzhu  Luo</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Dong</span>, <span class="hlFld-ContribAuthor ">Lixin  Zhang</span>, <span class="hlFld-ContribAuthor ">K. Barry  Sharpless</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of simple arylfluorosulfates as potent agents against resistant bacteria. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (28)
                                     , e2103513118. <a href="https://doi.org/10.1073/pnas.2103513118" title="DOI URL">https://doi.org/10.1073/pnas.2103513118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2103513118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2103513118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DIdentification%252Bof%252Bsimple%252Barylfluorosulfates%252Bas%252Bpotent%252Bagents%252Bagainst%252Bresistant%252Bbacteria%26aulast%3DZhang%26aufirst%3DJiong%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D28%26spage%3De2103513118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Runzhe  Song</span>, <span class="hlFld-ContribAuthor ">Yue  Wang</span>, <span class="hlFld-ContribAuthor ">Minghui  Wang</span>, <span class="hlFld-ContribAuthor ">Ruixuan  Gao</span>, <span class="hlFld-ContribAuthor ">Teng  Yang</span>, <span class="hlFld-ContribAuthor ">Song  Yang</span>, <span class="hlFld-ContribAuthor ">Cai-Guang  Yang</span>, <span class="hlFld-ContribAuthor ">Yongsheng  Jin</span>, <span class="hlFld-ContribAuthor ">Siyuan  Zou</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Cai</span>, <span class="hlFld-ContribAuthor ">Renhua  Fan</span>, <span class="hlFld-ContribAuthor ">Qiuqin  He</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel desfluoroquinolone-aminopyrimidine hybrids as potent anti-MRSA agents with low hERG activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>103 </em>, 104176. <a href="https://doi.org/10.1016/j.bioorg.2020.104176" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104176%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bdesfluoroquinolone-aminopyrimidine%252Bhybrids%252Bas%252Bpotent%252Banti-MRSA%252Bagents%252Bwith%252Blow%252BhERG%252Bactivity%26aulast%3DSong%26aufirst%3DRunzhe%26date%3D2020%26volume%3D103%26spage%3D104176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Wan-Yin  Fang</span>, <span class="hlFld-ContribAuthor ">L.  Ravindar</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>. </span><span class="cited-content_cbyCitation_article-title">Indole-based derivatives as potential antibacterial activity against methicillin-resistance Staphylococcus aureus (MRSA). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>194 </em>, 112245. <a href="https://doi.org/10.1016/j.ejmech.2020.112245" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112245%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndole-based%252Bderivatives%252Bas%252Bpotential%252Bantibacterial%252Bactivity%252Bagainst%252Bmethicillin-resistance%252BStaphylococcus%252Baureus%252B%252528MRSA%252529%26aulast%3DQin%26aufirst%3DHua-Li%26date%3D2020%26volume%3D194%26spage%3D112245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanjay R.  Chaudhari</span>, <span class="hlFld-ContribAuthor ">Pramod N.  Patil</span>, <span class="hlFld-ContribAuthor ">Ulhas K.  Patil</span>, <span class="hlFld-ContribAuthor ">Harun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Jamatsing D.  Rajput</span>, <span class="hlFld-ContribAuthor ">Nilesh S.  Pawar</span>, <span class="hlFld-ContribAuthor ">Dipak B.  Patil</span>. </span><span class="cited-content_cbyCitation_article-title">Green synthesis of N-substituted benzimidazoles: The promising methicillin resistant Staphylococcus aureus (MRSA) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Data Collections</span><span> <strong>2020,</strong> <em>25 </em>, 100344. <a href="https://doi.org/10.1016/j.cdc.2020.100344" title="DOI URL">https://doi.org/10.1016/j.cdc.2020.100344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cdc.2020.100344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cdc.2020.100344%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Data%2520Collections%26atitle%3DGreen%252Bsynthesis%252Bof%252BN-substituted%252Bbenzimidazoles%25253A%252BThe%252Bpromising%252Bmethicillin%252Bresistant%252BStaphylococcus%252Baureus%252B%252528MRSA%252529%252Binhibitors%26aulast%3DChaudhari%26aufirst%3DSanjay%2BR.%26date%3D2020%26volume%3D25%26spage%3D100344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George A.  Naclerio</span>, <span class="hlFld-ContribAuthor ">Nader S.  Abutaleb</span>, <span class="hlFld-ContribAuthor ">Kenneth I.  Onyedibe</span>, <span class="hlFld-ContribAuthor ">Mohamed N.  Seleem</span>, <span class="hlFld-ContribAuthor ">Herman O.  Sintim</span>. </span><span class="cited-content_cbyCitation_article-title">Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 102-110. <a href="https://doi.org/10.1039/C9MD00391F" title="DOI URL">https://doi.org/10.1039/C9MD00391F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00391F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00391F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Btrifluoromethoxy%25252C%252Btrifluoromethylsulfonyl%25252C%252Btrifluoromethylthio%252Band%252Bpentafluorosulfanyl%252Bcontaining%252B%2525281%25252C3%25252C4-oxadiazol-2-yl%252529benzamides%252Bagainst%252Bdrug-resistant%252BGram-positive%252Bbacteria%26aulast%3DNaclerio%26aufirst%3DGeorge%2BA.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D102%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuaishuai  Ni</span>, <span class="hlFld-ContribAuthor ">Baoli  Li</span>, <span class="hlFld-ContribAuthor ">Yixiang  Xu</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Lefu  Lan</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting virulence factors as an antimicrobial approach: Pigment inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (1)
                                     , 293-338. <a href="https://doi.org/10.1002/med.21621" title="DOI URL">https://doi.org/10.1002/med.21621</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21621%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252Bvirulence%252Bfactors%252Bas%252Ban%252Bantimicrobial%252Bapproach%25253A%252BPigment%252Binhibitors%26aulast%3DNi%26aufirst%3DShuaishuai%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D1%26spage%3D293%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srikanth  Gatadi</span>, <span class="hlFld-ContribAuthor ">Y.V.  Madhavi</span>, <span class="hlFld-ContribAuthor ">Sidharth  Chopra</span>, <span class="hlFld-ContribAuthor ">Srinivas  Nanduri</span>. </span><span class="cited-content_cbyCitation_article-title">Promising antibacterial agents against multidrug resistant Staphylococcus aureus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103252. <a href="https://doi.org/10.1016/j.bioorg.2019.103252" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103252%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPromising%252Bantibacterial%252Bagents%252Bagainst%252Bmultidrug%252Bresistant%252BStaphylococcus%252Baureus%26aulast%3DGatadi%26aufirst%3DSrikanth%26date%3D2019%26volume%3D92%26spage%3D103252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi  Xu</span>, <span class="hlFld-ContribAuthor ">Shijia  Zhao</span>, <span class="hlFld-ContribAuthor ">Zaosheng  Lv</span>, <span class="hlFld-ContribAuthor ">Lianshun  Feng</span>, <span class="hlFld-ContribAuthor ">Yinling  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Zhang</span>, <span class="hlFld-ContribAuthor ">Liuyang  Bai</span>, <span class="hlFld-ContribAuthor ">Jialun  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Benzofuran derivatives and their anti-tubercular, anti-bacterial activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 266-276. <a href="https://doi.org/10.1016/j.ejmech.2018.11.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzofuran%252Bderivatives%252Band%252Btheir%252Banti-tubercular%25252C%252Banti-bacterial%252Bactivities%26aulast%3DXu%26aufirst%3DZhi%26date%3D2019%26volume%3D162%26spage%3D266%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Mei  Dong</span>, <span class="hlFld-ContribAuthor ">Li-Lan  Huang</span>, <span class="hlFld-ContribAuthor ">Hang  Dai</span>, <span class="hlFld-ContribAuthor ">Qiao-Lin  Xu</span>, <span class="hlFld-ContribAuthor ">Jin-Kui  Ouyang</span>, <span class="hlFld-ContribAuthor ">Xu-Chao  Jia</span>, <span class="hlFld-ContribAuthor ">Wen-Xiang  Gu</span>, <span class="hlFld-ContribAuthor ">Jian-Wen  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-MRSA Sesquiterpenes from the Semi-Mangrove Plant Myoporum bontioides A. Gray. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2018,</strong> <em>16 </em>
                                    (11)
                                     , 438. <a href="https://doi.org/10.3390/md16110438" title="DOI URL">https://doi.org/10.3390/md16110438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md16110438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd16110438%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DAnti-MRSA%252BSesquiterpenes%252Bfrom%252Bthe%252BSemi-Mangrove%252BPlant%252BMyoporum%252Bbontioides%252BA.%252BGray%26aulast%3DDong%26aufirst%3DLi-Mei%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D11%26spage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuan  Gao</span>, <span class="hlFld-ContribAuthor ">Yi-Lei  Fan</span>, <span class="hlFld-ContribAuthor ">Feng  Zhao</span>, <span class="hlFld-ContribAuthor ">Qing-Cheng  Ren</span>, <span class="hlFld-ContribAuthor ">Xiang  Wu</span>, <span class="hlFld-ContribAuthor ">Le  Chang</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 1081-1095. <a href="https://doi.org/10.1016/j.ejmech.2018.08.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DQuinolone%252Bderivatives%252Band%252Btheir%252Bactivities%252Bagainst%252Bmethicillin-resistant%252BStaphylococcus%252Baureus%252B%252528MRSA%252529%26aulast%3DGao%26aufirst%3DChuan%26date%3D2018%26volume%3D157%26spage%3D1081%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0027.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0024.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical modification strategies and purpose for lead compound <b>1</b> and pigment inhibition activities of analogues <b>2a</b>–<b>j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of Derivatives <b>2a</b>–<b>d</b> and <b>5a</b>–<b>40a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ammonia in THF, DCM, NaBH(OAc)<sub>3</sub>, rt, 2 h, 30%; (b) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 43–85%, (2) bubbled into hydrogen chloride gas; (c) iodoethane or 2-iodopropane, NaH, DMF 0 °C to rt, overnight, under N<sub>2</sub>, 50%; (d) methylamine, MeOH, NaBH<sub>4</sub>, rt, 0 °C, 10 min, 55%; (e) NaBH<sub>4</sub>, methanol, 0 °C, 30 min; (f) phosphorus tribromide, diethyl ether, 0 °C to rt, overnight, under N<sub>2</sub>, 57–84% (2 steps); (g) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 43–85%, (2) bubbled into hydrogen chloride gas.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Syntheses of Derivatives <b>2e</b>–<b>j</b>, <b>3d</b>–<b>f</b>, and <b>5b</b>–<b>40b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ammonia in THF, DCM, NaBH(OAc)<sub>3</sub>, rt, 2 h, 30%; (b) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 43–85%, (2) bubbled into hydrogen chloride gas; (c) iodoethane or 2-iodopropane, NaH, DMF 0 °C to rt, overnight, under N<sub>2</sub>, 50%; (d) methylamine, MeOH, NaBH<sub>4</sub>, rt, 0 °C, 10 min, 55%; (e) NaBH<sub>4</sub>, methanol, 0 °C, 30 min; (f) phosphorus tribromide, diethyl ether, 0 °C to rt, overnight, under N<sub>2</sub>, 57–84% (2 steps); (g) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 43–85%, (2) bubbled into hydrogen chloride gas.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0011.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Derivatives <b>41a</b> and <b>41b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, TEA, 90 °C; (b) TBAF/THF; (c) PBr<sub>3</sub>, Et<sub>2</sub>O; (d) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 41–45%, (2) bubbled into hydrogen chloride gas.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0012.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Syntheses of Derivatives <b>42a</b> and <b>42b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, MeOH; (b) PBr<sub>3</sub>, CCl<sub>4</sub>, reflux, 4 h; (c) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 25–35%, (2) bubbled into hydrogen chloride gas.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0013.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Syntheses of Derivatives <b>43a</b> and <b>43b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl 2-(triphenyl-l5-phosphanylidene)propanoate, toluene, 100 °C; (b) DIABL-H, DCM, 0 °C; (c) PBr<sub>3</sub>, Et<sub>2</sub>O; (d) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 41–55%, (2) bubbled into hydrogen chloride gas.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0014.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Syntheses of Derivatives <b>44a</b> and <b>44b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a)(1) (2-carboxyethyl)triphenylphosphonium, NaH in THF/DMSO, (2) EtOH/H<sub>2</sub>SO<sub>4</sub>; (b) DIABL-H, DCM, 0 °C; (c) CBr<sub>4</sub>, PPh<sub>3</sub>, DCM; (d) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, (2) bubbled into hydrogen chloride gas.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Syntheses of Derivatives <b>45a</b> and <b>45b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethyl 2-(triphenyl-l5-phosphanylidene)acetate, toluene, 100 °C; (b) DIABL-H, DCM, 0 °C; (c) PBr<sub>3</sub>, Et<sub>2</sub>O; (d) (1) K<sub>2</sub>CO<sub>3</sub>, DMF, rt, overnight, 28–37%, (2) bubbled into hydrogen chloride gas.</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0025.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effects of <b>23a</b> and <b>23b</b> on the bacterial growth of <i>S. aureus</i> Newman (A and E), USA400 MW2 (B and F), USA300 LAC (C and G), and Mu50 (D and H). Data are presented as means ± SEM, <i>n</i> = 2 independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0026.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of <b>23a</b> and <b>23b</b> on susceptibility to hydrogen peroxide killing. <i>S. aureus</i> Newman (A), USA400 MW2 (B), USA300 LAC (C), and Mu50 (D); *** <i>p</i> < 0.001 via two-tailed <i>t</i> test (<i>n</i> = three biological replicates, each with two technical replicates).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0001.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of <b>23a</b> and <b>23b</b> on susceptibility to human whole blood killing. <i>S. aureus</i> Newman (A), USA400 MW2 (B), USA300 LAC (C), and Mu50 (D); *** <i>p</i> < 0.001 via two-tailed <i>t</i> test (<i>n</i> = three biological replicates, each with two technical replicates).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0002.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of analogues <b>23a</b> and <b>23b</b> on <i>S. aureus</i> bacteria (A and B), Mu50 (C and D), and NRS271 (E and F) survival in the hearts and livers of mice (<i>n</i> = 10 for each group) challenged with 2.3 × 10<sup>7</sup> CFU Newman bacteria, 1.1 × 10<sup>9</sup> CFU Mu50 bacteria, and 2.3 × 10<sup>8</sup> CFU NRS271 bacteria. P = pretreatment, drugs or compounds were intraperitoneally administered 24 h before infection compared with the normal treatment. (Drugs or compounds were intraperitoneally administered 6 h after infection.) The statistical significance was determined by a Mann–Whitney test (two-tailed): ** <i>p</i> < 0.01, *** <i>p</i> < 0.001. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0003.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of <b>23a</b> and <b>23b</b> on Mu50 survival in the kidneys (A) and hearts (B) of mice challenged with 1.3 × 10<sup>9</sup> CFU Mu50 bacteria. P = pretreatment, drugs or compounds were intraperitoneally administered 24 h before infection compared with the normal treatment. (Drugs or compounds were intraperitoneally administered 6 h after infection.) Statistical significance was determined by a Mann–Whitney test (two-tailed): * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001, n.s. indicates no significant difference. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0004.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>1</b> and <b>23a</b> on <i>S. aureus</i> survival in protecting mice (<i>n</i> = 15) from lethal <i>S. aureus</i> infection challenged with 2 × 10<sup>8</sup> CFU Newman bacteria.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0005.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of <b>23a</b> on LRSA45 (5.0 × 10<sup>7</sup> CFU), LRSA202 (7.0 × 10<sup>7</sup> CFU), NF65Y (3.5 × 10<sup>8</sup> CFU), and XN108 (2.1 × 10<sup>8</sup> CFU) survival in the kidneys (A) and hearts (B) of mice. P = pretreatment, drugs or compounds were intraperitoneally administered 24 h before infection compared with the normal treatment. (Drugs or compounds were intraperitoneally administered 6 h after infection.) Statistical significance was determined by a Mann–Whitney test (two-tailed): * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001, n.s. indicates no significant difference. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0006.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of <b>23a</b> on Newman (3.1 × 10<sup>7</sup> CFU), Mu50 (4.6 × 10<sup>9</sup> CFU), and NRS271 (3.5 × 10<sup>8</sup> CFU) survival in the kidneys (A, C, and E) and hearts (B, D, and F) of mice. P = pretreatment, drugs or compounds were intraperitoneally administered 24 h before infection compared with the normal treatment. (Drugs or compounds were intraperitoneally administered 6 h after infection.) Statistical significance was determined by a Mann–Whitney test (two-tailed): * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001, n.s. indicates no significant difference. Each symbol represents the value for an individual mouse. Horizontal bars indicate the observation means, and dashed lines mark the limits of detection.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0007.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Development of bacterial resistance in Newman toward erythromycin and H<sub>2</sub>O<sub>2</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/medium/jm-2017-013005_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0008.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Images of the treated and nontreated (control) TSA plates of 12 passages Newman (1000 CFU), which were under the sequential H<sub>2</sub>O<sub>2</sub> and CrtN inhibitors selection pressure. The concentrations of <b>23a</b> and <b>23b</b> were 7.5 nM/mL and 10.0 nM/mL (IC<sub>90</sub> of pigment inhibition).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-1/acs.jmedchem.7b01300/20180110/images/large/jm-2017-013005_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01300&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i151">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 35 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lepri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buonerba, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goracci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velilla, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzziconi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaatz, G. W.</span><span> </span><span class="NLM_article-title">G Cruciani. Indole based weapons to fight antibiotic: a structure-activity relationship study</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=867-891&author=S.+Lepriauthor=F.+Buonerbaauthor=L.+Goracciauthor=I.+Velillaauthor=R.+Ruzziconiauthor=B.+D.+Schindlerauthor=S.+M.+Seoauthor=G.+W.+Kaatz&title=G+Cruciani.+Indole+based+weapons+to+fight+antibiotic%3A+a+structure-activity+relationship+study&doi=10.1021%2Facs.jmedchem.5b01219"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01219%26sid%3Dliteratum%253Aachs%26aulast%3DLepri%26aufirst%3DS.%26aulast%3DBuonerba%26aufirst%3DF.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DVelilla%26aufirst%3DI.%26aulast%3DRuzziconi%26aufirst%3DR.%26aulast%3DSchindler%26aufirst%3DB.%2BD.%26aulast%3DSeo%26aufirst%3DS.%2BM.%26aulast%3DKaatz%26aufirst%3DG.%2BW.%26atitle%3DG%2520Cruciani.%2520Indole%2520based%2520weapons%2520to%2520fight%2520antibiotic%253A%2520a%2520structure-activity%2520relationship%2520study%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D867%26epage%3D891%26doi%3D10.1021%2Facs.jmedchem.5b01219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lowy, F. D.</span><span> </span><span class="NLM_article-title"><i>Staphylococcus aureus</i> infections</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span><span class="refDoi"> DOI: 10.1056/NEJM199808203390806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1056%2FNEJM199808203390806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=9709046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A280%3ADyaK1czmtlKltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=520-532&author=F.+D.+Lowy&title=Staphylococcus+aureus+infections&doi=10.1056%2FNEJM199808203390806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Staphylococcus aureus infections</span></div><div class="casAuthors">Lowy F D</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">520-32</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTK9d0Jprpbc56KlWarZTAzfW6udTcc2eb2Dkv3BwaUYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1czmtlKltw%253D%253D&md5=210aac522def7325e264aec01d7e8d9a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1056%2FNEJM199808203390806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199808203390806%26sid%3Dliteratum%253Aachs%26aulast%3DLowy%26aufirst%3DF.%2BD.%26atitle%3DStaphylococcus%2520aureus%2520infections%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D520%26epage%3D532%26doi%3D10.1056%2FNEJM199808203390806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">O’Connell, K. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgkinson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sore, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmond, G. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spring, D. R.</span><span> </span><span class="NLM_article-title">Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">10706</span><span class="NLM_x">–</span> <span class="NLM_lpage">10733</span><span class="refDoi"> DOI: 10.1002/anie.201209979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1002%2Fanie.201209979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=24038605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=10706-10733&author=K.+M.+G.+O%E2%80%99Connellauthor=J.+T.+Hodgkinsonauthor=H.+F.+Soreauthor=M.+Welchauthor=G.+P.+C.+Salmondauthor=D.+R.+Spring&title=Combating+multidrug-resistant+bacteria%3A+current+strategies+for+the+discovery+of+novel+antibacterials&doi=10.1002%2Fanie.201209979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Combating Multidrug-Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials</span></div><div class="casAuthors">O'Connell, Kieron M. G.; Hodgkinson, James T.; Sore, Hannah F.; Welch, Martin; Salmond, George P. C.; Spring, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10706-10733</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The introduction of effective antibacterial therapies for infectious diseases in the mid-20th century completely revolutionized clin. practices and helped to facilitate the development of modern medicine.  Many potentially life-threatening conditions became easily curable, greatly reducing the incidence of death or disability resulting from bacterial infections.  This overwhelming historical success makes it very difficult to imagine life without effective antibacterials; however, the inexorable rise of antibiotic resistance has made this a very real and disturbing possibility for some infections.  The ruthless selection for resistant bacteria, coupled with insufficient investment in antibacterial research, has led to a steady decline in the efficacy of existing therapies and a paucity of novel structural classes with which to replace them, or complement their use.  This situation has resulted in a very pressing need for the discovery of novel antibiotics and treatment strategies, the development of which is likely to be a key challenge to 21st century medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJpKYdiujdvrVg90H21EOLACvtfcHk0lhJymUeQwAh3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrtbfI&md5=797c2b503a9ee729093192ae216c0b20</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fanie.201209979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201209979%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DK.%2BM.%2BG.%26aulast%3DHodgkinson%26aufirst%3DJ.%2BT.%26aulast%3DSore%26aufirst%3DH.%2BF.%26aulast%3DWelch%26aufirst%3DM.%26aulast%3DSalmond%26aufirst%3DG.%2BP.%2BC.%26aulast%3DSpring%26aufirst%3DD.%2BR.%26atitle%3DCombating%2520multidrug-resistant%2520bacteria%253A%2520current%2520strategies%2520for%2520the%2520discovery%2520of%2520novel%2520antibacterials%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D10706%26epage%3D10733%26doi%3D10.1002%2Fanie.201209979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kawatkar, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keating, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breen, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guler, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentemann, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loch, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterson, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Botella, G.</span><span> </span><span class="NLM_article-title">Antibacterial inhibitors of gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding region</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4584</span><span class="NLM_x">–</span> <span class="NLM_lpage">4597</span><span class="refDoi"> DOI: 10.1021/jm500463c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500463c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4584-4597&author=S.+P.+Kawatkarauthor=T.+A.+Keatingauthor=N.+B.+Olivierauthor=J.+N.+Breenauthor=O.+M.+Greenauthor=S.+Y.+Gulerauthor=M.+F.+Hentemannauthor=J.+T.+Lochauthor=A.+R.+McKenzieauthor=J.+V.+Newmanauthor=L.+G.+Ottersonauthor=G.+Mart%C3%ADnez-Botella&title=Antibacterial+inhibitors+of+gram-positive+thymidylate+kinase%3A+structure-activity+relationships+and+chiral+preference+of+a+new+hydrophobic+binding+region&doi=10.1021%2Fjm500463c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm500463c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500463c%26sid%3Dliteratum%253Aachs%26aulast%3DKawatkar%26aufirst%3DS.%2BP.%26aulast%3DKeating%26aufirst%3DT.%2BA.%26aulast%3DOlivier%26aufirst%3DN.%2BB.%26aulast%3DBreen%26aufirst%3DJ.%2BN.%26aulast%3DGreen%26aufirst%3DO.%2BM.%26aulast%3DGuler%26aufirst%3DS.%2BY.%26aulast%3DHentemann%26aufirst%3DM.%2BF.%26aulast%3DLoch%26aufirst%3DJ.%2BT.%26aulast%3DMcKenzie%26aufirst%3DA.%2BR.%26aulast%3DNewman%26aufirst%3DJ.%2BV.%26aulast%3DOtterson%26aufirst%3DL.%2BG.%26aulast%3DMart%25C3%25ADnez-Botella%26aufirst%3DG.%26atitle%3DAntibacterial%2520inhibitors%2520of%2520gram-positive%2520thymidylate%2520kinase%253A%2520structure-activity%2520relationships%2520and%2520chiral%2520preference%2520of%2520a%2520new%2520hydrophobic%2520binding%2520region%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4584%26epage%3D4597%26doi%3D10.1021%2Fjm500463c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Fischbach, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span> </span><span class="NLM_article-title">Antibiotics for emerging pathogens</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1093</span><span class="refDoi"> DOI: 10.1126/science.1176667</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1126%2Fscience.1176667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=19713519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVersrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=1089-1093&author=M.+A.+Fischbachauthor=C.+T.+Walsh&title=Antibiotics+for+emerging+pathogens&doi=10.1126%2Fscience.1176667"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics for Emerging Pathogens</span></div><div class="casAuthors">Fischbach, Michael A.; Walsh, Christopher T.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5944</span>),
    <span class="NLM_cas:pages">1089-1093</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Antibiotic-resistant strains of pathogenic bacteria are increasingly prevalent in hospitals and the community.  New antibiotics are needed to combat these bacterial pathogens, but progress in developing them has been slow.  Historically, most antibiotics have come from a small set of mol. scaffolds whose functional lifetimes have been extended by generations of synthetic tailoring.  The emergence of multidrug resistance among the latest generation of pathogens suggests that the discovery of new scaffolds should be a priority.  Promising approaches to scaffold discovery are emerging; they include mining underexplored microbial niches for natural products, designing screens that avoid rediscovering old scaffolds, and repurposing libraries of synthetic mols. for use as antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZw1IG5S90IbVg90H21EOLACvtfcHk0liWOq2OCS3yOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVersrzK&md5=96d902c55376951663e06dcddf0d571d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1176667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1176667%26sid%3Dliteratum%253Aachs%26aulast%3DFischbach%26aufirst%3DM.%2BA.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26atitle%3DAntibiotics%2520for%2520emerging%2520pathogens%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D1089%26epage%3D1093%26doi%3D10.1126%2Fscience.1176667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Payne, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwynn, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span> </span><span class="NLM_article-title">Drugs for bad bugs: confronting the challenges of antibacterial discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1038/nrd2201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnrd2201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=17159923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGktbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=29-40&author=D.+J.+Payneauthor=M.+N.+Gwynnauthor=D.+J.+Holmesauthor=D.+L.+Pompliano&title=Drugs+for+bad+bugs%3A+confronting+the+challenges+of+antibacterial+discovery&doi=10.1038%2Fnrd2201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs for bad bugs: confronting the challenges of antibacterial discovery</span></div><div class="casAuthors">Payne, David J.; Gwynn, Michael N.; Holmes, David J.; Pompliano, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-40</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope for antibacterial drug discoverers, who now had the tools to search entire genomes for new antibacterial targets.  Several companies, including GlaxoSmithKline, moved back into the antibacterials area and embraced a genomics-derived, target-based approach to screen for new classes of drugs with novel modes of action.  Here, we share our experience of evaluating more than 300 genes and 70 high-throughput screening campaigns over a period of 7 years, and look at what we learned and how that has influenced GlaxoSmithKline's antibacterials strategy going forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH1tM2BSZbWLVg90H21EOLACvtfcHk0liWOq2OCS3yOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGktbfM&md5=18100253f9868af578ea621ab98a5c86</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrd2201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2201%26sid%3Dliteratum%253Aachs%26aulast%3DPayne%26aufirst%3DD.%2BJ.%26aulast%3DGwynn%26aufirst%3DM.%2BN.%26aulast%3DHolmes%26aufirst%3DD.%2BJ.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26atitle%3DDrugs%2520for%2520bad%2520bugs%253A%2520confronting%2520the%2520challenges%2520of%2520antibacterial%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D29%26epage%3D40%26doi%3D10.1038%2Fnrd2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Liu, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span> </span><span class="NLM_article-title">Color me bad: microbial pigments as virulence factors</span> <span class="citation_source-journal">Trends Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1016/j.tim.2009.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2Fj.tim.2009.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=19726196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFajtrnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=406-413&author=G.+Y.+Liuauthor=V.+Nizet&title=Color+me+bad%3A+microbial+pigments+as+virulence+factors&doi=10.1016%2Fj.tim.2009.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Color me bad: Microbial pigments as virulence factors</span></div><div class="casAuthors">Liu, George Y.; Nizet, Victor</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">406-413</span>CODEN:
                <span class="NLM_cas:coden">TRMIEA</span>;
        ISSN:<span class="NLM_cas:issn">0966-842X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A hallmark feature of several pathogenic microbes is the distinctive color of their colonies when propagated in the clin. lab.  Such pigmentation comes in a variety of hues, and has often proven useful in presumptive clin. diagnosis.  Recent advances in microbial pigment biochem. and the genetic basis of pigment prodn. have sometimes revealed a more sinister aspect to these curious materials that change the color of reflected light by selective light absorbance.  In many cases, the microbial pigment contributes to disease pathogenesis by interfering with host immune clearance mechanisms or by exhibiting pro-inflammatory or cytotoxic properties.  We review several examples of pigments that promote microbial virulence, including the golden staphyloxanthin of Staphylococcus aureus, the blue-green pyocyanin of Pseudomonas spp., and the dark brown or black melanin pigments of Cryptococcus neoformans and Aspergillus spp.  Targeted pigment neutralisation might represent a viable concept to enhance treatment of certain difficult infectious disease conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgjrCf7qVLxLVg90H21EOLACvtfcHk0liWOq2OCS3yOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFajtrnE&md5=f9ccbcb067f7c379db9189e5a2810d19</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.tim.2009.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tim.2009.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%2BY.%26aulast%3DNizet%26aufirst%3DV.%26atitle%3DColor%2520me%2520bad%253A%2520microbial%2520pigments%2520as%2520virulence%2520factors%26jtitle%3DTrends%2520Microbiol.%26date%3D2009%26volume%3D17%26spage%3D406%26epage%3D413%26doi%3D10.1016%2Fj.tim.2009.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">David, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glikman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle-Vavra, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daum, S.</span><span> </span><span class="NLM_article-title">What is community-associated methicillin-resistant <i>Staphylococcus aureus</i>?</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">197</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span><span class="refDoi"> DOI: 10.1086/533502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1086%2F533502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=18422435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A280%3ADC%252BD1c3mtlWktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2008&pages=1235-1243&author=M.+Z.+Davidauthor=D.+Glikmanauthor=S.+E.+Crawfordauthor=J.+Pengauthor=K.+J.+Kingauthor=M.+A.+Hostetlerauthor=S.+R.+Boyle-Vavraauthor=S.+Daum&title=What+is+community-associated+methicillin-resistant+Staphylococcus+aureus%3F&doi=10.1086%2F533502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">What is community-associated methicillin-resistant Staphylococcus aureus?</span></div><div class="casAuthors">David Michael Z; Glikman Daniel; Crawford Susan E; Peng Jie; King Kimberly J; Hostetler Mark A; Boyle-Vavra Susan; Daum Robert S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1235-43</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">BACKGROUND:  A community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infection has been defined as an MRSA infection in a patient who lacks specific risk factors for healthcare exposure.  We sought to determine whether the absence or presence of these risk factors still predicts the phenotypic or genotypic characteristics of MRSA strains.  METHODS:  All clinical MRSA isolates were prospectively collected at the University of Chicago Hospitals from July 2004 through June 2005.  Patients were interviewed and/or their medical records were reviewed.  Isolates underwent genotyping and susceptibility testing.  Data on patients and isolates were stratified in accordance with 8 frequently cited criteria for the identification of CA-MRSA and compared for concordance.  RESULTS:  Among 616 unique patients from whom MRSA isolates were recovered, 404 (65.6%) had risk factors for healthcare exposure.  Of the 404 isolates recovered from these patients, 166 (41.1%) were clindamycin susceptible, 190 (47.0%) carried staphylococcal cassette chromosome mec (SCCmec) type IV, 145 (35.9%) carried the Panton-Valentine leukocidin genes (PVL+), and 162 (40.1%) were identified as sequence type (ST) 8 by multilocus sequence typing (MLST), all of which are characteristics commonly attributed to CA-MRSA strains.  CONCLUSIONS:  Association with the healthcare environment now has little predictive value for distinguishing patients with infection due to multidrug resistant MRSA isolates from those infected by CA-MRSA isolates, that is, isolates that are clindamycin-susceptible, PVL+, ST8, and/or contain SCCmec type IV.  Defining CA-MRSA by the absence of risk factors for healthcare exposure greatly underestimates the burden of epidemic CA-MRSA disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHXzIjMB2CYPcsfMJQC1ZdfW6udTcc2eYHshNXWi2nHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3mtlWktQ%253D%253D&md5=024dbe20816d05655d1a68ec91ef3f60</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1086%2F533502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F533502%26sid%3Dliteratum%253Aachs%26aulast%3DDavid%26aufirst%3DM.%2BZ.%26aulast%3DGlikman%26aufirst%3DD.%26aulast%3DCrawford%26aufirst%3DS.%2BE.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DK.%2BJ.%26aulast%3DHostetler%26aufirst%3DM.%2BA.%26aulast%3DBoyle-Vavra%26aufirst%3DS.%2BR.%26aulast%3DDaum%26aufirst%3DS.%26atitle%3DWhat%2520is%2520community-associated%2520methicillin-resistant%2520Staphylococcus%2520aureus%253F%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2008%26volume%3D197%26spage%3D1235%26epage%3D1243%26doi%3D10.1086%2F533502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wulf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, A.</span><span> </span><span class="NLM_article-title">MRSA in livestock animals—an epidemic waiting to happen?</span> <span class="citation_source-journal">Clin. Microbiol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">521</span><span class="refDoi"> DOI: 10.1111/j.1469-0691.2008.01970.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1111%2Fj.1469-0691.2008.01970.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=18325034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A280%3ADC%252BD1c3pvFOqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=519-521&author=M.+Wulfauthor=A.+Voss&title=MRSA+in+livestock+animals%E2%80%94an+epidemic+waiting+to+happen%3F&doi=10.1111%2Fj.1469-0691.2008.01970.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">MRSA in livestock animals-an epidemic waiting to happen?</span></div><div class="casAuthors">Wulf M; Voss A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">519-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Screening of pig farmers and pigs in The Netherlands has revealed that >20% of pig farmers and 39% of slaughterhouse pigs are positive for an unusual strain of methicillin-resistant Staphylococcus aureus (MRSA) belonging to sequence type (ST) 398.  It is now clear that the emergence of ST398 is not just a Dutch problem, with human infections being described in several European countries, Canada and Singapore.  Furthermore, some human isolates have now acquired the genes encoding Panton-Valentine leukocidin.  Livestock may become an important source of community-acquired MRSA.  A concerted effort on the part of clinicians, infection control practitioners and veterinarians will be required to prevent further spread of this novel strain of MRSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOzzNumf7fWr7NkxioyDXTfW6udTcc2eYHshNXWi2nHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3pvFOqtw%253D%253D&md5=8b52f14cb981912289d6890b6021cbcf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2008.01970.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2008.01970.x%26sid%3Dliteratum%253Aachs%26aulast%3DWulf%26aufirst%3DM.%26aulast%3DVoss%26aufirst%3DA.%26atitle%3DMRSA%2520in%2520livestock%2520animals%25E2%2580%2594an%2520epidemic%2520waiting%2520to%2520happen%253F%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2008%26volume%3D14%26spage%3D519%26epage%3D521%26doi%3D10.1111%2Fj.1469-0691.2008.01970.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Van Cleef, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnet, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krziwanek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allerberger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struelens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zemlickova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skov, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuopio-Varkila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiliopoulou, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paszti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardardottir, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantosti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller-Premru, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson-Liljequist, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbarth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluytmans, J. A.</span><span> </span><span class="NLM_article-title">Livestock-associated methicillin-resistant <i>Staphylococcus aureus</i> in humans, Europe</span> <span class="citation_source-journal">Emerging Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span><span class="refDoi"> DOI: 10.3201/eid1703.101036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.3201%2Feid1703.101036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=21392444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A280%3ADC%252BC3MvkslyrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=502-505&author=B.+A.+Van+Cleefauthor=D.+L.+Monnetauthor=A.+Vossauthor=K.+Krziwanekauthor=F.+Allerbergerauthor=M.+Struelensauthor=H.+Zemlickovaauthor=R.+L.+Skovauthor=J.+Vuopio-Varkilaauthor=C.+Cunyauthor=A.+W.+Friedrichauthor=I.+Spiliopoulouauthor=J.+Pasztiauthor=H.+Hardardottirauthor=A.+Rossneyauthor=A.+Panauthor=A.+Pantostiauthor=M.+Borgauthor=H.+Grundmannauthor=M.+Mueller-Premruauthor=B.+Olsson-Liljequistauthor=A.+Widmerauthor=S.+Harbarthauthor=A.+Schweigerauthor=S.+Unalauthor=J.+A.+Kluytmans&title=Livestock-associated+methicillin-resistant+Staphylococcus+aureus+in+humans%2C+Europe&doi=10.3201%2Feid1703.101036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe</span></div><div class="casAuthors">van Cleef Brigitte A G L; Monnet Dominique L; Voss Andreas; Krziwanek Karina; Allerberger Franz; Struelens Marc; Zemlickova Helena; Skov Robert L; Vuopio-Varkila Jaana; Cuny Christiane; Friedrich Alexander W; Spiliopoulou Iris; Paszti Judit; Hardardottir Hjordis; Rossney Angela; Pan Angelo; Pantosti Annalisa; Borg Michael; Grundmann Hajo; Mueller-Premru Manica; Olsson-Liljequist Barbro; Widmer Andreas; Harbarth Stephan; Schweiger Alexander; Unal Serhat; Kluytmans Jan A J W</div><div class="citationInfo"><span class="NLM_cas:title">Emerging infectious diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">502-5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To estimate the proportion of methicillin-resistant Staphylococcus aureus (MRSA) isolates from humans that were sequence type (ST) 398, we surveyed 24 laboratories in 17 countries in Europe in 2007.  Livestock-associated MRSA ST398 accounted for only a small proportion of MRSA isolates from humans; most were from the Netherlands, Belgium, Denmark, and Austria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjctboFGiEHnwOGIfWJ7-GfW6udTcc2eb1A2xHflPT-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MvkslyrsQ%253D%253D&md5=fa02a6b1f75d33934f3cf975904bd54b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3201%2Feid1703.101036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3201%252Feid1703.101036%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BCleef%26aufirst%3DB.%2BA.%26aulast%3DMonnet%26aufirst%3DD.%2BL.%26aulast%3DVoss%26aufirst%3DA.%26aulast%3DKrziwanek%26aufirst%3DK.%26aulast%3DAllerberger%26aufirst%3DF.%26aulast%3DStruelens%26aufirst%3DM.%26aulast%3DZemlickova%26aufirst%3DH.%26aulast%3DSkov%26aufirst%3DR.%2BL.%26aulast%3DVuopio-Varkila%26aufirst%3DJ.%26aulast%3DCuny%26aufirst%3DC.%26aulast%3DFriedrich%26aufirst%3DA.%2BW.%26aulast%3DSpiliopoulou%26aufirst%3DI.%26aulast%3DPaszti%26aufirst%3DJ.%26aulast%3DHardardottir%26aufirst%3DH.%26aulast%3DRossney%26aufirst%3DA.%26aulast%3DPan%26aufirst%3DA.%26aulast%3DPantosti%26aufirst%3DA.%26aulast%3DBorg%26aufirst%3DM.%26aulast%3DGrundmann%26aufirst%3DH.%26aulast%3DMueller-Premru%26aufirst%3DM.%26aulast%3DOlsson-Liljequist%26aufirst%3DB.%26aulast%3DWidmer%26aufirst%3DA.%26aulast%3DHarbarth%26aufirst%3DS.%26aulast%3DSchweiger%26aufirst%3DA.%26aulast%3DUnal%26aufirst%3DS.%26aulast%3DKluytmans%26aufirst%3DJ.%2BA.%26atitle%3DLivestock-associated%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520in%2520humans%252C%2520Europe%26jtitle%3DEmerging%2520Infect.%2520Dis.%26date%3D2011%26volume%3D17%26spage%3D502%26epage%3D505%26doi%3D10.3201%2Feid1703.101036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Nicholson, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frana, T. S.</span><span> </span><span class="NLM_article-title">Livestock-associated methicillin-resistant <i>Staphylococcus aureus</i> (LA-MRSA) isolates of swine origin form robust biofilms</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e73376</span><span class="refDoi"> DOI: 10.1371/journal.pone.0073376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1371%2Fjournal.pone.0073376" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e73376&author=T.+L.+Nicholsonauthor=S.+M.+Shoreauthor=T.+C.+Smithauthor=T.+S.+Frana&title=Livestock-associated+methicillin-resistant+Staphylococcus+aureus+%28LA-MRSA%29+isolates+of+swine+origin+form+robust+biofilms&doi=10.1371%2Fjournal.pone.0073376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0073376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0073376%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DT.%2BL.%26aulast%3DShore%26aufirst%3DS.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BC.%26aulast%3DFrana%26aufirst%3DT.%2BS.%26atitle%3DLivestock-associated%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528LA-MRSA%2529%2520isolates%2520of%2520swine%2520origin%2520form%2520robust%2520biofilms%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De73376%26doi%3D10.1371%2Fjournal.pone.0073376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Barber, M.</span><span> </span><span class="NLM_article-title">Editorial</span> <span class="citation_source-journal">J. Clin. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">393</span><span class="refDoi"> DOI: 10.1136/jcp.14.4.385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1136%2Fjcp.14.4.385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=13686776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADyaF38Xps1Oq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1961&pages=385-393&author=M.+Barber&title=Editorial&doi=10.1136%2Fjcp.14.4.385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Methicillin-resistant staphylococci</span></div><div class="casAuthors">Barber, Mary</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pathology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">385-93</span>CODEN:
                <span class="NLM_cas:coden">JCPAAK</span>;
        ISSN:<span class="NLM_cas:issn">0021-9746</span>.
    </div><div class="casAbstract">After repeated passage on Celbenin (Methicillin) ditch plates, 18 strains of Staphylococcus aureus showed an increase in resistance to Celbenin; resistance was of the drug-tolerant type and Celbenin was not inactivated.  There was an assocd. increase in tolerance to benzylpenicillin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyNOtS6b7CebVg90H21EOLACvtfcHk0lghymBjXall9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF38Xps1Oq&md5=2001b633999fdd8b159f3ceee6277604</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1136%2Fjcp.14.4.385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.14.4.385%26sid%3Dliteratum%253Aachs%26aulast%3DBarber%26aufirst%3DM.%26atitle%3DEditorial%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D1961%26volume%3D14%26spage%3D385%26epage%3D393%26doi%3D10.1136%2Fjcp.14.4.385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span> <span class="citation_source-book">Antibiotic Resistance Threats in the United States</span>; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Antibiotic+Resistance+Threats+in+the+United+States%3B+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DAntibiotic%2520Resistance%2520Threats%2520in%2520the%2520United%2520States%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Rex, J. H.</span><span> </span><span class="NLM_article-title">ND4BB: addressing the antimicrobial resistance crisis</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1038/nrmicro3245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnrmicro3245" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVyrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=231-232&author=J.+H.+Rex&title=ND4BB%3A+addressing+the+antimicrobial+resistance+crisis&doi=10.1038%2Fnrmicro3245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">ND4BB: addressing the antimicrobial resistance crisis</span></div><div class="casAuthors">Rex, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The Innovative Medicines Initiative (IMI) recently launched its third public-private partnership, ENABLE (European Gram-neg. Antibacterial Engine), to tackle the shortage of effective antimicrobial agents for Gram-neg. pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXa_dkTisl6LVg90H21EOLACvtfcHk0likEcVYi93nNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVyrsb0%253D&md5=67453f4239e7f1c55762751a8a854efd</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro3245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro3245%26sid%3Dliteratum%253Aachs%26aulast%3DRex%26aufirst%3DJ.%2BH.%26atitle%3DND4BB%253A%2520addressing%2520the%2520antimicrobial%2520resistance%2520crisis%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2014%26volume%3D12%26spage%3D231%26epage%3D232%26doi%3D10.1038%2Fnrmicro3245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span> <span class="citation_source-book">National Action Plan for Combating Antibiotic-resistant Bacteria</span>; <span class="NLM_publisher-name">White House</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Action+Plan+for+Combating+Antibiotic-resistant+Bacteria%3B+White+House%3A+Washington%2C+DC%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DNational%2520Action%2520Plan%2520for%2520Combating%2520Antibiotic-resistant%2520Bacteria%26pub%3DWhite%2520House%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Appelbaum, P. C.</span><span> </span><span class="NLM_article-title">The emergence of vancomycin-intermediate and vancomycin-resistant <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Clin. Microbiol. Infect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span><span class="refDoi"> DOI: 10.1111/j.1469-0691.2006.01344.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1111%2Fj.1469-0691.2006.01344.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=16445720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFOrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=16-23&author=P.+C.+Appelbaum&title=The+emergence+of+vancomycin-intermediate+and+vancomycin-resistant+Staphylococcus+aureus&doi=10.1111%2Fj.1469-0691.2006.01344.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Appelbaum, P. C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology and Infection</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">16-23</span>CODEN:
                <span class="NLM_cas:coden">CMINFM</span>;
        ISSN:<span class="NLM_cas:issn">1198-743X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Methicillin-resistant Staphylococcus aureus (MRSA) is well-recognized as a major cause of infection in the healthcare setting but, even more worryingly, is now emerging in the community.  The glycopeptides - notably vancomycin - have traditionally been the mainstay of treatment of MRSA but overuse has led to the emergence of vancomycin-intermediate and vancomycin-resistant MRSA (VISA and VRSA, resp.).  Although the mechanisms underlying vancomycin resistance are not yet fully understood, changes to the bacterial cell wall - the site of action of the glycopeptides - are believed to be key.  Recent evidence also supports the transfer of genetic material among bacteria as contributing to the development of VRSA.  Based on the cases identified to date, risk factors for the development of VRSA may include older age, compromised blood flow to the lower limbs, and the presence of chronic ulcers.  The true extent of the problem, however, remains to be detd. - it is likely that many cases of VISA and VRSA infection go undetected because of suboptimal screening programs and possible limitations of automated and non-automated detection methods.  Effective screening directed at those patients considered to be most at risk should therefore be a priority.  Not surprisingly, the spread of MRSA from the hospital to the community setting, coupled with the emergence of VISA and VRSA, has become a major cause of concern among clinicians and microbiologists.  The treatment options available for these infections are now severely compromised and thus new classes of antimicrobial agents effective against MRSA, VISA and VRSA are urgently required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdTpzSqp0FNLVg90H21EOLACvtfcHk0lgBsospELmCJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFOrur0%253D&md5=e4cfd011e9834649da5733a4b8edc02e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2006.01344.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2006.01344.x%26sid%3Dliteratum%253Aachs%26aulast%3DAppelbaum%26aufirst%3DP.%2BC.%26atitle%3DThe%2520emergence%2520of%2520vancomycin-intermediate%2520and%2520vancomycin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2006%26volume%3D12%26spage%3D16%26epage%3D23%26doi%3D10.1111%2Fj.1469-0691.2006.01344.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Tsiodras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gold, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakoulas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliopoulos, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wennersten, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moellering, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraro, J.</span><span> </span><span class="NLM_article-title">Linezolid resistance in a clinical isolate of <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span><span class="refDoi"> DOI: 10.1016/S0140-6736(01)05410-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2FS0140-6736%2801%2905410-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=11476839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlymsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=207-208&author=S.+Tsiodrasauthor=H.+S.+Goldauthor=G.+Sakoulasauthor=G.+M.+Eliopoulosauthor=C.+Wennerstenauthor=L.+Venkataramanauthor=R.+C.+Moelleringauthor=J.+Ferraro&title=Linezolid+resistance+in+a+clinical+isolate+of+Staphylococcus+aureus&doi=10.1016%2FS0140-6736%2801%2905410-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid resistance in a clinical isolate of Staphylococcus aureus</span></div><div class="casAuthors">Tsiodras, S.; Gold, H. S.; Sakoulas, G.; Eliopoulos, G. M.; Wennersten, C.; Venkataraman, L.; Moellering, R. C.; Ferraro, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">9277</span>),
    <span class="NLM_cas:pages">207-208</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various Gram-pos. bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).  Although instances of linezolid resistance in VRE have been reported, resistance has not been encountered among clin. isolates of S aureus.  The authors have characterized an MRSA isolate resistant to linezolid that was recovered from a patient treated with this agent for dialysis-assocd. peritonitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRryTK5F9tc7Vg90H21EOLACvtfcHk0lgBsospELmCJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlymsr8%253D&md5=d8574bd50d0f1129cbc8d5dae0ac8127</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2801%2905410-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252801%252905410-1%26sid%3Dliteratum%253Aachs%26aulast%3DTsiodras%26aufirst%3DS.%26aulast%3DGold%26aufirst%3DH.%2BS.%26aulast%3DSakoulas%26aufirst%3DG.%26aulast%3DEliopoulos%26aufirst%3DG.%2BM.%26aulast%3DWennersten%26aufirst%3DC.%26aulast%3DVenkataraman%26aufirst%3DL.%26aulast%3DMoellering%26aufirst%3DR.%2BC.%26aulast%3DFerraro%26aufirst%3DJ.%26atitle%3DLinezolid%2520resistance%2520in%2520a%2520clinical%2520isolate%2520of%2520Staphylococcus%2520aureus%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D207%26epage%3D208%26doi%3D10.1016%2FS0140-6736%2801%2905410-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Prystowsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chosay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinabarger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millichap, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noskin, A. G.</span><span> </span><span class="NLM_article-title">Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2154</span><span class="NLM_x">–</span> <span class="NLM_lpage">2156</span><span class="refDoi"> DOI: 10.1128/AAC.45.7.2154-2156.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FAAC.45.7.2154-2156.2001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=2154-2156&author=J.+Prystowskyauthor=F.+Siddiquiauthor=J.+Chosayauthor=D.+L.+Shinabargerauthor=J.+Millichapauthor=L.+R.+Petersonauthor=A.+G.+Noskin&title=Resistance+to+linezolid%3A+characterization+of+mutations+in+rRNA+and+comparison+of+their+occurrences+in+vancomycin-resistant+enterococci&doi=10.1128%2FAAC.45.7.2154-2156.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.7.2154-2156.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.7.2154-2156.2001%26sid%3Dliteratum%253Aachs%26aulast%3DPrystowsky%26aufirst%3DJ.%26aulast%3DSiddiqui%26aufirst%3DF.%26aulast%3DChosay%26aufirst%3DJ.%26aulast%3DShinabarger%26aufirst%3DD.%2BL.%26aulast%3DMillichap%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DL.%2BR.%26aulast%3DNoskin%26aufirst%3DA.%2BG.%26atitle%3DResistance%2520to%2520linezolid%253A%2520characterization%2520of%2520mutations%2520in%2520rRNA%2520and%2520comparison%2520of%2520their%2520occurrences%2520in%2520vancomycin-resistant%2520enterococci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D2154%26epage%3D2156%26doi%3D10.1128%2FAAC.45.7.2154-2156.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Silverman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrew, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span> </span><span class="NLM_article-title">Resistance studies with daptomycin</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1799</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span><span class="refDoi"> DOI: 10.1128/AAC.45.6.1799-1802.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FAAC.45.6.1799-1802.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=11353628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslyqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2001&pages=1799-1802&author=J.+A.+Silvermanauthor=N.+Oliverauthor=T.+Andrewauthor=T.+Li&title=Resistance+studies+with+daptomycin&doi=10.1128%2FAAC.45.6.1799-1802.2001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Resistance studies with daptomycin</span></div><div class="casAuthors">Silverman, Jared A.; Oliver, Nicole; Andrew, Ted; Li, Tongchuan</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1799-1802</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The authors studied the in vitro emergence of resistance to daptomycin using 3 methods; spontaneous resistance incidence, serial passage in the presence of increasing drug concns., and chem. mutagenesis.  No spontaneously resistant mutants were obtained for any organism tested (<10-10 for Staphylococcus aureus, <10-9 for Staphylococcus epidermidis, <10-9 for Enterococcus faecalis, <10-9 for Enterococcus faecium, <10-8 for Streptococcus pneumoniae).  Population anal. demonstrated that bacterial susceptibility to daptomycin is heterogeneous.  Assay results were sensitive to Ca concn. and culture d., both of which can affect apparent resistance rates.  Stable S. aureus mutants were isolated by both serial passage in liq. media and chem. mutagenesis.  The daptomycin MICs for these isolates were 8- to 32-fold higher than for the parental strain.  Many mutants with high MICs (>12.5 μg/mL) had growth defects but did not display phenotypes typical of S. aureus small colony variants.  The voltage component (Δψ) of the bacterial membrane potential was increased in 3 independent resistant isolates.  In vivo data showed that some daptomycin-resistant mutants had lost virulence.  For other mutants, the degree of in vitro resistance was greater than the change in in vivo susceptibility.  These results suggest that infection with some daptomycin-resistant organisms may still be easily treatable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4J9V61A8j0rVg90H21EOLACvtfcHk0lgBsospELmCJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslyqsLc%253D&md5=37ec8b901b719a3d373b139a1de0901d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2FAAC.45.6.1799-1802.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.45.6.1799-1802.2001%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DJ.%2BA.%26aulast%3DOliver%26aufirst%3DN.%26aulast%3DAndrew%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DT.%26atitle%3DResistance%2520studies%2520with%2520daptomycin%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2001%26volume%3D45%26spage%3D1799%26epage%3D1802%26doi%3D10.1128%2FAAC.45.6.1799-1802.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sabol, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadena, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, J. H.</span><span> </span><span class="NLM_article-title">Emergence of daptomycin resistance in enterococcus faecium during daptomycin therapy</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1665</span><span class="refDoi"> DOI: 10.1128/AAC.49.4.1664-1665.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FAAC.49.4.1664-1665.2005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1664-1665&author=K.+Sabolauthor=J.+E.+Pattersonauthor=J.+S.+Lewisauthor=A.+Owensauthor=J.+Cadenaauthor=J.+H.+Jorgensen&title=Emergence+of+daptomycin+resistance+in+enterococcus+faecium+during+daptomycin+therapy&doi=10.1128%2FAAC.49.4.1664-1665.2005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.4.1664-1665.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.4.1664-1665.2005%26sid%3Dliteratum%253Aachs%26aulast%3DSabol%26aufirst%3DK.%26aulast%3DPatterson%26aufirst%3DJ.%2BE.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DOwens%26aufirst%3DA.%26aulast%3DCadena%26aufirst%3DJ.%26aulast%3DJorgensen%26aufirst%3DJ.%2BH.%26atitle%3DEmergence%2520of%2520daptomycin%2520resistance%2520in%2520enterococcus%2520faecium%2520during%2520daptomycin%2520therapy%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D1664%26epage%3D1665%26doi%3D10.1128%2FAAC.49.4.1664-1665.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mendes, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsakris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sader, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGhee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelbaum, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosowska-Shick, K.</span><span> </span><span class="NLM_article-title">Charaterization of methicillin-resistant <i>Staphylococcus aureus</i> displaying increased MICs of ceftaroline</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1324</span><span class="refDoi"> DOI: 10.1093/jac/dks069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1093%2Fjac%2Fdks069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=22398650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvF2qt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=1321-1324&author=R.+E.+Mendesauthor=A.+Tsakrisauthor=H.+S.+Saderauthor=R.+N.+Jonesauthor=D.+Biekauthor=P.+McGheeauthor=P.+C.+Appelbaumauthor=K.+Kosowska-Shick&title=Charaterization+of+methicillin-resistant+Staphylococcus+aureus+displaying+increased+MICs+of+ceftaroline&doi=10.1093%2Fjac%2Fdks069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline</span></div><div class="casAuthors">Mendes, Rodrigo E.; Tsakris, Athanassios; Sader, Helio S.; Jones, Ronald N.; Biek, Donald; McGhee, Pamela; Appelbaum, Peter C.; Kosowska-Shick, Klaudia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1321-1324</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The objective of this study was to characterize the mechanisms responsible for elevated MICs of ceftaroline for methicillin-resistant Staphylococcus aureus (MRSA).  During the 2008 Assessing Worldwide Antimicrobial Resistance Evaluation ( AWARE') surveillance program, four S. aureus collected from sep. patients in Athens, Greece, demonstrated ceftaroline MICs of 4 mg/L.  These isolates were clonally related and one strain (13101) was selected for further characterization.  Two strains (4981 and 4977) displaying ceftaroline MICs of 1 and 2 mg/L, resp., were included for comparison.  All strains originated from the same hospital.  Penicillin-binding protein (PBP) affinities for ceftaroline and comparators were detd.  Strains were typed by single-locus typing (i.e. spa typing), multilocus sequence typing ( MLST') and by multiple-locus variable-no. tandem repeat fingerprinting (MLVF).  The presence of Pantone-Valentine leucocidin and the staphylococcal cassette chromosome mec types was assessed.  The authors also performed nucleotide sequencing of the mecA (encoding PBP2a) promoter and ribosomal binding site (rbs) regions and mecR1.  Ceftaroline demonstrated the highest PBP2a affinity with strain 4981 (ST5-MRSA-II) (IC50 0.06 mg/L; MIC 1 mg/L).  Strains 4977 and 13101 (both ST239-MRSA-III) showed indistinguishable MLVF profiles.  Ceftaroline PBP2a binding affinity in strains 4977 (IC50 0.25 mg/L; MIC 2 mg/L) and 13101 (IC50 1 mg/L; MIC 4 mg/L) was 4- and 16-fold lower than 4981, resp.  Strain 4981 contains a wild-type PBP2a, while strains 4977 and 13101 have N146K and E150K alterations in the non-penicillin-binding domain.  Addnl., 13101 has one substitution (H351N) in the transpeptidase domain.  Alterations in the mecR1, mecA promoter or rbs regions were not obsd.  Thus, increased ceftaroline MICs were assocd. with decreased PBP2a binding affinity and reflected alterations in PBP2a.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKfKJDYcNUfLVg90H21EOLACvtfcHk0liTJqrmtBk8bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvF2qt7g%253D&md5=24f80a4d1cb592fd498d1aa09a7809f0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks069%26sid%3Dliteratum%253Aachs%26aulast%3DMendes%26aufirst%3DR.%2BE.%26aulast%3DTsakris%26aufirst%3DA.%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DJones%26aufirst%3DR.%2BN.%26aulast%3DBiek%26aufirst%3DD.%26aulast%3DMcGhee%26aufirst%3DP.%26aulast%3DAppelbaum%26aufirst%3DP.%2BC.%26aulast%3DKosowska-Shick%26aufirst%3DK.%26atitle%3DCharaterization%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520displaying%2520increased%2520MICs%2520of%2520ceftaroline%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D1321%26epage%3D1324%26doi%3D10.1093%2Fjac%2Fdks069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jameson-Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OttoWang, M.</span><span> </span><span class="NLM_article-title"><i>Staphylococcus</i> epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1510</span><span class="NLM_x">–</span> <span class="NLM_lpage">1514</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnm1656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=17994102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtl2gs7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1510-1514&author=R.+Wangauthor=B.+Khanauthor=G.+Cheungauthor=T.+Bachauthor=M.+Jameson-Leeauthor=K.+Kongauthor=S.+Queckauthor=M.+OttoWang&title=Staphylococcus+epidermidis+surfactant+peptides+promote+biofilm+maturation+and+dissemination+of+biofilm-associated+infection+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA</span></div><div class="casAuthors">Wang, Rong; Braughton, Kevin R.; Kretschmer, Dorothee; Bach, Thanh-Huy L.; Queck, Shu Y.; Li, Min; Kennedy, Adam D.; Dorward, David W.; Klebanoff, Seymour J.; Peschel, Andreas; DeLeo, Frank R.; Otto, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1510-1514</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Methicillin-resistant Staphylococcus aureus (MRSA) remains a major human pathogen.  Traditionally, MRSA infections occurred exclusively in hospitals and were limited to immunocompromised patients or individuals with predisposing risk factors.  However, recently there has been an alarming epidemic caused by community-assocd. (CA)-MRSA strains, which can cause severe infections that can result in necrotizing fasciitis or even death in otherwise healthy adults outside of healthcare settings.  In the US, CA-MRSA is now the cause of the majority of infections that result in trips to the emergency room.  It is unclear what makes CA-MRSA strains more successful in causing human disease compared with their hospital-assocd. counterparts.  Here we describe a class of secreted staphylococcal peptides that have a remarkable ability to recruit, activate and subsequently lyse human neutrophils, thus eliminating the main cellular defense against S. aureus infection.  These peptides are produced at high concns. by std. CA-MRSA strains and contribute significantly to the strains' ability to cause disease in animal models of infection.  Our study reveals a previously uncharacterized set of S. aureus virulence factors that account at least in part for the enhanced virulence of CA-MRSA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYAQsZnMB2cLVg90H21EOLACvtfcHk0lgAE5ZgLpIsTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtl2gs7fN&md5=0d0178f9f2e78c40f2686ca916f0f3e0</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1038%2Fnm1656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1656%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DKhan%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DG.%26aulast%3DBach%26aufirst%3DT.%26aulast%3DJameson-Lee%26aufirst%3DM.%26aulast%3DKong%26aufirst%3DK.%26aulast%3DQueck%26aufirst%3DS.%26aulast%3DOttoWang%26aufirst%3DM.%26atitle%3DStaphylococcus%2520epidermidis%2520surfactant%2520peptides%2520promote%2520biofilm%2520maturation%2520and%2520dissemination%2520of%2520biofilm-associated%2520infection%2520in%2520mice%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1510%26epage%3D1514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_contrib-group">Escaich, S.</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2008.06.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2Fj.cbpa.2008.06.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=18639647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2jsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Escaich%2C+S.Curr.+Opin.+Chem.+Biol.+2008%2C+12%2C+400%E2%80%93408+10.1016%2Fj.cbpa.2008.06.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Antivirulence as a new antibacterial approach for chemotherapy</span></div><div class="casAuthors">Escaich, Sonia</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">400-408</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Bacterial resistance to antibiotics is an issue that has led to the search for new antibacterial approaches.  Drugs targeting virulence is an alternative approach to treat infections due to resistant bacteria.  There is extensive literature and knowledge in the field of bacterial pathogenesis and genomic determinant of virulence.  As therapeutic targets, virulence factors have been primarily addressed in the vaccine field to prevent infection by specific pathogens.  Recently novel strategies to identify virulence inhibitors have been numerous and several new compds. were recently reported.  This review emphasizes the new virulence inhibitors that have shown a biol. activity and have made a proof of concept that disarming bacteria lead to the inhibition of bacterial infection in exptl. models in vivo.  Moreover, some of these new anti-virulence compds. are able to inhibit the virulence of different related pathogenic species, indicating that it is possible to target common virulence mechanisms.  The progress reported recently with proof of concept for anti-virulence mols. at the preclin. stages should allow the anti-virulence concept to become a reality as a new antibacterial approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJbkQsVpfmtrVg90H21EOLACvtfcHk0lgAE5ZgLpIsTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2jsrvI&md5=6563c3f594233a0960cb2de36309c657</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.06.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.06.022%26sid%3Dliteratum%253Aachs%26aulast%3DEscaich%26aufirst%3DS.%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D400%26epage%3D408%26doi%3D10.1016%2Fj.cbpa.2008.06.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Clauditz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Götz, F.</span><span> </span><span class="NLM_article-title">Staphyloxanthin plays a role in the fitness of <i>Staphylococcus aureus</i> and its ability to cope with oxidative stress</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">4950</span><span class="NLM_x">–</span> <span class="NLM_lpage">4953</span><span class="refDoi"> DOI: 10.1128/IAI.00204-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FIAI.00204-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=16861688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvFWqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2006&pages=4950-4953&author=A.+Clauditzauthor=A.+Reschauthor=K.+Wielandauthor=A.+Peschelauthor=F.+G%C3%B6tz&title=Staphyloxanthin+plays+a+role+in+the+fitness+of+Staphylococcus+aureus+and+its+ability+to+cope+with+oxidative+stress&doi=10.1128%2FIAI.00204-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress</span></div><div class="casAuthors">Clauditz, Alexandra; Resch, Alexandra; Wieland, Karsten-Peter; Peschel, Andreas; Goetz, Friedrich</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4950-4953</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Staphyloxanthin is a membrane-bound carotenoid of Staphylococcus aureus.  Here we studied the interaction of staphyloxanthin with reactive oxygen substances (ROS) and showed by comparative anal. of the wild type (WT) and an isogenic crtM mutant that the WT is more resistant to hydrogen peroxide, superoxide radical, hydroxyl radical, hypochlorite, and neutrophil killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIqSybpc3xXLVg90H21EOLACvtfcHk0lgAE5ZgLpIsTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvFWqt74%253D&md5=3a6cc24dd4e751718645378006170103</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FIAI.00204-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.00204-06%26sid%3Dliteratum%253Aachs%26aulast%3DClauditz%26aufirst%3DA.%26aulast%3DResch%26aufirst%3DA.%26aulast%3DWieland%26aufirst%3DK.%26aulast%3DPeschel%26aufirst%3DA.%26aulast%3DG%25C3%25B6tz%26aufirst%3DF.%26atitle%3DStaphyloxanthin%2520plays%2520a%2520role%2520in%2520the%2520fitness%2520of%2520Staphylococcus%2520aureus%2520and%2520its%2520ability%2520to%2520cope%2520with%2520oxidative%2520stress%26jtitle%3DInfect.%2520Immun.%26date%3D2006%26volume%3D74%26spage%3D4950%26epage%3D4953%26doi%3D10.1128%2FIAI.00204-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, L.</span><span> </span><span class="NLM_article-title">Small molecule targeting of a diapophytoene desaturase inhibits <i>S. aureus</i> virulence</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1038/nchembio.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnchembio.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=26780405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=174-179&author=F.+Chenauthor=H.+Diauthor=Y.+Wangauthor=Q.+Caoauthor=B.+Xuauthor=X.+Zhangauthor=N.+Yangauthor=G.+Liuauthor=C.+G.+Yangauthor=Y.+Xuauthor=H.+Jiangauthor=F.+Lianauthor=N.+Zhangauthor=J.+Liauthor=L.+Lan&title=Small+molecule+targeting+of+a+diapophytoene+desaturase+inhibits+S.+aureus+virulence&doi=10.1038%2Fnchembio.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence</span></div><div class="casAuthors">Chen, Feifei; Di, Hongxia; Wang, Youxin; Cao, Qiao; Xu, Bin; Zhang, Xue; Yang, Nana; Liu, Guijie; Yang, Cai-Guang; Xu, Yong; Jiang, Hualiang; Lian, Fulin; Zhang, Naixia; Li, Jian; Lan, Lefu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">174-179</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The surge of antibiotic resistance in Staphylococcus aureus has created a dire need for innovative anti-infective agents that attack new targets, to overcome resistance.  In S. aureus, carotenoid pigment is an important virulence factor because it shields the bacterium from host oxidant killing.  Here we show that naftifine, a US Food and Drug Administration (FDA)-approved antifungal drug, blocks biosynthesis of carotenoid pigment at nanomolar concns.  This effect is mediated by competitive inhibition of S. aureus diapophytoene desaturase (CrtN), an essential enzyme for carotenoid pigment synthesis.  We found that naftifine attenuated the virulence of a variety of clin. S. aureus isolates, including methicillin-resistant S. aureus (MRSA) strains, in mouse infection models.  Specifically, we detd. that naftifine is a lead compd. for potent CrtN inhibitors.  In sum, these findings reveal that naftifine could serve as a chem. probe to manipulate CrtN activity, providing proof of concept that CrtN is a druggable target against S. aureus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3544UnQ977LVg90H21EOLACvtfcHk0lg6A47NTWwXOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmslyjtw%253D%253D&md5=77be3d6b1b252ea24f011b711f348130</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2003%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DC.%2BG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLian%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLan%26aufirst%3DL.%26atitle%3DSmall%2520molecule%2520targeting%2520of%2520a%2520diapophytoene%2520desaturase%2520inhibits%2520S.%2520aureus%2520virulence%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D174%26epage%3D179%26doi%3D10.1038%2Fnchembio.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span> </span><span class="NLM_article-title">A cholesterol biosynthesis inhibitor blocks <i>Staphylococcus aureus</i> virulence</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">1391</span><span class="NLM_x">–</span> <span class="NLM_lpage">1394</span><span class="refDoi"> DOI: 10.1126/science.1153018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1126%2Fscience.1153018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=18276850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislSkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=1391-1394&author=C.+Liuauthor=G.+Liuauthor=Y.+Songauthor=F.+Yinauthor=M.+Henslerauthor=W.+Jengauthor=V.+Nizetauthor=A.+Wangauthor=E.+Oldfield&title=A+cholesterol+biosynthesis+inhibitor+blocks+Staphylococcus+aureus+virulence&doi=10.1126%2Fscience.1153018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence</span></div><div class="casAuthors">Liu, Chia-I.; Liu, George Y.; Song, Yongcheng; Yin, Fenglin; Hensler, Mary E.; Jeng, Wen-Yih; Nizet, Victor; Wang, Andrew H.-J.; Oldfield, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">5868</span>),
    <span class="NLM_cas:pages">1391-1394</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Staphylococcus aureus produces hospital- and community-acquired infections, with methicillin-resistant S. aureus posing a serious public health threat.  The golden carotenoid pigment of S. aureus, staphyloxanthin, promotes resistance to reactive oxygen species and host neutrophil-based killing, and early enzymic steps in staphyloxanthin prodn. resemble those for cholesterol biosynthesis.  The authors detd. the crystal structures of S. aureus dehydrosqualene synthase (CrtM) at 1.58 angstrom resoln., finding structural similarity to human squalene synthase (SQS).  They screened nine SQS inhibitors and detd. the structures of three, bound to CrtM.  One, previously tested for cholesterol-lowering activity in humans, blocked staphyloxanthin biosynthesis in vitro (median inhibitory concn. ∼100 nM), resulting in colorless bacteria with increased susceptibility to killing by human blood and to innate immune clearance in a mouse infection model.  This finding represents proof of principle for a virulence factor-based therapy against S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSU79aY2tk2LVg90H21EOLACvtfcHk0lg6A47NTWwXOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislSkt78%253D&md5=dc5cad808833e6fb2d0c5ef65dd21013</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1126%2Fscience.1153018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1153018%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DF.%26aulast%3DHensler%26aufirst%3DM.%26aulast%3DJeng%26aufirst%3DW.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DA%2520cholesterol%2520biosynthesis%2520inhibitor%2520blocks%2520Staphylococcus%2520aureus%2520virulence%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D1391%26epage%3D1394%26doi%3D10.1126%2Fscience.1153018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poveda, C. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukkamala, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacanowska, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nizet, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span> </span><span class="NLM_article-title">Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in <i>staphylococcus aureus</i></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1021/jm801023u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801023u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=976-988&author=Y.+Songauthor=F.+Linauthor=F.+Yinauthor=M.+Henslerauthor=C.+A.+R.+Povedaauthor=D.+Mukkamalaauthor=R.+Caoauthor=H.+Wangauthor=C.+Moritaauthor=D.+G.+Pacanowskaauthor=V.+Nizetauthor=E.+Oldfield&title=Phosphonosulfonates+are+potent%2C+selective+inhibitors+of+dehydrosqualene+synthase+and+staphyloxanthin+biosynthesis+in+staphylococcus+aureus&doi=10.1021%2Fjm801023u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm801023u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801023u%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DYin%26aufirst%3DF.%26aulast%3DHensler%26aufirst%3DM.%26aulast%3DPoveda%26aufirst%3DC.%2BA.%2BR.%26aulast%3DMukkamala%26aufirst%3DD.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DMorita%26aufirst%3DC.%26aulast%3DPacanowska%26aufirst%3DD.%2BG.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DPhosphonosulfonates%2520are%2520potent%252C%2520selective%2520inhibitors%2520of%2520dehydrosqualene%2520synthase%2520and%2520staphyloxanthin%2520biosynthesis%2520in%2520staphylococcus%2520aureus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D976%26epage%3D988%26doi%3D10.1021%2Fjm801023u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axelson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, E.</span><span> </span><span class="NLM_article-title">Head-to-head prenyl tranferases: anti-infective drug targets</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4367</span><span class="NLM_x">–</span> <span class="NLM_lpage">4372</span><span class="refDoi"> DOI: 10.1021/jm300208p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300208p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4367-4372&author=F.+Linauthor=Y.+Liuauthor=K.+Liauthor=R.+Caoauthor=W.+Zhuauthor=J.+Axelsonauthor=R.+Pangauthor=E.+Oldfield&title=Head-to-head+prenyl+tranferases%3A+anti-infective+drug+targets&doi=10.1021%2Fjm300208p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300208p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300208p%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DAxelson%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DR.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DHead-to-head%2520prenyl%2520tranferases%253A%2520anti-infective%2520drug%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4367%26epage%3D4372%26doi%3D10.1021%2Fjm300208p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Discovery of potent benzofuran-derived diapophytoene desaturase (CrtN) inhibitors with enhanced oral bioavailability for the treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) Infections</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3215</span><span class="NLM_x">–</span> <span class="NLM_lpage">3230</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01984</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFCisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3215-3230&author=Y.+Wangauthor=F.+Chenauthor=H.+Diauthor=Y.+Xuauthor=Q.+Xiaoauthor=X.+Wangauthor=H.+Weiauthor=Y.+Luauthor=L.+Zhangauthor=J.+Zhuauthor=C.+Shengauthor=L.+Lanauthor=J.+Li&title=Discovery+of+potent+benzofuran-derived+diapophytoene+desaturase+%28CrtN%29+inhibitors+with+enhanced+oral+bioavailability+for+the+treatment+of+methicillin-resistant+Staphylococcus+aureus+%28MRSA%29+Infections&doi=10.1021%2Facs.jmedchem.5b01984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections</span></div><div class="casAuthors">Wang, Youxin; Chen, Feifei; Di, Hongxia; Xu, Yong; Xiao, Qiang; Wang, Xuehai; Wei, Hanwen; Lu, Yanli; Zhang, Lingling; Zhu, Jin; Sheng, Chunquan; Lan, Lefu; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3215-3230</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Blocking the staphyloxanthin biosynthesis process has emerged as a new promising antivirulence strategy.  Previously, we first revealed that CrtN is a druggable target against infections caused by pigmented Staphylococcus aureus (S. aureus) and that naftifine was an effective CrtN inhibitor.  Here, we identify a new type of benzofuran-derived CrtN inhibitor with submicromolar IC50 values that is based on the naftifine scaffold.  The most potent analog, 5m, inhibits the pigment prodn. of S. aureus Newman and three MRSA strains, with IC50 values of 0.38-5.45 nM, without any impact on the survival of four strains (up to 200 μM).  Notably, compd. 5m (1 μM) could significantly sensitize four strains to immune clearance and could effectively attenuate the virulence of three strains in vivo.  Moreover, 5m was detd. to be a weak antifungal reagent (MIC > 16 μg/mL).  Combined with good oral bioavailability (F = 42.2%) and excellent safety profiles, these data demonstrate that 5m may be a good candidate for the treatment of MRSA infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqahz7Kq8Z-k7Vg90H21EOLACvtfcHk0litu39q0ejJ-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFCisLo%253D&md5=109908ff78289f118ced8c8883622f02</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01984%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DDi%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520potent%2520benzofuran-derived%2520diapophytoene%2520desaturase%2520%2528CrtN%2529%2520inhibitors%2520with%2520enhanced%2520oral%2520bioavailability%2520for%2520the%2520treatment%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520%2528MRSA%2529%2520Infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3215%26epage%3D3230%26doi%3D10.1021%2Facs.jmedchem.5b01984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">David, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daum, R. S.</span><span> </span><span class="NLM_article-title">Community-associated methicillin-resistant <i>Staphylococcus aureus</i>: epidemiology and clinical consequences of an emerging epidemic</span> <span class="citation_source-journal">Clin. Microbiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">616</span><span class="NLM_x">–</span> <span class="NLM_lpage">687</span><span class="refDoi"> DOI: 10.1128/CMR.00081-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1128%2FCMR.00081-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=20610826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFWgtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=616-687&author=M.+Z.+Davidauthor=R.+S.+Daum&title=Community-associated+methicillin-resistant+Staphylococcus+aureus%3A+epidemiology+and+clinical+consequences+of+an+emerging+epidemic&doi=10.1128%2FCMR.00081-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic</span></div><div class="casAuthors">David, Michael Z.; Daum, Robert S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">616-687</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review.  Staphylococcus aureus is an important cause of skin and soft-tissue infections (SSTIs), endovascular infections, pneumonia, septic arthritis, endocarditis, osteomyelitis, foreign-body infections, and sepsis.  Methicillin-resistant S. aureus (MRSA) isolates were once confined largely to hospitals, other health care environments, and patients frequenting these facilities.  Since the mid-1990s, however, there has been an explosion in the no. of MRSA infections reported in populations lacking risk factors for exposure to the health care system.  This increase in the incidence of MRSA infection has been assocd. with the recognition of new MRSA clones known as community-assocd. MRSA (CA-MRSA).  CA-MRSA strains differ from the older, health care-assocd. MRSA strains; they infect a different group of patients, they cause different clin. syndromes, they differ in antimicrobial susceptibility patterns, they spread rapidly among healthy people in the community, and they frequently cause infections in health care environments as well.  This review details what is known about the epidemiol. of CA-MRSA strains and the clin. spectrum of infectious syndromes assocd. with them that ranges from a commensal state to severe, overwhelming infection.  It also addresses the therapy of these infections and strategies for their prevention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdAu5V8JgWQrVg90H21EOLACvtfcHk0lhYzcLFR4zStA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFWgtLnN&md5=09da2efa326503462593abd5367dff30</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FCMR.00081-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00081-09%26sid%3Dliteratum%253Aachs%26aulast%3DDavid%26aufirst%3DM.%2BZ.%26aulast%3DDaum%26aufirst%3DR.%2BS.%26atitle%3DCommunity-associated%2520methicillin-resistant%2520Staphylococcus%2520aureus%253A%2520epidemiology%2520and%2520clinical%2520consequences%2520of%2520an%2520emerging%2520epidemic%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2010%26volume%3D23%26spage%3D616%26epage%3D687%26doi%3D10.1128%2FCMR.00081-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">de Matos, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Oliveira, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalcante, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iorio, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamon, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dos Santos, K. R.</span><span> </span><span class="NLM_article-title">Molecular markers of antimicrobial resistance in methicillin-resistant <i>staphylococcus aureus</i> SCCmec IV presenting different genetic backgrounds</span> <span class="citation_source-journal">Microb. Drug. Resist.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">700</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1089%2Fmdr.2015.0255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=700-706&author=P.+D.+de+Matosauthor=T.+L.+de+Oliveiraauthor=F.+S.+Cavalcanteauthor=D.+C.+Ferreiraauthor=N.+L.+Iorioauthor=E.+M.+Pereiraauthor=R.+C.+Chamonauthor=K.+R.+Dos+Santos&title=Molecular+markers+of+antimicrobial+resistance+in+methicillin-resistant+staphylococcus+aureus+SCCmec+IV+presenting+different+genetic+backgrounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1089%2Fmdr.2015.0255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fmdr.2015.0255%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMatos%26aufirst%3DP.%2BD.%26aulast%3Dde%2BOliveira%26aufirst%3DT.%2BL.%26aulast%3DCavalcante%26aufirst%3DF.%2BS.%26aulast%3DFerreira%26aufirst%3DD.%2BC.%26aulast%3DIorio%26aufirst%3DN.%2BL.%26aulast%3DPereira%26aufirst%3DE.%2BM.%26aulast%3DChamon%26aufirst%3DR.%2BC.%26aulast%3DDos%2BSantos%26aufirst%3DK.%2BR.%26atitle%3DMolecular%2520markers%2520of%2520antimicrobial%2520resistance%2520in%2520methicillin-resistant%2520staphylococcus%2520aureus%2520SCCmec%2520IV%2520presenting%2520different%2520genetic%2520backgrounds%26jtitle%3DMicrob.%2520Drug.%2520Resist.%26date%3D2016%26volume%3D5%26spage%3D700%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kuroda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuzawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oguchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanamori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumaru, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani-Ui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawano, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekimizu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yabuzaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanehisa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshino, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasawara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, K.</span><span> </span><span class="NLM_article-title">Whole genome sequencing of meticillin-resistant <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">1225</span><span class="NLM_x">–</span> <span class="NLM_lpage">1240</span><span class="refDoi"> DOI: 10.1016/S0140-6736(00)04403-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2FS0140-6736%2800%2904403-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=11418146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvVClur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=1225-1240&author=M.+Kurodaauthor=T.+Ohtaauthor=I.+Uchiyamaauthor=T.+Babaauthor=H.+Yuzawaauthor=I.+Kobayashiauthor=L.+Cuiauthor=A.+Oguchiauthor=K.-i.+Aokiauthor=Y.+Nagaiauthor=J.+Lianauthor=T.+Itoauthor=M.+Kanamoriauthor=H.+Matsumaruauthor=A.+Maruyamaauthor=H.+Murakamiauthor=A.+Hosoyamaauthor=Y.+Mizutani-Uiauthor=N.+Takahashiauthor=R.+Sawanoauthor=i.+Inoueauthor=C.+Kaitoauthor=K.+Sekimizuauthor=H.+Hirakawaauthor=S.+Kuharaauthor=S.+Gotoauthor=J.+Yabuzakiauthor=M.+Kanehisaauthor=A.+Yamashitaauthor=K.+Oshimaauthor=K.+Furuyaauthor=C.+Yoshinoauthor=T.+Shibaauthor=M.+Hattoriauthor=N.+Ogasawaraauthor=H.+Hayashiauthor=K.+Hiramatsu&title=Whole+genome+sequencing+of+meticillin-resistant+Staphylococcus+aureus&doi=10.1016%2FS0140-6736%2800%2904403-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Whole genome sequencing of meticillin-resistant Staphylococcus aureus</span></div><div class="casAuthors">Kuroda, Makoto; Ohta, Toshiko; Uchiyama, Ikuo; Baba, Tadashi; Yuzawa, Harumi; Kobayashi, Ichizo; Cui, Longzhu; Oguchi, Akio; Aoki, Ken-ichi; Nagai, Yoshimi; Lian, JianQi; Ito, Teruyo; Kanamori, Mutsumi; Matsumaru, Hiroyuki; Maruyama, Atsushi; Murakami, Hiroyuki; Hosoyama, Akira; Mizutani-Ui, Yoko; Takahashi, Noriko K.; Sawano, Toshihiko; Inoue, Ryu-ichi; Kaito, Chikara; Sekimizu, Kazuhisa; Hirakawa, Hideki; Kuhara, Satoru; Goto, Susumu; Yabuzaki, Junko; Kanehisa, Minoru; Yamashita, Atsushi; Oshima, Kenshiro; Furuya, Keiko; Yoshino, Chie; Shiba, Tadayoshi; Hattori, Masahira; Ogasawara, Naotake; Hayashi, Hideo; Hiramatsu, Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9264</span>),
    <span class="NLM_cas:pages">1225-1240</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">Staphylococcus aureus is one of the major causes of community-acquired and hospital-acquired infections.  It produces numerous toxins including superantigens that cause unique disease entities such as toxic-shock syndrome and staphylococcal scarlet fever, and has acquired resistance to practically all antibiotics.  Whole genome anal. is a necessary step towards future development of countermeasures against this organism.  Whole genome sequences of two related S aureus strains (N315 and Mu50) were detd. by shot-gun random sequencing.  N315 is a meticillin-resistant S aureus (MRSA) strain isolated in 1982, and Mu50 is an MRSA strain with vancomycin resistance isolated in 1997.  The open reading frames were identified by use of GAMBLER and GLIMMER programs, and annotation of each was done with a BLAST homol. search, motif anal., and protein localization prediction.  The Staphylococcus genome was composed of a complex mixt. of genes, many of which seem to have been acquired by lateral gene transfer.  Most of the antibiotic resistance genes were carried either by plasmids or by mobile genetic elements including a unique resistance island.  Three classes of new pathogenicity islands were identified in the genome: a toxic shock syndrome toxin island family, exotoxin islands, and enterotoxin islands.  In the latter two pathogenicity islands, clusters of exotoxin and enterotoxin genes were found closely linked with other gene clusters encoding putative pathogenic factors.  The anal. also identified 70 candidates for new virulence factors.  The remarkable ability of S aureus to acquire useful genes from various organisms was revealed through the observation of genome complexity and evidence of lateral gene transfer.  Repeated duplication of genes encoding superantigens explains why S aureus is capable of infecting humans of diverse genetic backgrounds, eliciting severe immune reactions.  Investigation of many newly identified gene products, including the 70 putative virulence factors, will greatly improve our understanding of the biol. of staphylococci and the processes of infectious diseases caused by S aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpU6n9OxpCX7Vg90H21EOLACvtfcHk0ljxKtPEqzYyPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvVClur0%253D&md5=3b46b4b35182e65e5794bd2e689b740b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2800%2904403-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252800%252904403-2%26sid%3Dliteratum%253Aachs%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DI.%26aulast%3DBaba%26aufirst%3DT.%26aulast%3DYuzawa%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DI.%26aulast%3DCui%26aufirst%3DL.%26aulast%3DOguchi%26aufirst%3DA.%26aulast%3DAoki%26aufirst%3DK.-i.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DLian%26aufirst%3DJ.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKanamori%26aufirst%3DM.%26aulast%3DMatsumaru%26aufirst%3DH.%26aulast%3DMaruyama%26aufirst%3DA.%26aulast%3DMurakami%26aufirst%3DH.%26aulast%3DHosoyama%26aufirst%3DA.%26aulast%3DMizutani-Ui%26aufirst%3DY.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DSawano%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3Di.%26aulast%3DKaito%26aufirst%3DC.%26aulast%3DSekimizu%26aufirst%3DK.%26aulast%3DHirakawa%26aufirst%3DH.%26aulast%3DKuhara%26aufirst%3DS.%26aulast%3DGoto%26aufirst%3DS.%26aulast%3DYabuzaki%26aufirst%3DJ.%26aulast%3DKanehisa%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DA.%26aulast%3DOshima%26aufirst%3DK.%26aulast%3DFuruya%26aufirst%3DK.%26aulast%3DYoshino%26aufirst%3DC.%26aulast%3DShiba%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DM.%26aulast%3DOgasawara%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DHiramatsu%26aufirst%3DK.%26atitle%3DWhole%2520genome%2520sequencing%2520of%2520meticillin-resistant%2520Staphylococcus%2520aureus%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D1225%26epage%3D1240%26doi%3D10.1016%2FS0140-6736%2800%2904403-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wilson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlesworth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walesby, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, M.</span><span> </span><span class="NLM_article-title">Linezolid resistance in clinical isolates of <i>Staphylococcus aureus</i></span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1093/jac/dkg104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1093%2Fjac%2Fdkg104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=12493812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BD38XpslOgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2003&pages=186-188&author=P.+Wilsonauthor=J.+Andrewsauthor=R.+Charlesworthauthor=R.+Walesbyauthor=M.+Singerauthor=D.+J.+Farrelauthor=M.+Robbins&title=Linezolid+resistance+in+clinical+isolates+of+Staphylococcus+aureus&doi=10.1093%2Fjac%2Fdkg104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Linezolid resistance in clinical isolates of Staphylococcus aureus</span></div><div class="casAuthors">Wilson, Peter; Andrews, J. A.; Charlesworth, R.; Walesby, R.; Singer, M.; Farrell, D. J.; Robbins, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">186-188</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A 52-yr-old man underwent thoracotomy and drainage of right-sided empyema and showed a second clin. infection due to a resistant methicillin-resistant Staphylococcus aureus (MRSA) that developed from a susceptible isolate during treatment.  Eleven isolates of MRSA from this patient were collected during his hospital stay and were tested in parallel by BSAC disk testing.  The linezolid-resistant isolate was first detected in a sample 20 days after linezolid treatment was over.  Phage typing of susceptible and resistant isolates showed them to be indistinguishable E-MRSA 15.  An isolate with an MIC for linezolid of 8 mg/L had a G2576T mutation in two of six alleles, but the mutation was in five of six alleles in an isolate with an MIC of 32 mg/L.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTjVV7YpQN7LVg90H21EOLACvtfcHk0ljxKtPEqzYyPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpslOgtL0%253D&md5=c90fd768194f976ffc8e5582eb6a8819</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkg104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkg104%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DAndrews%26aufirst%3DJ.%26aulast%3DCharlesworth%26aufirst%3DR.%26aulast%3DWalesby%26aufirst%3DR.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DFarrel%26aufirst%3DD.%2BJ.%26aulast%3DRobbins%26aufirst%3DM.%26atitle%3DLinezolid%2520resistance%2520in%2520clinical%2520isolates%2520of%2520Staphylococcus%2520aureus%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2003%26volume%3D51%26spage%3D186%26epage%3D188%26doi%3D10.1093%2Fjac%2Fdkg104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span> </span><span class="NLM_article-title">Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China</span> <span class="citation_source-journal">BMC Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1186/s12866-014-0292-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1186%2Fs12866-014-0292-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=25420718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Kgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=292-307&author=Y.+Tianauthor=T.+Liauthor=Y.+Zhuauthor=B.+Wangauthor=X.+Zouauthor=M.+Li&title=Mechanisms+of+linezolid+resistance+in+staphylococci+and+enterococci+isolated+from+two+teaching+hospitals+in+Shanghai%2C+China&doi=10.1186%2Fs12866-014-0292-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China</span></div><div class="casAuthors">Tian, Yueru; Li, Tianming; Zhu, Yuanjun; Wang, Bei; Zou, Xue; Li, Min</div><div class="citationInfo"><span class="NLM_cas:title">BMC Microbiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">292/1-292/27, 27 pp.</span>CODEN:
                <span class="NLM_cas:coden">BMMIBC</span>;
        ISSN:<span class="NLM_cas:issn">1471-2180</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Linezolid is one of the most effective treatments against Gram-pos. pathogens.  However, linezolid-resistant/intermediate strains have recently emerged worldwide.  The purpose of this study was to analyze the prevalence and resistance mechanisms of linezolid-resistant/intermediate staphylococci and enterococci in Shanghai, China.  Thirty-two linezolid-resistant/intermediate strains, including 14 Staphylococcus capitis, three Staphylococcus aureus, 14 Enterococcus faecalis and one Enterococcus faecium clin. isolates, were collected in this study which displayed linezolid MICs of 8 to 512 μg/mL, 8-32 μg/mL, 4-8 μg/mL and 4 μg/mL, resp.  All linezolid-resistant S. capitis isolates had a novel C2131T mutation and a G2603T mutation in the 23S rRNA region, and some had a C316T (Arg106Cys) substitution in protein L4 and/or harbored cfr.  Linezolid-resistant S. aureus isolates carried a C389G (Ala130Gly) substitution in protein L3, and/or harbored cfr.  The cfr gene was flanked by two copies of the IS256-like element, with a downstream orf1 gene.  Linezolid-resistant/intermediate enterococci lacked major resistance mechanisms.  The semi-quant. biofilm assay showed that 14 linezolid-resistant E. faecalis isolates produced a larger biofilm than linezolid-susceptible E. faecalis strains. (P < 0.0001, two-tailed t-test).  TEM showed the cell walls of linezolid-resistant/intermediate strains were thicker than linezolid-susceptible strains.  Thus, major resistance mechanisms, such as mutations in 23S rRNA and ribosomal proteins L3 and L4, along with cfr acquisition, played an important role in linezolid resistance.  Secondary resistance mechanisms, such as biofilm formation and cell wall thickness, should also be taken into account.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjD-V4j1nZl7Vg90H21EOLACvtfcHk0ljwbffE5FFgzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Kgt70%253D&md5=24c54d66de4344515f35d5c5c012d175</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1186%2Fs12866-014-0292-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12866-014-0292-5%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DZou%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520linezolid%2520resistance%2520in%2520staphylococci%2520and%2520enterococci%2520isolated%2520from%2520two%2520teaching%2520hospitals%2520in%2520Shanghai%252C%2520China%26jtitle%3DBMC%2520Microbiol.%26date%3D2014%26volume%3D14%26spage%3D292%26epage%3D307%26doi%3D10.1186%2Fs12866-014-0292-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villaruz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diep, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, Ml.</span><span> </span><span class="NLM_article-title">MRSA epidemic linked to a quickly spreading colonization and virulence determinant</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span><span class="refDoi"> DOI: 10.1038/nm.2692</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1038%2Fnm.2692" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=22522561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvVKlt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=816-819&author=M.+Liauthor=X.+Duauthor=E.+Villaruzauthor=A.+Diepauthor=D.+Wangauthor=Y.+Songauthor=Y.+Tianauthor=J.+Huauthor=F.+Yuauthor=Y.+Luauthor=Ml.+Otto&title=MRSA+epidemic+linked+to+a+quickly+spreading+colonization+and+virulence+determinant&doi=10.1038%2Fnm.2692"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">MRSA epidemic linked to a quickly spreading colonization and virulence determinant</span></div><div class="casAuthors">Li, Min; Du, Xin; Villaruz, Amer E.; Diep, Binh An; Wang, Decheng; Song, Yan; Tian, Yueru; Hu, Jinhui; Yu, Fangyou; Lu, Yuan; Otto, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">816-819</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mol. processes underlying epidemic waves of methicillin-resistant Staphylococcus aureus (MRSA) infection are poorly understood.  Although a major role has been attributed to the acquisition of virulence determinants by horizontal gene transfer, there are insufficient epidemiol. and functional data supporting that concept.  The authors report the spread of clones contg. a previously extremely rare mobile genetic element-encoded gene, sasX.  They demonstrate that sasX has a key role in MRSA colonization and pathogenesis, substantially enhancing nasal colonization, lung disease and abscess formation and promoting mechanisms of immune evasion.  Moreover, the authors obsd. the recent spread of sasX from sequence type 239 (ST239) to invasive clones belonging to other sequence types.  Thus, this study identifies sasX as a quickly spreading crucial determinant of MRSA pathogenic success and a promising target for therapeutic interference.  The results provide proof of principle that horizontal gene transfer of key virulence determinants drives MRSA epidemic waves.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppHNhvCumCTLVg90H21EOLACvtfcHk0ljwbffE5FFgzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvVKlt78%253D&md5=01b8b38ddfd81fcfc65b8e3f7153b54f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnm.2692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2692%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DVillaruz%26aufirst%3DE.%26aulast%3DDiep%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DOtto%26aufirst%3DMl.%26atitle%3DMRSA%2520epidemic%2520linked%2520to%2520a%2520quickly%2520spreading%2520colonization%2520and%2520virulence%2520determinant%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D816%26epage%3D819%26doi%3D10.1038%2Fnm.2692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, X.</span><span> </span><span class="NLM_article-title">First report of a sequence type 239 vancomycin-intermediate <i>Staphylococcus aureus</i> isolate in Mainland China</span> <span class="citation_source-journal">Diagn. Microbiol. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1016/j.diagmicrobio.2013.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=10.1016%2Fj.diagmicrobio.2013.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=23876353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCqs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2013&pages=64-68&author=X.+Zhangauthor=Q.+Huauthor=W.+Yuanauthor=W.+Shangauthor=H.+Chengauthor=J.+Yuanauthor=J.+Zhuauthor=Z.+Huauthor=S.+Liauthor=W.+Chenauthor=X.+Huauthor=X.+Rao&title=First+report+of+a+sequence+type+239+vancomycin-intermediate+Staphylococcus+aureus+isolate+in+Mainland+China&doi=10.1016%2Fj.diagmicrobio.2013.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">First report of a sequence type 239 vancomycin-intermediate Staphylococcus aureus isolate in Mainland China</span></div><div class="casAuthors">Zhang, Xia; Hu, Qiwen; Yuan, Wenchang; Shang, Weilong; Cheng, Hang; Yuan, Jizhen; Zhu, Junmin; Hu, Zhen; Li, Shu; Chen, Wei; Hu, Xiaomei; Rao, Xiancai</div><div class="citationInfo"><span class="NLM_cas:title">Diagnostic Microbiology and Infectious Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-68</span>CODEN:
                <span class="NLM_cas:coden">DMIDDZ</span>;
        ISSN:<span class="NLM_cas:issn">0732-8893</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen that causes a wide range of both hospital- and community-acquired infections.  The high prevalence of MRSA and the extensive use of vancomycin in Mainland China may lead to the emergence of vancomycin-intermediate S. aureus (VISA) isolates.  In this case, we report a VISA isolate from a 34-yr-old male patient with steam burn.  The isolate was detd. to be sequence type 239 staphylococcal cassette chromosome mec type III, the most prevalent MRSA clone in Mainland China.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI3w10l06J5LVg90H21EOLACvtfcHk0lgZIcebh7bCNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCqs7zJ&md5=caae96c840204893eb13c82f56e59c7d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.diagmicrobio.2013.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.diagmicrobio.2013.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DShang%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DRao%26aufirst%3DX.%26atitle%3DFirst%2520report%2520of%2520a%2520sequence%2520type%2520239%2520vancomycin-intermediate%2520Staphylococcus%2520aureus%2520isolate%2520in%2520Mainland%2520China%26jtitle%3DDiagn.%2520Microbiol.%2520Infect.%2520Dis.%26date%3D2013%26volume%3D77%26spage%3D64%26epage%3D68%26doi%3D10.1016%2Fj.diagmicrobio.2013.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i146"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01300">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27320"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01300">10.1021/acs.jmedchem.7b01300</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures and characterizations of derivatives, bacterial growth assays of <i>S. aureus</i> Newman and MRSA strains, the hERG inhibition assay, MIC values of derivatives against MRSA strains, pigment inhibition assay, CrtN enzyme inhibition assay, hydrogen peroxide killing and human whole blood killing, <i>S. aureus</i> systemic infection models, antifungal assay, cytochrome P450 inhibition assay, pharmacokinetic methods (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf">PDF</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_001.pdf">jm7b01300_si_001.pdf (252.19 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01300/suppl_file/jm7b01300_si_002.csv">jm7b01300_si_002.csv (6.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01300&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01300%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01300" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679984fdcd6e32d7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
